US20120227136A1 - Nucleotide sequences mediating male fertility and method of using same - Google Patents

Nucleotide sequences mediating male fertility and method of using same Download PDF

Info

Publication number
US20120227136A1
US20120227136A1 US13/470,618 US201213470618A US2012227136A1 US 20120227136 A1 US20120227136 A1 US 20120227136A1 US 201213470618 A US201213470618 A US 201213470618A US 2012227136 A1 US2012227136 A1 US 2012227136A1
Authority
US
United States
Prior art keywords
plant
male
gene
promoter
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/470,618
Inventor
Marc C. Albertsen
Tim Fox
Gary Huffman
Mary Trimnell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pioneer Hi Bred International Inc
Original Assignee
Pioneer Hi Bred International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/412,000 external-priority patent/US7151205B2/en
Priority claimed from US11/166,609 external-priority patent/US7517975B2/en
Application filed by Pioneer Hi Bred International Inc filed Critical Pioneer Hi Bred International Inc
Priority to US13/470,618 priority Critical patent/US20120227136A1/en
Publication of US20120227136A1 publication Critical patent/US20120227136A1/en
Priority to US14/136,988 priority patent/US20140123338A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289—Male sterility
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823—Reproductive tissue-specific promoters
    • C12N15/8231—Male-specific, e.g. anther, tapetum, pollen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis

Definitions

  • Field crops are bred through techniques that take advantage of the plant's method of pollination.
  • a plant is self-pollinating if pollen from one flower is transferred to the same or another flower of the same plant.
  • a plant is cross-pollinated if the pollen comes from a flower on a different plant.
  • Brassica In Brassica , the plant is normally self-sterile and can only be cross-pollinated. In self-pollinating species, such as soybeans and cotton, the male and female plants are anatomically juxtaposed. During natural pollination, the male reproductive organs of a given flower pollinate the female reproductive organs of the same flower.
  • Maize plants ( Zea mays L.) present a unique situation in that they can be bred by both self-pollination and cross-pollination techniques. Maize has male flowers, located on the tassel and female flowers, located on the ear, on the same plant. It can self or cross pollinate. Natural pollination occurs in maize when wind blows pollen from the tassels to the silks that protrude from the tops of the incipient ears.
  • a reliable method of controlling fertility in plants would offer the opportunity for improved plant breeding. This is especially true for development of maize hybrids, which relies upon some sort of male sterility system and where a female sterility system would reduce production costs.
  • a hybrid maize variety is the cross of two such inbred lines, each of which may have one or more desirable characteristics lacked by the other or which complement the other.
  • the new inbreds are crossed with other inbred lines and the hybrids from these crosses are evaluated to determine which have commercial potential.
  • the hybrid progeny of the first generation is designated F 1 .
  • F 1 hybrid In the development of hybrids only the F 1 hybrid plants are sought.
  • the F 1 hybrid is more vigorous than its inbred parents. This hybrid vigor, or heterosis, can be manifested in many ways, including increased vegetative growth and increased yield.
  • Hybrid maize seed can be produced by a male sterility system incorporating manual detasseling.
  • the male tassel is removed from the growing female inbred parent, which can be planted in various alternating row patterns with the male inbred parent. Consequently, providing that there is sufficient isolation from sources of foreign maize pollen, the ears of the female inbred will be fertilized only with pollen from the male inbred. The resulting seed is therefore hybrid (F 1 ) and will form hybrid plants.
  • the female inbred can be mechanically detasseled by machine.
  • Mechanical detasseling is approximately as reliable as hand detasseling, but is faster and less costly.
  • most detasseling machines produce more damage to the plants than hand detasseling.
  • no form of detasseling is presently entirely satisfactory and a need continues to exist for alternatives which further reduce production costs and to eliminate self-pollination of the female parent in the production of hybrid seed.
  • CMS cytoplasmic male-sterile
  • a male sterility plant trait is expressed by maintenance of a homozygous recessive condition. Difficulties arise in maintaining the homozygous condition, when a transgenic restoration gene must be used for maintenance. For example, a natural mutation in a gene critical to male sterility can impart a male sterility phenotype to plants when this mutant allele is in the homozygous state. This sterility can be restored when the non-mutant form of the gene is introduced into the plant. However, this form of restoration removes the desired homozygous recessive condition, restores full male fertility and prevents maintenance of pure male sterile maternal lines.
  • Such a gene can be used in a variety of systems to control male fertility including those described herein.
  • a male fertility gene has been identified in Arabidopsis thaliana and used to produce a male sterile plant. Aarts, et al., (1993) Nature, 363:715-717.
  • U.S. Pat. No. 5,478,369 discloses therein one such gene impacting male fertility.
  • the inventors provide novel DNA molecules and the amino acid sequence encoded that are critical to male fertility in plants. These can be used in any of the systems where control of fertility is useful, including those described above.
  • one object of the invention is to provide a nucleic acid sequence, the expression of which is critical to male fertility in plants.
  • Another object of the invention is to provide a DNA molecule encoding an amino acid sequence, the expression of which is critical to male fertility in plants.
  • Yet another object of the invention is to provide a promoter of such nucleotide sequence and its essential sequences.
  • a further object of the invention is to provide a method of using such DNA molecules to mediate male fertility in plants.
  • This invention relates to nucleic acid sequences, and, specifically, DNA molecules and the amino acid encoded by the DNA molecules, which are critical to male fertility.
  • a promoter of the DNA is identified, as well as its essential sequences. It also relates to use of such DNA molecules to mediate fertility in plants.
  • FIG. 1 is a locus map of the male fertility gene Ms26.
  • FIG. 2A is a Southern blot of the ms26-m2::Mu8 family hybridized with a Mu8 probe
  • FIG. 2B is a Southern blot of the ms26-m2::Mu8 family hybridized with a PstI fragment isolated from the ms26 clone.
  • FIG. 3 is a Northern Blot analysis gel hybridized with a PstI fragment isolated from the Ms26 gene.
  • FIG. 4A-4D is the sequence of Ms26 (The cDNA is SEQ ID NO: 1, the protein is SEQ ID NOS: 2 and 34).
  • FIG. 5A-5C is the genomic Ms26 sequence (also referred to as SEQ ID NO: 7).
  • FIG. 6A-6D is a comparison of the genomic Ms26 sequence (Residues 1051-1450, 1501-2100 and 2201-3326 of SEQ ID NO: 7) with the cDNA of Ms26 (SEQ ID NO: 1).
  • FIG. 7A is a Northern analysis gel showing expression in various plant tissues and FIG. 7B is a gel showing expression stages of microsporogenesis.
  • FIG. 8 is the full length promoter of Ms26 (SEQ ID NO: 5)
  • FIG. 9 is a bar graph showing luciferase activity after deletions of select regions of the Ms26 promoter.
  • FIG. 10 shows essential regions of the Ms26 promoter (SEQ ID NO: 6).
  • FIG. 11 is a bar graph showing luciferase activity after substitution by restriction site linker scanning of select small (9-10 bp) regions of the Ms26 essential promoter fragment.
  • FIGS. 12A and 12B is a comparison of the nucleotide sequence (SEQ ID NO: 3) from the Ms26 orthologue from a sorghum panicle and Ms26 maize cDNA (Residues 201-750 of SEQ ID NO: 1), and the sorghum protein sequence (SEQ ID NO: 4) and Ms26 maize protein (Residues 87-244 of SEQ ID NO: 2).
  • FIG. 13 is a representation of the mapping of the male sterility gene ms26.
  • FIG. 14 shows a sequence comparison of the region of excision of the ms26-ref allele (SEQ ID NO: 8) with wild-type Ms26 (SEQ ID NO: 9).
  • FIG. 15 shows the transposon sequence within ms26-ref (SEQ ID NO: 10).
  • FIG. 16A-16B shows the entire ms26-ref sequence (SEQ ID NO: 11).
  • FIG. 17A shows a translated protein sequence alignment between regions of the CYP704B1, a P450 gene (SEQ ID NO: 12) and Ms26 (SEQ ID NO: 13);
  • FIG. 17B shows the phylogenetic tree analysis of select P450 genes.
  • FIG. 18 demonstrates the heme binding domain frame shift, showing the translated sequence alignment of regions of the Ms26 cDNA (SEQ ID NOS: 14 and 28-29), the genomic regions of exon 5 in fertile plants (SEQ ID NOS: 15 and 30-31) and sterile plants (SEQ ID NOS: 16 and 32-33).
  • FIG. 19 shows the rice Ms26 cDNA (SEQ ID NO: 17) and protein (SEQ ID NO: 18).
  • FIG. 20 shows alignment of the Ms26 promoter of corn (Residues 650-1091 of SEQ ID NO: 5), sorghum (SEQ ID NO: 19) and rice (SEQ ID NO: 20).
  • FIG. 21 shows alignment of the maize Ms26 protein (SEQ ID NO: 21); rice Ms26 protein (SEQ ID NO: 18) and sorghum Ms26 protein (SEQ ID NO: 22) along with a consensus sequence.
  • FIG. 22 is a plasmid map of PHP 18091, containing Ms45 fertility gene with a pollen promoter, cytotoxic gene and selectable marker.
  • FIG. 23 is a plasmid map of PHP 24101, containing the Ms26 fertility gene with a pollen promoter, cytotoxic gene and selectable marker.
  • FIG. 24 shows a sequence of the Zea mays ⁇ -amylase 1 coding region (SEQ ID NOS: 26 (DNA) and 36 (protein)).
  • male sterility results from a mutation, suppression or other impact to one of the genes critical to a specific step in microsporogenesis, the term applied to the entire process of pollen formulation. These genes can be collectively referred to as male fertility genes (or, alternatively, male sterility genes). There are many steps in the overall pathway where gene function impacts fertility. This seems aptly supported by the frequency of genetic male sterility in maize. New alleles of male sterility mutants are uncovered in materials that range from elite inbreds to unadapted populations.
  • genes that have been discovered subsequently that are critical to male fertility are numerous and include the Arabidopsis ABORTED MICROSPORES (AMS) gene, Sorensen, et al., (2003) The Plant Journal 33(2):413-423); the Arabidopsis MS1 gene (Wilson, et al., (2001) The Plant Journal 39(2):170-181); the NEF1 gene (Ariizumi, et al., (2004) The Plant Journal 39(2):170-181); Arabidopsis AtGPAT1 gene (Zheng, et al., (2003) The Plant Cell 15:1872-1887); the Arabdiopsis dde2-2 mutation was shown to be defective in the allene oxide syntase gene (Malek, et al., (2002) Planta 216:187-192); the Arabidopsis faceless pollen-1 gene (flp1) (Ariizumi, et al., (2003) Plant Mol.
  • AMS Arabidopsis ABORTED
  • the table below lists a number of known male fertility mutants or genes from Zea mays .
  • MNL 59 87 ms25 male sterile25 ms*-6065, ms*-6057, ms25, Loukides, C A; Broadwater, male sterile25, ms*-6022 A H; Bedinger, P A. 1995.
  • Am J Bot 82 1017-1023 ms27 male sterile27 ms27, male sterile27 Albertsen, M C. 1996.
  • MNL 70 30-31 ms28 male sterile28 ms28, male sterile28 Golubovskaya, I N. 1979.
  • MNL 53 66-70 ms29 male sterile29 male sterile29, ms*-JH84A, Trimnell, M R et al. 1998.
  • MNL ms29 72 37-38 ms3 male sterile3 Group 3, ms3, male sterile3 Eyster, W H. 1931.
  • J Hered 22 99-102 ms30 male sterile30 ms30, msx, ms*-6028, ms*- Albertsen, M C et al. 1999.
  • Li89, male sterile30, ms*-LI89 MNL 73 48 ms31 male sterile31 ms*-CG889D, ms31, male Trimnell, M R et al. 1998.
  • MNL sterile31 72 38 ms32 male sterile32 male sterile32, ms32 Trimnell, M R et al. 1999.
  • MNL 73 48-49 ms33 male sterile33 : ms*-6054, ms*-6024, ms33, Patterson, E B. 1995.
  • MNL 6055, ms*-6026 76 39 ms7 male sterile7 ms7, male sterile7 Beadle, G W. 1932. Genetics 17: 413-431 ms8 male sterile8 male sterile8, ms8 Beadle, G W. 1932. Genetics 17: 413-431 ms9 male sterile9 Group 5, male sterile9, ms9 Beadle, G W. 1932. Genetics 17: 413-431 ms49 male sterile49 ms*-MB92, ms49, male Trimnell, M et al. 2002. MNL sterile49 76: 38-39
  • the invention includes using the sequences shown herein to impact male fertility in a plant, that is, to control male fertility by manipulation of the genome using the genes of the invention.
  • any of the methods described infra can be used with the sequence of the invention such as introducing a mutant sequence into a plant to cause sterility, causing mutation to the native sequence, introducing an antisense of the sequence into the plant, use of hairpin formations, linking it with other sequences to control its expression or any one of a myriad of processes available to one skilled in the art to impact male fertility in a plant.
  • the Ms26 gene described herein is located on maize chromosome 1 and its dominant allele is critical to male fertility.
  • the locus map is represented at FIG. 1 . It can be used in the systems described above, and other systems impacting male fertility.
  • the maize family cosegregating for sterility was named ms*-SBMu200 and was found to have an approximately 5.5 Kb EcoRI fragment that hybridized with a Mu8 probe ( FIG. 2A ).
  • a genomic clone from the family was isolated which contained a Mu8 transposon.
  • a probe made from DNA bordering the transposon was found to hybridize to the same ⁇ 5.5 Kb EcoRI fragment ( FIG. 2B ).
  • This probe was used to isolate cDNA clones from a tassel cDNA library. The cDNA is 1906 bp, and the Mu insertion occurred in exon 1 of the gene. This probe was also used to map the mutation in an RFLP mapping population.
  • the mutant mapped to the short arm of chromosome 1, near Ms26. Allelism crosses between ms26-ref and ms*-SBMu200 showed that these were allelic, indicating that the mutations occurred in the same gene.
  • the ms*-SBMu200 allele was renamed ms26-m2::Mu8. Two additional alleles for the Ms26 gene were cloned, one containing a Mutator element in the second exon, named ms26-m3::Mu* and one containing an unknown transposon in the fifth exon from the ms26-ref allele.
  • FIG. 5 represents the genomic nucleotide sequence. Expression patterns, as determined by Northern analysis, show tassel specificity with peak expression at about the quartet to quartet release stages of microsporogenesis.
  • sequences of the invention may be isolated from any plant, including, but not limited to corn ( Zea mays ), canola ( Brassica napus, Brassica rapa ssp.), alfalfa ( Medicago sativa ), rice ( Oryza sativa ), rye ( Secale cereale ), sorghum ( Sorghum bicolor, Sorghum vulgare ), sunflower ( Helianthus annuus ), wheat ( Triticum aestivum ), soybean ( Glycine max ), tobacco ( Nicotiana tabacum ), millet ( Panicum spp.), potato ( Solanum tuberosum ), peanuts ( Arachis hypogaea ), cotton ( Gossypium hirsutum ), sweet potato ( Ipomoea batatus ), cassava ( Manihot esculenta ), coffee ( Cofea spp.), coconut ( Cocos nucifera ), pineapple ( Ananas comosus ), citrus trees
  • Sequences from other plants may be isolated according to well-known techniques based on their sequence homology to the homologous coding region of the coding sequences set forth herein. In these techniques, all or part of the known coding sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e. genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences.
  • the invention also includes those nucleotide sequences which selectively hybridize to the Ms26 nucleotide sequences under stringent conditions.
  • sequence that “selectively hybridizes” with Ms26 the term includes reference to hybridization, under stringent hybridization conditions, of a nucleic acid sequence to the specified nucleic acid target sequence to a detectably greater degree than its hybridization to non-target nucleic acid.
  • stringent conditions or “stringent hybridization conditions” includes reference to conditions under which a probe will hybridize to its target sequence, to a detectably greater degree than to other sequences.
  • Stringent conditions are target-sequence-dependent and will differ depending on the structure of the polynucleotide.
  • target sequences can be identified which are 100% complementary to a probe (homologous probing).
  • stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing).
  • probes of this type are in a range of about 1000 nucleotides in length to about 250 nucleotides in length.
  • sequences that correspond to the nucleotide sequences of the present invention and hybridize to the nucleotide sequence disclosed herein will be at least 50% homologous, 70% homologous, and even 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence. That is, the sequence similarity between probe and target may range, sharing at least about 50%, about 70% and even about 85% or more sequence similarity.
  • stringent wash temperature conditions are selected to be about 5° C. to about 2° C. lower than the melting point (Tm) for the specific sequence at a defined ionic strength and pH.
  • Tm melting point
  • the melting point, or denaturation, of DNA occurs over a narrow temperature range and represents the disruption of the double helix into its complementary single strands. The process is described by the temperature of the midpoint of transition, Tm, which is also called the melting temperature. Formulas are available in the art for the determination of melting temperatures.
  • Preferred hybridization conditions for the nucleotide sequence of the invention include hybridization at 42° C. in 50% (w/v) formamide, 6 ⁇ SSC, 0.5% (w/v) SDS, 100(g/ml salmon sperm DNA.
  • Exemplary low stringency washing conditions include hybridization at 42° C. in a solution of 2 ⁇ SSC, 0.5% (w/v) SDS for 30 minutes and repeating.
  • Exemplary moderate stringency conditions include a wash in 2 ⁇ SSC, 0.5% (w/v) SDS at 50° C. for 30 minutes and repeating.
  • Exemplary high stringency conditions include a wash in 0.1 ⁇ SSC, 0.1% (w/v) SDS, at 65° C. for 30 minutes to one hour and repeating. Sequences that correspond to the promoter of the present invention may be obtained using all the above conditions. For purposes of defining the invention, the high stringency conditions are used.
  • sequence relationships between two or more nucleic acids or polynucleotides are used to describe the sequence relationships between two or more nucleic acids or polynucleotides: (a) “reference sequence”, (b) “comparison window”, (c) “sequence identity” and (d) “percentage of sequence identity.”
  • reference sequence is a defined sequence used as a basis for sequence comparison.
  • a reference sequence may be a subset or the entirety of a specified sequence; for example, as a segment of a full-length cDNA or gene sequence or the complete cDNA or gene sequence.
  • comparison window makes reference to a contiguous and specified segment of a polynucleotide sequence, wherein the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences.
  • the comparison window is at least 20 contiguous nucleotides in length, and optionally can be 30, 40, 50 or 100 nucleotides in length or longer.
  • Computer implementations of these mathematical algorithms can be utilized for comparison of sequences to determine sequence identity. Such implementations include, but are not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics, Mountain View, Calif.); the ALIGN program (Version 2.0) and GAP, BESTFIT, BLAST, FASTA and TFASTA in the GCG Wisconsin Genetics Software Package, Version 10 (available from Accelrys Inc., 9685 Scranton Road, San Diego, Calif., USA). Alignments using these programs can be performed using the default parameters.
  • the CLUSTAL program is well described by Higgins, et al., (1988) Gene 73:237-244 (1988); Higgins, et al., (1989) CABIOS 5:151-153; Corpet, et al., (1988) Nucleic Acids Res. 16:10881-90; Huang, et al., (1992) CABIOS 8:155-65 and Pearson, et al., (1994) Meth. Mol. Biol. 24:307-331.
  • the ALIGN program is based on the algorithm of Myers and Miller, (1988) supra. A PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4 can be used with the ALIGN program when comparing amino acid sequences.
  • Gapped BLAST in BLAST 2.0
  • PSI-BLAST in BLAST 2.0
  • the default parameters of the respective programs e.g., BLASTN for nucleotide sequences, BLASTX for proteins
  • Alignment may also be performed manually by inspection.
  • sequence identity/similarity values provided herein refer to the value obtained using GAP Version 10 using the following parameters: % identity and % similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3 and the nwsgapdna.cmp scoring matrix; % identity and % similarity for an amino acid sequence using GAP Weight of 8 and Length Weight of 2 and the BLOSUM62 scoring matrix or any equivalent program thereof.
  • equivalent program is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by GAP Version 10.
  • GAP uses the algorithm of Needleman and Wunsch, (1970) J. Mol. Biol. 48:443-453, to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. GAP considers all possible alignments and gap positions and creates the alignment with the largest number of matched bases and the fewest gaps. It allows for the provision of a gap creation penalty and a gap extension penalty in units of matched bases. GAP must make a profit of gap creation penalty number of matches for each gap it inserts. If a gap extension penalty greater than zero is chosen, GAP must, in addition, make a profit for each gap inserted of the length of the gap times the gap extension penalty.
  • gap creation penalty values and gap extension penalty values in Version 10 of the GCG Wisconsin Genetics Software Package for protein sequences are 8 and 2, respectively.
  • the default gap creation penalty is 50 while the default gap extension penalty is 3.
  • the gap creation and gap extension penalties can be expressed as an integer selected from the group of integers consisting of from 0 to 200.
  • the gap creation and gap extension penalties can be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65 or greater.
  • GAP presents one member of the family of best alignments. There may be many members of this family, but no other member has a better quality. GAP displays four figures of merit for alignments: Quality, Ratio, Identity and Similarity.
  • the Quality is the metric maximized in order to align the sequences. Ratio is the quality divided by the number of bases in the shorter segment.
  • Percent Identity is the percent of the symbols that actually match.
  • Percent Similarity is the percent of the symbols that are similar. Symbols that are across from gaps are ignored.
  • a similarity is scored when the scoring matrix value for a pair of symbols is greater than or equal to 0.50, the similarity threshold.
  • the scoring matrix used in Version 10 of the GCG Wisconsin Genetics Software Package is BLOSUM62 (see, Henikoff and Henikoff, (1989) Proc. Natl. Acad. Sci. USA 89:10915).
  • sequence identity or “identity” in the context of two nucleic acid or polypeptide sequences makes reference to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window.
  • percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule.
  • sequences differ in conservative substitutions the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution.
  • Sequences that differ by such conservative substitutions are said to have “sequence similarity” or “similarity”. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated, e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif.).
  • percentage of sequence identity means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
  • polynucleotide is not intended to limit the present invention to polynucleotides comprising DNA.
  • polynucleotides can comprise ribonucleotides and combinations of ribonucleotides and deoxyribonucleotides. Such deoxyribonucleotides and ribonucleotides include both naturally occurring molecules and synthetic analogues.
  • the polynucleotides of the invention also encompass all forms of sequences including, but not limited to, single-stranded forms, double-stranded forms, hairpins, stem-and-loop structures and the like.
  • Identity to the sequence of the present invention would mean a polynucleotide sequence having at least 65% sequence identity, more preferably at least 70% sequence identity, more preferably at least 75% sequence identity, more preferably at least 80% identity, more preferably at least 85% A 88%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity.
  • Promoter regions can be readily identified by one skilled in the art.
  • the putative start codon containing the ATG motif is identified and upstream from the start codon is the presumptive promoter.
  • promoter is intended a regulatory region of DNA usually comprising a TATA box capable of directing RNA polymerase II to initiate RNA synthesis at the appropriate transcription initiation site for a particular coding sequence.
  • a promoter can additionally comprise other recognition sequences generally positioned upstream or 5′ to the TATA box, referred to as upstream promoter elements, which influence the transcription initiation rate.
  • the promoter region disclosed herein is generally further defined by comprising upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like.
  • upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like.
  • core promoter is meant the minimal sequence required to initiate transcription, such as the sequence called the TATA box which is common to promoters in genes encoding proteins.
  • the upstream promoter of Ms26 can optionally be used in conjunction with its own or core promoters from other sources.
  • the promoter may be native or non-native to the cell in which it is found.
  • the isolated promoter sequence of the present invention can be modified to provide for a range of expression levels of the heterologous nucleotide sequence. Less than the entire promoter region can be utilized and the ability to drive anther-preferred expression retained. However, it is recognized that expression levels of mRNA can be decreased with deletions of portions of the promoter sequence. Thus, the promoter can be modified to be a weak or strong promoter. Generally, by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended levels of about 1/10,000 transcripts to about 1/100,000 transcripts to about 1/500,000 transcripts.
  • a strong promoter drives expression of a coding sequence at a high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts. Generally, at least about 30 nucleotides of an isolated promoter sequence will be used to drive expression of a nucleotide sequence. It is recognized that to increase transcription levels, enhancers can be utilized in combination with the promoter regions of the invention. Enhancers are nucleotide sequences that act to increase the expression of a promoter region. Enhancers are known in the art and include the SV40 enhancer region, the 35S enhancer element, and the like.
  • the promoter of the present invention can be isolated from the 5′ region of its native coding region of 5′ untranslation region (5′UTR). Likewise the terminator can be isolated from the 3′ region flanking its respective stop codon.
  • isolated refers to material such as a nucleic acid or protein which is substantially or essentially free from components which normally accompany or interact with the material as found in it naturally occurring environment or if the material is in its natural environment, the material has been altered by deliberate human intervention to a composition and/or placed at a locus in a cell other than the locus native to the material. Methods for isolation of promoter regions are well known in the art.
  • Functional variants include, for example, the native regulatory sequences of the invention having one or more nucleotide substitutions, deletions or insertions. Functional variants of the invention may be created by site-directed mutagenesis, induced mutation or may occur as allelic variants (polymorphisms).
  • a “functional fragment” of the regulatory sequence is a nucleotide sequence that is a regulatory sequence variant formed by one or more deletions from a larger sequence.
  • the 5′ portion of a promoter up to the TATA box near the transcription start site can be deleted without abolishing promoter activity, as described by Opsahl-Sorteberg, et al., (2004) Gene 341:49-58.
  • Such variants should retain promoter activity, particularly the ability to drive expression in male tissues. Activity can be measured by Northern blot analysis, reporter activity measurements when using transcriptional fusions, and the like. See, for example, Sambrook, et al., (1989) Molecular Cloning: A Laboratory Manual (2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.), herein incorporated by reference.
  • Functional fragments can be obtained by use of restriction enzymes to cleave the naturally occurring regulatory element nucleotide sequences disclosed herein; by synthesizing a nucleotide sequence from the naturally occurring DNA sequence; or can be obtained through the use of PCR technology See particularly, Mullis, et al., (1987) Methods Enzymol. 155:335-350 and Erlich, ed. (1989) PCR Technology (Stockton Press, New York).
  • Sequences which hybridize to the regulatory sequences of the present invention are within the scope of the invention. Sequences that correspond to the promoter sequences of the present invention and hybridize to the promoter sequences disclosed herein will be at least 50% homologous, 70% homologous, and even 85% 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence.
  • Smaller fragments may yet contain the regulatory properties of the promoter so identified and deletion analysis is one method of identifying essential regions.
  • Deletion analysis can occur from both the 5′ and 3′ ends of the regulatory region. Fragments can be obtained by site-directed mutagenesis, mutagenesis using the polymerase chain reaction and the like. (See, Directed Mutagenesis: A Practical Approach IRL Press (1991)).
  • the 3′ deletions can delineate the essential region and identify the 3′ end so that this region may then be operably linked to a core promoter of choice.
  • transcription of an exogenous gene may be controlled by the essential region plus a core promoter.
  • core promoter is meant the sequence called the TATA box which is common to promoters in all genes encoding proteins.
  • the upstream promoter of Ms26 can optionally be used in conjunction with its own or core promoters from other sources.
  • the promoter may be native or non-native to the cell in which it is found.
  • the core promoter can be any one of known core promoters such as the Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), ubiquitin promoter (U.S. Pat. No. 5,510,474) the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al., “Vectors for Plant Transformation” Methods in Plant Molecular Biology and Biotechnology ) et al. eds, CRC Press pp. 89-119 (1993)).
  • core promoters such as the Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), ubiquitin promoter (U.S. Pat. No. 5,510,474) the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Figwort Mosaic Virus promoter (G
  • the regulatory region of Ms26 has been identified as including the 1005 bp region upstream of the putative TATA box. See, FIG. 8 . Further, using the procedures outlined above, it has been determined that an essential region of the promoter includes the ⁇ 180 bp upstream of the TATA box and specifically, the ⁇ 176 to ⁇ 44 region is particularly essential.
  • Promoter sequences from other plants may be isolated according to well-known techniques based on their sequence homology to the promoter sequence set forth herein. In these techniques, all or part of the known promoter sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e., genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences.
  • the entire promoter sequence or portions thereof can be used as a probe capable of specifically hybridizing to corresponding promoter sequences.
  • probes include sequences that are unique and are preferably at least about 10 nucleotides in length and most preferably at least about 20 nucleotides in length.
  • Such probes can be used to amplify corresponding promoter sequences from a chosen organism by the well-known process of polymerase chain reaction (PCR). This technique can be used to isolate additional promoter sequences from a desired organism or as a diagnostic assay to determine the presence of the promoter sequence in an organism. Examples include hybridization screening of plated DNA libraries (either plaques or colonies; see, e.g., Innis, et al., eds., (1990) PCR Protocols, A Guide to Methods and Applications , Academic Press).
  • a promoter of the present invention can be linked with nucleotide sequences other than the Ms26 gene to express other heterologous nucleotide sequences.
  • the nucleotide sequence for the promoter of the invention, as well as fragments and variants thereof, can be provided in expression cassettes along with heterologous nucleotide sequences for expression in the plant of interest, more particularly in the male tissue of the plant.
  • Such an expression cassette is provided with a plurality of restriction sites for insertion of the nucleotide sequence to be under the transcriptional regulation of the promoter.
  • nucleotide sequences which can be used as the exogenous gene of the expression vector with the Ms26 promoter, or other promoters taught herein or known to those of skill in the art or other promoters taught herein or known to those of skill in the art complementary nucleotidic units such as antisense molecules (callase antisense RNA, barnase antisense RNA and chalcone synthase antisense RNA, Ms45 antisense RNA), ribozymes and external guide sequences, an aptamer or single stranded nucleotides.
  • antisense molecules callase antisense RNA, barnase antisense RNA and chalcone synthase antisense RNA, Ms45 antisense RNA
  • ribozymes and external guide sequences
  • external guide sequences an aptamer or single stranded nucleotides.
  • exogenous nucleotide sequence can also encode carbohydrate degrading or modifying enzymes, amylases, debranching enzymes and pectinases, such as the alpha amylase gene of FIG. 24 , auxins, rol B, cytotoxins, diptheria toxin, DAM methylase, avidin or may be selected from a prokaryotic regulatory system.
  • the rolB gene of Agrobacterium rhizogenes codes for an enzyme that interferes with auxin metabolism by catalyzing the release of free indoles from indoxyl- ⁇ -glucosides.
  • DNA molecules encoding the diphtheria toxin gene can be obtained from the American Type Culture Collection (Rockville, Md.), ATCC Number 39359 or ATCC Number 67011 and see, Fabijanski, et al., EP Application Number 90902754.2, for examples and methods of use.
  • the DAM methylase gene is used to cause sterility in the methods discussed at U.S. Pat. No. 5,689,049 and PCT/US95/15229 Cigan and Albertsen, “Reversible Nuclear Genetic System for Male Sterility in Transgenic Plants.” Also see, discussion of use of the avidin gene to cause sterility at U.S. Pat. No. 5,962,769 “Induction of Male Sterility in Plants by Expression of High Levels of Avidin” by Albertsen, et al.
  • the invention includes vectors with the Ms26 gene.
  • a vector is prepared comprising Ms26, a promoter that will drive expression of the gene in the plant and a terminator region.
  • the promoter in the construct may be the native promoter or a substituted promoter which will provide expression in the plant.
  • the promoter in the construct may be an inducible promoter, so that expression of the sense or antisense molecule in the construct can be controlled by exposure to the inducer.
  • any plant-compatible promoter elements can be employed in the construct, influenced by the end result desired.
  • CaMV cauliflower mosaic virus
  • LTP2 barley lipid transfer protein promoter
  • the range of available plant compatible promoters includes tissue specific and inducible promoters.
  • An inducible regulatory element is one that is capable of directly or indirectly activating transcription of one or more DNA sequences or genes in response to an inducer. In the absence of an inducer the DNA sequences or genes will not be transcribed.
  • the protein factor that binds specifically to an inducible regulatory element to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer.
  • the inducer can be a chemical agent such as a protein, metabolite, growth regulator, herbicide or phenolic compound or a physiological stress imposed directly by heat, cold, salt or toxic elements or indirectly through the actin of a pathogen or disease agent such as a virus.
  • a plant cell containing an inducible regulatory element may be exposed to an inducer by externally applying the inducer to the cell or plant such as by spraying, watering, heating or similar methods.
  • any inducible promoter can be used in the instant invention. See, Ward, et al., (1993) Plant Mol. Biol. 22:361-366.
  • Exemplary inducible promoters include ecdysone receptor promoters, U.S. Pat. No. 6,504,082; promoters from the ACE1 system which responds to copper (Mett, et al., (1993) PNAS 90:4567-4571); In2-1 and In2-2 gene from maize which respond to benzenesulfonamide herbicide safeners (U.S. Pat. No. 5,364,780; Hershey, et al., (1991) Mol. Gen.
  • Tissue-preferred promoters can be utilized to target enhanced transcription and/or expression within a particular plant tissue. Promoters may express in the tissue of interest, along with expression in other plant tissue, may express strongly in the tissue of interest and to a much lesser degree than other tissue or may express highly preferably in the tissue of interest. Tissue-preferred promoters include those described in Yamamoto, et al., (1997) Plant J. 12(2):255-265; Kawamata, et al., (1997) Plant Cell Physiol. 38(7):792-803; Hansen, et al., (1997) Mol. Gen. Genet. 254(3):337-343; Russell, et al., (1997) Transgenic Res.
  • the promoters are those which preferentially express to the male or female tissue of the plant.
  • the invention does not require that any particular male tissue-preferred promoter be used in the process, and any of the many such promoters known to one skilled in the art may be employed.
  • the native Ms26 promoter described herein is one example of a useful promoter.
  • Another such promoter is the 5126 promoter, which preferentially directs expression of the gene to which it is linked to male tissue of the plants, as described in U.S. Pat. Nos. 5,837,851 and 5,689,051.
  • Male gamete preferred promoters include the PG47 promoter, supra as well as ZM13 promoter (Hamilton, et al., (1998) Plant Mol. Biol. 38:663-669); actin depolymerizing factor promoters (such as Zmabp1, Zmabp2; see, for example Lopez, et al., (1996) Proc. Natl. Acad. Sci. USA 93:7415-7420); the promoter of the maize pectin methylesterase-liked gene, ZmC5 (Wakeley, et al., (1998) Plant Mol. Biol.
  • vectors may be included, also depending upon intended use of the gene. Examples include selectable markers, targeting or regulatory sequences, stabilizing or leader sequences, introns etc.
  • General descriptions and examples of plant expression vectors and reporter genes can be found in Gruber, et al., “Vectors for Plant Transformation” in Method in Plant Molecular Biology and Biotechnology , Glick, et al., eds; CRC Press pp. 89-119 (1993). The selection of an appropriate expression vector will depend upon the host and the method of introducing the expression vector into the host.
  • the expression cassette will also include at the 3′ terminus of the heterologous nucleotide sequence of interest, a transcriptional and translational termination region functional in plants.
  • the termination region can be native with the promoter nucleotide sequence of the present invention, can be native with the DNA sequence of interest, or can be derived from another source.
  • Convenient termination regions are available from the Ti-plasmid of A. tumefaciens , such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau, et al., (1991) Mol. Gen. Genet. 262:141-144; Proudfoot, (1991) Cell 64:671-674; Sanfacon, et al., (1991) Genes Dev.
  • the expression cassettes can additionally contain 5′ leader sequences.
  • leader sequences can act to enhance translation.
  • Translation leaders are known in the art and include by way of example, picornavirus leaders, EMCV leader (Encephalomyocarditis 5′ noncoding region), Elroy-Stein, et al., (1989) Proc. Nat. Acad. Sci.
  • the expression cassette can further comprise a coding sequence for a transit peptide.
  • Transit peptides are well known in the art and include, but are not limited to, the transit peptide for the acyl carrier protein, the small subunit of RUBISCO, plant EPSP synthase, Zea mays Brittle-1 chloroplast transit peptide (Nelson, et al., (1998) Plant Physiol 117(4):1235-1252; Sullivan, et al., Plant Cell 3(12):1337-48; Sullivan, et al., (1995) Planta 196(3):477-84; Sullivan, et al., (1992) J. Biol. Chem. 267(26):18999-9004) and the like.
  • barley alpha amylase sequence is often used to direct expression to the endoplasmic reticulum (Rogers, (1985) J. Biol. Chem. 260:3731-3738).
  • Use of transit peptides is well known (e.g., see, U.S. Pat. Nos. 5,717,084; 5,728,925).
  • the various DNA fragments can be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate, in the proper reading frame.
  • adapters or linkers can be employed to join the DNA fragments or other manipulations can be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites or the like.
  • in vitro mutagenesis, primer repair, restriction digests, annealing and resubstitutions, such as transitions and transversions can be involved.
  • the present invention provides vectors capable of expressing genes of interest.
  • the vectors should be functional in plant cells.
  • it may be preferable to have vectors that are functional in E. coli e.g., production of protein for raising antibodies, DNA sequence analysis, construction of inserts, obtaining quantities of nucleic acids.
  • Vectors and procedures for cloning and expression in E. coli are discussed in Sambrook, et al. (supra).
  • the transformation vector comprising the promoter sequence of the present invention operably linked to a heterologous nucleotide sequence in an expression cassette can also contain at least one additional nucleotide sequence for a gene to be cotransformed into the organism.
  • the additional sequence(s) can be provided on another transformation vector.
  • Reporter genes can be included in the transformation vectors.
  • suitable reporter genes known in the art can be found in, for example, Jefferson, et al., (1991) in Plant Molecular Biology Manual , ed. Gelvin, et al., (Kluwer Academic Publishers), pp. 1-33; DeWet, et al., (1987) Mol. Cell. Biol. 7:725-737; Goff, et al., (1990) EMBO J. 9:2517-2522; Kain, et al., (1995) BioTechniques 19:650-655 and Chiu, et al., (1996) Current Biology 6:325-330.
  • Selectable reporter genes for selection of transformed cells or tissues can be included in the transformation vectors. These can include genes that confer antibiotic resistance or resistance to herbicides. Examples of suitable selectable marker genes include, but are not limited to, genes encoding resistance to chloramphenicol, Herrera Estrella, et al., (1983) EMBO J. 2:987-992; methotrexate, Herrera Estrella, et al., (1983) Nature 303:209-213; Meijer, et al., (1991) Plant Mol. Biol. 16:807-820; hygromycin, Waldron, et al., (1985) Plant Mol. Biol.
  • Scorable or screenable markers may also be employed, where presence of the sequence produces a measurable product.
  • examples include a ⁇ -glucuronidase, or uidA gene (GUS), which encodes an enzyme for which various chromogenic substrates are known (for example, U.S. Pat. Nos. 5,268,463 and 5,599,670); chloramphenicol acetyl transferase (Jefferson, et al., The EMBO Journal 6(13):3901-3907) and alkaline phosphatase.
  • anthocyanin/flavonoid genes in general (see discussion at Taylor and Briggs, (1990) The Plant Cell 2:115-127) including, for example, a R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta, et al., in Chromosome Structure and Function , Kluwer Academic Publishers, Appels and Gustafson eds., pp. 263-282 (1988)); the genes which control biosynthesis of flavonoid pigments, such as the maize C1 gene (Kao, et al., (1996) Plant Cell 8:1171-1179; Scheffler, et al., (1994) Mol. Gen.
  • Suitable markers include the cyan fluorescent protein (CYP) gene (Bolte, et al., (2004) J. Cell Science 117: 943-54 and Kato, et al., (2002) Plant Physiol 129:913-42), the yellow fluorescent protein gene (PhiYFPTM from Evrogen; see, Bolte, et al., (2004) J.
  • a lux gene which encodes a luciferase, the presence of which may be detected using, for example, X-ray film, scintillation counting, fluorescent spectrophotometry, low-light video cameras, photon counting cameras or multiwell luminometry (Teeri, et al., (1989) EMBO J. 8:343); a green fluorescent protein (GFP) gene (Sheen, et al., (1995) Plant J. 8(5):777-84) and DsRed2 where plant cells transformed with the marker gene are red in color, and thus visually selectable (Dietrich, et al., (2002) Biotechniques 2(2):286-293).
  • GFP green fluorescent protein
  • Additional examples include a p-lactamase gene (Sutcliffe, (1978) Proc. Nat'l. Acad. Sci. U.S.A. 75:3737), which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a xylE gene (Zukowsky, et al., (1983) Proc. Nat'l. Acad. Sci. U.S.A. 80:1101), which encodes a catechol dioxygenase that can convert chromogenic catechols; an ⁇ -amylase gene (Ikuta, et al., (1990) Biotech.
  • transformation/transfection is not critical to the instant invention; various methods of transformation or transfection are currently available. As newer methods are available to transform crops or other host cells they may be directly applied. Accordingly, a wide variety of methods have been developed to insert a DNA sequence into the genome of a host cell to obtain the transcription or transcript and translation of the sequence to effect phenotypic changes in the organism. Thus, any method which provides for efficient transformation/transfection may be employed.
  • the DNA construct may be introduced into the genomic DNA of the plant cell using techniques such as microprojectile-mediated delivery, Klein, et al., (1987) Nature 327:70-73; electroporation, Fromm, et al., (1985) Proc. Natl. Acad. Sci. 82:5824; polyethylene glycol (PEG) precipitation, Paszkowski, et al., (1984) EMBO J. 3:2717-2722; direct gene transfer WO 85/01856 and EP Number 0 275 069; in vitro protoplast transformation, U.S. Pat. No. 4,684,611 and microinjection of plant cell protoplasts or embryogenic callus, Crossway, (1985) Mol. Gen.
  • microprojectile-mediated delivery Klein, et al., (1987) Nature 327:70-73
  • electroporation Fromm, et al., (1985) Proc. Natl. Acad. Sci. 82:5824
  • Co-cultivation of plant tissue with Agrobacterium tumefaciens is another option, where the DNA constructs are placed into a binary vector system. See e.g., U.S. Pat. No. 5,591,616; Ishida, et al., (1996) Nature Biotechnology 14:745-750.
  • the virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct into the plant cell DNA when the cell is infected by the bacteria. See, for example, Horsch, et al., (1984) Science 233:496-498 and Fraley, et al., (1983) Proc. Natl. Acad. Sci. 80:4803.
  • introduction of the nucleotide sequence into a plant, it is meant that this can occur by direct transformation methods, such as Agrobacterium transformation of plant tissue, microprojectile bombardment, electroporation or any one of many methods known to one skilled in the art or, it can occur by crossing a plant having the heterologous nucleotide sequence with another plant so that progeny have the nucleotide sequence incorporated into their genomes. Such breeding techniques are well known to one skilled in the art.
  • Backcrossing methods may be used to introduce a gene into the plants. This technique has been used for decades to introduce traits into a plant. An example of a description of this and other plant breeding methodologies that are well known can be found in references such as Plant Breeding Methodology , edit. Neal Jensen, John Wiley & Sons, Inc. (1988). In a typical backcross protocol, the original variety of interest (recurrent parent) is crossed to a second variety (nonrecurrent parent) that carries the single gene of interest to be transferred.
  • homozygosity is a genetic condition existing when identical alleles reside at corresponding loci on homologous chromosomes.
  • Heterozygosity is a genetic condition existing when different alleles reside at corresponding loci on homologous chromosomes.
  • Hemizygosity is a genetic condition existing when there is only one copy of a gene (or set of genes) with no allelic counterpart on the sister chromosome.
  • the homozygous recessive condition results in conferring on the plant a trait of interest, which can be any trait desired and which results from the recessive genotype, such as increased drought or cold tolerance, early maturity, changed oil or protein content or any of a multitude of the many traits of interest to plant breeders.
  • the homozygous recessive condition confers male sterility upon the plant.
  • transgene it is meant any nucleic acid sequence which is introduced into the genome of a cell by genetic engineering techniques.
  • a transgene may be a native DNA sequence, or a heterologous DNA sequence (i.e., “foreign DNA”).
  • native DNA sequence refers to a nucleotide sequence which is naturally found in the cell but that may have been modified from its original form.
  • the pollen from the maintainer can be used to fertilize plants that are homozygous for the recessive trait, and the progeny will therefore retain their homozygous recessive condition.
  • the maintainer plant containing the restoring transgene construct is propagated by self-fertilization, with the resulting seed used to produce further plants that are homozygous recessive plants and contain the restoring transgene construct.
  • the maintainer plant serves as a pollen donor to the plant having the homozygous recessive trait.
  • the maintainer is optimally produced from a plant having the homozygous recessive trait and which also has nucleotide sequences introduced therein which would restore the trait created by the homozygous recessive alleles.
  • the restoration sequence is linked to nucleotide sequences which interfere with the function or formation of male gametes.
  • the gene can operate to prevent formation of male gametes or prevent function of the male gametes by any of a variety of well-know modalities and is not limited to a particular methodology. By way of example but not limitation, this can include use of genes which express a product cytotoxic to male gametes (See for example, U.S. Pat. Nos.
  • Dominant negative genes include diphtheria toxin A-chain gene (Czako and An (1991) Plant Physiol. 95:687-692 and Greenfield, et al., (1983) PNAS 80:6853, Palmiter, et al., (1987) Cell 50:435); cell cycle division mutants such as CDC in maize (Colasanti, et al., (1991) PNAS 88:3377-3381); the WT gene (Farmer, et al., (1994) Hum. Mol. Genet. 3:723-728) and P68 (Chen, et al., (1991) PNAS 88:315-319).
  • cytotoxic genes can include, but are not limited to pectate lyase gene pelE, from Erwinia chrysanthermi (Kenn, et al., (1986) J. Bacteriol 168:595); T-urf13 gene from cms-T maize mitochondrial genomes (Braun, et al., (1990) Plant Cell 2:153; Dewey, et al., (1987) PNAS 84:5374); CytA toxin gene from Bacillus thuringiensis Israeliensis that causes cell membrane disruption (McLean, et al., (1987) J. Bacteriol 169:1017, U.S. Pat. No.
  • RNAses U.S. Pat. No. 5,633,441
  • proteases or a genes expressing anti-sense RNA may also encode a protein involved in inhibiting pistil development, pollen stigma interactions, pollen tube growth or fertilization or a combination thereof.
  • genes that either interfere with the normal accumulation of starch in pollen or affect osmotic balance within pollen may also be suitable.
  • the DAM-methylase gene is used, discussed supra and at U.S. Pat. Nos. 5,792,852 and 5,689,049, the expression product of which catalyzes methylation of adenine residues in the DNA of the plant.
  • Methylated adenines will affect cell viability and will be found only in the tissues in which the DAM-methylase gene is expressed.
  • an ⁇ -amylase gene can be used with a male tissue-preferred promoter.
  • the aleurone layer cells will synthesize ⁇ -amylase, which participates in hydrolyzing starch to form glucose and maltose, so as to provide the nutrients needed for the growth of the germ (Rogers and Milliman, (1984) J. Biol. Chem. 259(19):12234-12240; Rogers, (1985) J. Biol. Chem. 260:3731-3738).
  • the ⁇ -amylase gene used can be the Zea mays ⁇ -amylase-1 gene. Young, et al., Plant Physiol. 105(2):759-760 and GenBank Accession Numbers L25805, GI:426481). Sequences encoding ⁇ -amylase are not typically found in pollen cells and when expression is directed to male tissue, the result is a breakdown of the energy source for the pollen grains and repression of pollen development.
  • a sporophytic gene is one which operates independently of the gametes.
  • the maintainer plant When the homozygous recessive condition is one which produces male sterility by preventing male sporophyte development, the maintainer plant, of necessity, must contain a functional restoring transgene construct capable of complementing the mutation and rendering the homozygous recessive plant able to produce viable pollen.
  • Linking this sporophytic restoration gene with a second functional nucleotide sequence which interferes with the function or formation of the male gametes of the plant results in a maintainer plant that produces pollen containing only the recessive allele of the sporophytic gene at the its native locus due to the action of the second nucleotide sequence in interfering with pollen formation or function.
  • This viable pollen fraction is non-transgenic with regard to the restoring transgene construct.
  • a marker gene may be provided in the construct with the restoring transgene.
  • a herbicide resistant marker such as bar allows one to eliminate cells not having the restoring transgene.
  • a scorable marker such as a red fluorescent marker, such as DsRed2
  • any inadvertent transmission of the transgene can also be detected visually, and such escapes eliminated from progeny.
  • many other variations in the restoring construct are available to one skilled in the art.
  • a method of maintaining a homozygous recessive condition of a male sterile plant at a genetic locus in which is employed a first nucleotide sequence which is a gene critical to male fertility, a second nucleotide sequence which inhibits the function or formation of viable male gametes, an optional third nucleotide sequence which is operably linked to the first sequence and preferentially expresses the sequence in male plant cells, an optional fourth nucleotide sequence operably linked to a fourth nucleotide sequence, the fourth sequence directing expression to male gametes, and an optional fifth nucleotide sequence which is a selectable or scorable marker allowing for selection of plant cells.
  • a plant which is ms45/ms45 homozygous recessive may have introduced into it a functional sporophytic Ms45 gene, and thus is male fertile.
  • This gene can be linked to a gene which operates to render pollen containing the restoring transgene construct nonfunctional or prevents its formation or which produces a lethal product in pollen, linked to the promoter directing its expression to the male gametes to produce a plant that only produced pollen containing ms45 without the restoring transgene construct.
  • An example is a construct which includes the Ms45 gene, linked with a 5126 promoter, a male tissue-preferred promoter (see, U.S. Pat. Nos. 5,750,868; 5,837,851 and 5,689,051) and further linked to the cytotoxic DAM methylase gene under control of the polygalacturonase promoter, PG47 promoter (see, U.S. Pat. Nos. 5,792,853; 5,689,049) in a hemizygotic condition. Therefore the resulting plant produces pollen, but the only viable pollen results from the alle not containing the restoring Ms45/DAM methylase construct and thus contains only the ms45 gene.
  • progeny produced will continue to be male sterile as a result of maintaining homozygosity for ms45.
  • the progeny will also not contain the introduced restoring transgene construct.
  • the Ms26 gene is linked with a 5126 promoter, and further linked to the Zea mays ⁇ -amylase gene under control of the male tissue-preferred PG47 promoter.
  • the scorable marker used in an embodiment is DS-RED EXPRESS.
  • a desirable result of the process of the invention is that the plant having the restorer nucleotide sequence may be self-fertilized, that is pollen from the plant transferred to the flower of the same plant to achieve the propagation of restorer plants.
  • self fertilization it includes the situation where the plant producing the pollen is fertilized with that same the pollen and the situation where two or more identical inbred plants are planted together and pollen from the identical inbred plant pollinate a different identical inbred plant).
  • the pollen will not have the restoring transgene construct but it will be contained in 50% of the ovules (the female gamete).
  • the seed resulting from the self-fertilization can be planted, and selection made for the seed having the restoring transgene construct.
  • the selection process can occur by any one of many known processes; the most common where the restoration nucleotide sequence is linked to a marker gene.
  • the marker can be scorable or selectable, and allows those plants produced from the seed having the restoration gene to be identified.
  • the male gamete-tissue preferred promoter is inducible. Additional control is thus allowed in the process, where so desired, by providing that the plant having the restoration nucleotide sequences is constitutively male sterile.
  • This type of male sterility is set forth the in U.S. Pat. No. 5,859,341.
  • the inducing substance In order for the plant to become fertile, the inducing substance must be provided and the plant will become fertile. Again, when combined with the process of the invention as described supra, the only pollen produced will not contain the restoration nucleotide sequences.
  • Southern analysis was performed to confirm association of Mu with sterility.
  • Southern analysis is a well known technique to those skilled in the art. This common procedure involves isolating the plant DNA, cutting with restriction endonucleases, fractioning the cut DNA by molecular weight on an agarose gel and transferring to nylon membranes to fix the separated DNA. These membranes are subsequently hybridized with a probe fragment that was radioactively labeled with P 32 P-dCTP, and washed in an SDS solution.
  • Southern (1975) J. Mol. Biol. 98:503-317. Plants from a segregating F 2 ms26*-SBMu200 family were grown and classified for male fertility/sterility. Leaf samples and subsequent DNA isolation was conducted on approximately 20 plants per phenotypic classification.
  • DNA ( ⁇ 7 ug) from 5 fertile and 12 sterile plants was digested with EcoRI and electrophoresed through a 0.75% agarose gel. The digested DNA was transferred to nylon membrane via Southern transfer. The membrane was hybridized with an internal fragment from the Mu8 transposon. Autoradiography of the membrane revealed cosegregation of an approximately 5.6 Kb EcoRI fragment with the sterility phenotype as shown in FIG. 1 . This EcoRI band segregated in the fertile plants suggesting a heterozygous wild type condition for the allele
  • DNA from a sterile plant was digested with EcoRI and run on a preparative gel. DNA with a molecular weight between 5.0 and 6.0 Kb was excised from the gel, electroeluted and ethanol precipitated. This DNA was ligated into the Lambda Zap vector (StratageneTM) using the manufacturer's protocol. The ligated DNA was packaged into phage particles using Gigapack Gold (StratageneTM). Approximately 500,000 PFU were plated and lifted onto nitrocellulose membranes. Membranes were hybridized with the Mu8 probe. A pure clone was obtained after 3 rounds of screening. The insert was excised from the phage as a plasmid and designated SBMu200-3.1.
  • a PstI border fragment from this clone was isolated and used to reprobe the orginal EcoRI cosegregation blot as shown in FIG. 2B .
  • the approximately 5.6 kb EcoRI fragment is homozygous in all the sterile plants, which confirms that the correct Mu fragment was isolated.
  • Three of the fertile plants are heterozygous for the 5.5 kb EcoRI band and a 4.3 Kb EcoRI band.
  • Two of the fertile plants are homozygous for the 4.3 kb EcoRI band, presumably the wild type allele.
  • the PstI probe was used to map the ms*-SBMu200 mutation in an RFLP mapping population.
  • the mutant mapped to the short arm of chromosome 1, near the male sterile locus, Ms26 (Loukides, et al., (1995) Amer. J. Bot 82:1017-1023).
  • Ms26 Longer sterile locus
  • the testcross progeny segregated male-sterile and wild-type plants in a 1:1 ratio, indicating allelism between ms*-SBMu200 and ms26-ref.
  • the ms*-SBMu200 allele was designated ms26-m2::Mu8.
  • the map location is shown in FIG. 13 .
  • Mu insertion mutations in Ms26 was identified by using a polymerase chain reaction (PCR) primer for Mu and a gene specific primer for Ms26 and screening a population of Mu F 1 families. Sequence analyses of the PCR products showed that all three Mu insertions occurred in the second exon ( FIG. 1 ). The F 2 seeds from one of these families were grown and examined for male fertility/sterility. Southern blot analyses of this family confirmed the cosegregation of the Mu insertion in Ms26 with the male-sterile phenotype and the allele was designated ms26-m3::Mu.
  • PCR polymerase chain reaction
  • Ms26 genomic sequences were cloned from ms26-ref sterile and fertile plants.
  • Ms26 was cloned as a ⁇ 4.2 kb EcoRI fragment and ms26-ref cloned as a ⁇ 6 kb HindIII fragment and an overlapping ⁇ 2.3 kb EcoRI fragment from the sterile plant.
  • Sequence analysis revealed the presence of a new segment (1,430 bp) in the last exon of the ms26-ref allele shown in FIG. 1 .
  • An 8 bp host site duplication (GCCGGAGC) was found that flanks the inserted element and the element also contains a 15 bp terminal inverted repeat (TIR) (TAGGGGTGAAAACGG; SEQ ID NO: 23).
  • TIR 15 bp terminal inverted repeat
  • the transposon sequence is shown in FIG. 15 (SEQ ID NO: 10).
  • the ms26-ref genomic sequence in its entirety is shown in FIG. 16 , SEQ ID NO: 11. A variant of the ms26-ref allele was also found.
  • ms26′-0406 Sequence analysis of this allele, designated ms26′-0406, was found to have lost the 1430 bp segment found in the last exon of the ms26-ref allele but left an 8 bp footprint at the site of insertion. Plants homozygous for the ms26′-0406 allele were male sterile. A comparison of the excision allele, ms26′-0406 (SEQ ID NO: 8) with the region in the wild-type Ms26 gene (SEQ ID NO: 9) is shown in FIG. 14 .
  • Northern analysis can be used to detect expression of genes characteristic of anther development at various states of microsporogenesis.
  • Northern analysis is also a commonly used technique known to those skilled in the art and is similar to Southern analysis except that mRNA rather than DNA is isolated and placed on the gel. The RNA is then hybridzed with the labeled probe. Potter, et al., (1981) Proc. Nat. Acad. Sci. USA 78:6662-6666, Lechelt, et al., (1989) Mol. Gen. Genet. 219:225-234.
  • the PstI fragment from the SBMu200-3.1 clone was used to probe a Northern blot containing kernel, immature ear, seedling and tassel RNA.
  • the transcript is about 2.3 kb in length.
  • the same probe was also used to screen a cDNA library constructed from mRNA isolated from meiotic to late uninucleate staged anthers. One clone, designated Ms26-8.1, was isolated from the library.
  • the SBMu200-3.1 genomic clone and the Ms26-8.1 cDNA clone were sequenced by Loftstrand Labs Limited. Sanger, et al., (1977) Proc. Natl. Acad. Sci. USA 74:5463-5467. The sequences are set forth in FIGS. 4 and 5 and the comparison is at FIG. 6 .
  • the cDNA/genomic comparison reveals five introns are present in the genomic clone.
  • the Mu8 insertion occurs in exon 1. Testing for codon preference and non-randomness in the third position of each codon was consistent with the major ORF in the cDNA being the likely protein-coding ORF. There is a putative Met start codon at position 1089 in the genomic clone.
  • Ms26-8.1 does not represent a full length clone and lacks 5 bases up to the putative Met start codon.
  • a database search revealed significant homology to P450 enzymes found in yeast, plants and mammals. P450 enzymes have been widely studied and three characteristic protein domains have been elucidated.
  • the Ms26 protein contains several structural motifs characteristic of eukaryotic P450's, including the heme-binding domain FxxGxRxCxG (domain D; SEQ ID NO: 24), domain A A/GGXD/ETT/S (dioxygen-binding), domain B (steroid-binding) and domain C.
  • the highly conserved heme-binding motif was found in MS26 as FQAGPRICLG (SEQ ID NO: 25), 51 amino acids away from C-terminus.
  • the dioxygen binding domain AGRDTT (SEQ ID NO: 35) was located between amino acids 320-325.
  • the steroid-binding domain was found as LVYLHACVTETLR (SEQ ID NO: 27), amino acids 397-409.
  • the most significant homologous sequence detected in Genebank database is a deduced protein sequence from rice (GeneBank Accession Number 19071651).
  • the second highest homologous sequence is a putative Arabidopsis P450 gene (CYP704B1) whose function is also unknown.
  • FIG. 17A shows a sequence alignment between CYP704B1 (SEQ ID NO: 12) and Ms26 (SEQ ID NO: 13).
  • Phylogenetic tree analysis of some P450 genes revealed that Ms26 is most closely related to P450s involved in fatty acid omega-hydroxylation found in Arabidopsis thaliana and Vicia sativa ( FIG. 17B ).
  • the translational frame shift caused in the ms26′-0406 excision mutation is believed to destroy the activity of the heme binding domain, thus resulting in sterility. See, the comparison at FIG. 18 (Ms26 cDNA at SEQ ID NO: 14; fertile exon 5 region at SEQ ID NO: 15 and sterile exon 5 region is SEQ ID NO: 16).
  • FIG. 7A shows a Northern blot with RNA samples from different tissues including root (1), leaf (2), husk (3), cob (4), ear spikelet (5), silk (6), immature embryo (7) mature embryo (8) and tassel from, fertile plant (9), ms26-m2::Mu8 sterile plant (10), ms26-ref sterile plant (11) and fertile plant (12).
  • a hybridization signal using Ms26 cDNA was detected only in tassel tissues.
  • FIG. 7B shows a Northern blot containing mRNA at discrete stages of microsporogenesis.
  • Hybridization signals using Ms26 cDNA were detected from meiosis II/quartet stage (4) to late-uninucleate stage (10), with the maximal signal being observed from early-uninucleate through late-uninucleate stage (10).
  • a putative TATA box can be identified by primer extension analysis as described in by Current Protocols in Molecular Biology , Ausubel, et al., eds; John Wiley and Sons, New York pp. 4.8.1-4.8.5 (1987).
  • Regulatory regions of anther genes may be identified in genomic subclones using functional analysis, usually verified by the observation of reporter gene expression in anther tissue and a lower level or absence of reporter gene expression in non-anther tissue.
  • the possibility of the regulatory regions residing “upstream” or 5′ ward of the translational start site can be tested by subcloning a DNA fragment that contains the upstream region into expression vectors for transient expression experiments. It is expected that smaller subgenomic fragments may contain the regions essential for male-tissue preferred expression.
  • the essential regions of the CaMV 19S and 35S promoters have been identified in relatively small fragments derived from larger genomic pieces as described in U.S. Pat. No. 5,352,605.
  • the regions in the vector include regions that control initiation of transcription and control processing. These regions are operably linked to a reporter gene such as UidA, encoding-glucuronidase (GUS), or luciferase.
  • a reporter gene such as UidA, encoding-glucuronidase (GUS), or luciferase.
  • GUS expression vectors and GUS gene cassettes are commercially available from Clonetech, Palo Alto, Calif., while luciferase expression vectors and luciferase gene cassettes are available from Promega Corporation, Madison, Wis. Ti plasmids and other Agrobacterium vectors are described in Ishida, et al., (1996) Nature Biotechnology 14:745-750 and in U.S. Pat. No. 5,591,616.
  • Expression vectors containing putative regulatory regions located in genomic fragments can be introduced into intact tissues such as staged anthers, embryos or into callus.
  • Methods of DNA delivery include microprojectile bombardment, DNA injection, electroporation and Agrobacterium -mediated gene transfer (see, Gruber, et al., “Vectors for Plant Transformation,” in Methods in Plant Molecular Biology and Biotechnology , Glick, et al., eds.; CRC Press; (1993); U.S. Pat. No. 5,591,616 and Ishida, et al., (1996) Nature Biotechnology 14:745-750). General methods of culturing plant tissues are found in Gruber, et al., supra and Glick, supra.
  • staged, isolated anthers are immediately placed onto tassel culture medium (Pareddy and Petelino, (1989) Crop Sci. J.; 29:1564-1566) solidified with 0.5% Phytagel (Sigma, St. Louis) or other solidifying media.
  • the expression vector DNA is introduced within 5 hours preferably by microprojectile-mediated delivery with 1.2 ⁇ m particles at 1000-1100 Psi. After DNA delivery, the anthers are incubated at 26° C. upon the same tassel culture medium for 17 hours and analyzed by preparing a whole tissue homogenate and assaying for GUS or for lucifierase activity (see, Gruber, et al., supra).
  • the genomic clone ms26-m2::Mu8 thus includes about 1005 bp upstream of the possible TATA box.
  • the start of transcription is 26-36 bp downstream of the TATA box, which would give the Ms26 mRNA a 5′-nontranslated leader of about 48-58 nt.
  • TATATCA The putative TATA box (TATATCA) is underlined.
  • the present invention encompasses a DNA molecule having a nucleotide sequence of SEQ ID NO: 5 (or those with sequence identity) and having the function of a male tissue-preferred regulatory region.
  • Deletion analysis can occur from both the 5′ and 3′ ends of the regulatory region: fragments can be obtained by site-directed mutagenesis, mutagenesis using the polymerase chain reaction, and the like ( Directed Mutagenesis: A Practical Approach ; IRL Press; (1991)).
  • the 3′ end of the male tissue-preferred regulatory region can be delineated by proximity to the putative TATA box or by 3′ deletions if necessary.
  • the essential region may then be operably linked to a core promoter of choice. Once the essential region is identified, transcription of an exogenous gene may be controlled by the male tissue-preferred region of Ms26 plus a core promoter.
  • the core promoter can be any one of known core promoters such as a Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), Ubiquitin (U.S. Pat. No. 5,510,474), the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al., “Vectors for Plant Transformation” in Methods in Plant Molecular Biology and Biotechnology ; Glick, et al., eds.; CRC Press; pp. 89-119; (1993)).
  • core promoters such as a Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), Ubiquitin (U.S. Pat. No. 5,510,474), the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Fig
  • the promoter is the core promoter of a male tissue-preferred gene or the CaMV 35S core promoter. More preferably, the promoter is a promoter of a male tissue-preferred gene and in particular, the Ms26 core promoter.
  • mutational analysis for example by linker scanning, a method well known to the art, can identify small segments containing sequences required for anther-preferred expression. These mutations may introduce modifications of functionality such as in the levels of expression, in the timing of expression, or in the tissue of expression. Mutations may also be silent and have no observable effect.
  • the foregoing procedures were used to identify essential regions of the Ms26 promoter. After linking the promoter with the luciferase marker gene deletion analysis was performed on the regions of the promoter upstream of the putative TATA box, as represented in FIG. 9 .
  • the x-axis of the bar graph indicates the number of base pairs immediately upstream of the putative TATA box retained in a series of deletion derivatives starting from the 5′ end of the promoter.
  • the y-axis shows the normalized luciferase activity as a percent of full-length promoter activity.
  • ⁇ 176 to ⁇ 44 bp region contains an essential region and thus would constitute an upstream enhancer element conferring anther expression on the promoter, which we refer to as an “anther box”.
  • Linker scanning analysis was conducted across the anther box in 9-10 bp increments. The locations of the linker scanning substitutions in this region are shown in FIG. 10 and the expression levels of the mutants relative to the wild type sequence are shown in FIG. 11 . The most drastic effect on transient expression in anthers was observed for mutants LS12 and LS13, in the region 52-71 bp upstream of the putative TATA box. A major effect on transient expression in anthers was also observed for mutants LS06, LS07, LS08 and LS10, within the region 82-131 bp upstream of the putative TATA box.
  • Sequences within the anther box required for wild type levels of transient expression in anthers are thus demonstrated in the ⁇ 52 to ⁇ 131 region relative to the putative TATA box, particularly the ⁇ 52 to ⁇ 71 region.
  • the essential regions are shown at SEQ ID NO: 6 ( FIG. 10 ) and, as compared to the genomic sequence, SEQ ID NO: 7 ( FIG. 5 ) are bases 1-1088; 830-962; 830-914; 917-962; 875-954; 935-954 and 875-924.
  • Ms26 is a male fertility gene in maize. When it is mutated, and made homozygous recessive, male sterility will result.
  • An orthologue of Ms26 was identified in sorghum.
  • the sorghum orthologue of the Ms26 cDNA was isolated by using the maize Ms26 gene primers in a polymerase chain reaction with sorghum tassel cDNA as the template.
  • the resultant cDNA fragment was sequenced by methods described supra and then compared to the Ms26 cDNA from maize. Nucleotide sequence comparisons are set forth in FIG. 12 and show 90% identity.
  • FIG. 20 shows an alignment of the Ms26 promoter of corn (SEQ ID NO: 5), sorghum (SEQ ID NO: 19) and rice (SEQ ID NO: 20). The last three bases of the corn promoter shown in the figure is the ATG start of translation.
  • FIG. 21 Alignment as reflected in FIG. 21 of the maize Ms26 protein (SEQ ID NO: 2), rice Ms26 protein (SEQ ID NO: 18) and sorghum Ms26 protein (SEQ ID NO: 4) and a consensus sequence (SEQ ID NO: 21).
  • the comparison of protein sequences shows the protein is highly conserved among the orthologues, with the rice protein sharing 92% similarity and 86% identity when compared to the maize orthologue.
  • the predicted tissue specificity in rice and sorghum is further reflected in a comparison of the Ms26 protein in the sorghum and rice EST database derived from panicle (flower) libraries.
  • Sorghum sequences producing significant alignments (GenBank Accession Numbers BI075441.1; BI075273.1; BI246000.1; BI246162.1; BG948686.1; BI099541.1 and BG948366.1, among others) all were sequences from immature panicle of sorghum, and sequences showing significant alignment in rice (GenBank Accession Numbers C73892.1; CR290740.1, among others) were also from rice immature panicle.
  • nucleotide sequences which map to the short arm of chromosome 1 of the Zea mays genome, at the same site as the Ms26 gene, ms26-m2::Mu8 and its alleles are genes critical to male fertility in plants, that is, are necessary for fertility of a plant, or, when mutated from the sequence found in a fertile plant, cause sterility in the plant.
  • a construct designated PHP18091, shown in FIG. 22 is made by assembling following DNA components:
  • ms45′ 9301 A male-sterile female which was homozygous for an ms45 mutant Ac excision allele, ms45′ 9301 (ms45) was repeatedly crossed with bulked pollen from maize Hi-type II plants (Armstrong, 1994, In: Freeling and Walbot (eds). The Maize Handbook . Springer, New York, pp 663-671) resulting in the introgression of this ms45 allele in transformation amenable maize germplasm over multiple generations.
  • the resultant source of material for transformation consisted of embryos segregating (1:1 or 3:1) for ms45 and allowed for both transformation directly into a homozygous ms45 background and to test the genetic complementation of the ms45 mutation in T 0 plants.
  • Agrobacterum -mediated transformation was performed according to Zhao, et al., 1999, (U.S. Pat. No. 5,981,840). Genotyping and molecular analysis (integration and PTU) of transformants were done according Cigan, et al., ( Sex. Plant. Reprod . (2001) 14:135-142). Transformants with single-integration and complete PTU were selected for further studies.
  • Transgenic plants (T 0 ) from Example 9 were evaluated for the whole plant morphology and analyzed for transgene transmission through both pollen and egg cells. No morphological difference was observed between the transgenic plants and the non-transgenic control plants except for the degree of male fertility. Transformants with single-integration and intact PTU were partial male fertile while non-transgenic control plants were completely male sterile, indicating that the expression of Ms45 gene complemented the homozygous recessive ms45 male sterile phenotype. This also demonstrated that the expression of the DAM gene caused partial male sterility by eliminating the pollen grains carrying the transgenes.
  • DAM gene can completely recover the ms45 male sterile mutation (Cigan, et al., (2001) Sex. Plant. Reprod. 14:135-142).
  • the correct function of DAM gene was further determined by controlled pollinations between T 0 transgenic plants and non-transgenic plants. Pollen grains from T 0 transgenic plants were used to pollinate non-transgenic plants control plants. Immature embryos were harvested from ears of these non-transgenic plants 18 days after pollination and cultured either on MS media or MS media containing 3.0 mg/L of bialaphos (Murashige and Skoog, (1962) Physiol. Plant 15:437-439). 100% of the embryos were able to germinate on control medium while none of the embryos were able to germinate on media containing 3 mg/L of bialaphos, indicating that the restoring transgene construct was not transmitted through pollen to progeny.
  • T 0 transgenic maintainer plants pollen from non-transgenic plants was used to pollinate the T 0 transgenic maintainer plants. Immature embryos were harvested from ears of these T 0 transgenic maintainer plants 18 days after pollination and cultured as above control media or media containing 3 mg/L of bialaphos. All embryos were able to germinate on control medium while 50% of the embryos were able to germinate on the medium containing bialaphos, indicating that the restoring transgene construct was transmitted through the ovule to progeny at the expected frequency. The results of embryo rescues are summarized in Tables 1 and 2.
  • T 0 transgenic maintainer plants from Example 9 were converted into different inbred backgrounds through repeated backcross by pollination from inbred lines such as PH09B. To accomplish this, pollen produced by PH09B that is ms45 heterozygous background were used to pollinate the ears of T 0 maintainer plants that were homozygous for the ms45 mutant alleles. T 1 seed harvested from these T 0 plants segregated for both transgenes and ms45 alleles. T 1 plants that did not contain the restoring transgene construct were eliminated by herbicide selection. T 1 plants containing transgenes were analyzed for ms45 background and male fertility according to Cigan, et al., ( Sex. Plant.
  • T 1 plants in homozygous ms45 condition that contained the restoring transgene construct showed partial male fertility like that observed for the T 0 parent plants, while the T 1 plants in homozygous ms45 condition but containing no transgenes were complete male sterile. This suggested that the Ms45 transgene continued to function correctly in a different genetic background. Pollen grains from T 1 plants were examined for viability using microscopic and histochemical staining. Pollen grains at different developmental stages were collected and stained with fluorescein diacetate (FDA), 4′, 6-diamidino-2-phenylindole (DAPI) and ethidium bromide (EB).
  • FDA fluorescein diacetate
  • DAPI 6-diamidino-2-phenylindole
  • EB ethidium bromide
  • T 1 plants derived from T 0 14089277 as described in Example 9 were used as males to pollinate either wild type inbred plants or ms45/ms45 male sterile inbred plants.
  • the 10,117 T 2 progeny from the wild type crosses and 6688 T 2 progeny from the ms45/ms45 crosses were evaluated for transgene transmission by screening for herbicide resistance. For both types of crosses a total of 16786 T 2 plants were found to be herbicide sensitive, yielding a non-transmission frequency of 99.89%. All T 2 plants from the ms45/ms45 crosses that did not contain the transgene, were completely male sterile, indicating that this transgenic line can maintain ms45 sterility.
  • a construct designated PHP24101, shown in FIG. 23 is made by assembling following DNA components:
  • the resultant source of material for transformation consisted of embryos segregating (1:1 or 3:1) for ms26 and allowed for both transformation directly into a homozygous ms26 background and to test the genetic complementation of the ms26 mutation in T 0 plants.
  • Agrobacterium -mediated transformation was performed according to Zhao, et al., 1999, (U.S. Pat. No. 5,981,840). Genotyping and molecular analysis (integration and PTU) of transformants were done according Cigan, et al., ( Sex. Plant. Reprod . (2001) 1(4):135-142). Transformants with single-integration and complete PTU were selected for further studies.
  • Transgenic plants (T 0 ) from Example 14 were evaluated for the whole plant morphology and analyzed for transgene transmission through pollen. No morphological difference was observed between the transgenic plants and the non-transgenic control plants except for the degree of male fertility. Transformants with single-integration and intact PTU were partial male fertile while non-transgenic control plants were completely male sterile, indicating that the expression of the Ms26 gene complemented the homozygous recessive ms26 male sterile phenotype. This also suggested that the pollen expression of the alpha amylase (AA) gene caused partial male sterility by disrupting the normal function of the pollen grains carrying the transgenes.
  • AA alpha amylase

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Nucleotide sequences mediating male fertility in plants are described, with DNA molecule and amino acid sequences set forth. Promoter sequences and their essential regions are also identified. The nucleotide sequences and promoter sequences are useful in methods mediating male fertility in plants, as described. Vectors, plant cells, and plants comprising the nucleotide sequences and/or promoter regions are also provided.

Description

    REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of previously filed and co-pending U.S. patent application Ser. No. 13/189,631 filed Jul. 25, 2011 which is a continuation of U.S. patent application Ser. No. 12/966,606, filed Dec. 13, 2010, now U.S. Pat. No. 8,013,218 issued Sep. 6, 2011, which is a continuation of U.S. patent application Ser. No. 12/400,578, filed Mar. 9, 2009, now U.S. Pat. No. 7,875,764, which is a divisional application of previously filed U.S. patent application Ser. No. 11/471,202, filed Jun. 20, 2006, now U.S. Pat. No. 7,612,251, which is a continuation-in-part of U.S. patent application Ser. No. 11/166,609 filed Jun. 24, 2005, now U.S. Pat. No. 7,517,975, which is a continuation-in-part of U.S. patent application Ser. No. 10/412,000 filed Apr. 11, 2003, now issued as U.S. Pat. No. 7,151,205, which is a continuation of previously filed application U.S. patent application Ser. No. 09/670,153, filed Sep. 26, 2000, now abandoned, all of which are incorporated by reference in their entirety.
    • BACKGROUND OF THE INVENTION
  • Development of hybrid plant breeding has made possible considerable advances in quality and quantity of crops produced. Increased yield and combination of desirable characteristics, such as resistance to disease and insects, heat and drought tolerance, along with variations in plant composition are all possible because of hybridization procedures. These procedures frequently rely heavily on providing for a male parent contributing pollen to a female parent to produce the resulting hybrid.
  • Field crops are bred through techniques that take advantage of the plant's method of pollination. A plant is self-pollinating if pollen from one flower is transferred to the same or another flower of the same plant. A plant is cross-pollinated if the pollen comes from a flower on a different plant.
  • In Brassica, the plant is normally self-sterile and can only be cross-pollinated. In self-pollinating species, such as soybeans and cotton, the male and female plants are anatomically juxtaposed. During natural pollination, the male reproductive organs of a given flower pollinate the female reproductive organs of the same flower.
  • Maize plants (Zea mays L.) present a unique situation in that they can be bred by both self-pollination and cross-pollination techniques. Maize has male flowers, located on the tassel and female flowers, located on the ear, on the same plant. It can self or cross pollinate. Natural pollination occurs in maize when wind blows pollen from the tassels to the silks that protrude from the tops of the incipient ears.
  • A reliable method of controlling fertility in plants would offer the opportunity for improved plant breeding. This is especially true for development of maize hybrids, which relies upon some sort of male sterility system and where a female sterility system would reduce production costs.
  • The development of maize hybrids requires the development of homozygous inbred lines, the crossing of these lines and the evaluation of the crosses. Pedigree breeding and recurrent selection are two of the breeding methods used to develop inbred lines from populations. Breeding programs combine desirable traits from two or more inbred lines or various broad-based sources into breeding pools from which new inbred lines are developed by selfing and selection of desired phenotypes. A hybrid maize variety is the cross of two such inbred lines, each of which may have one or more desirable characteristics lacked by the other or which complement the other. The new inbreds are crossed with other inbred lines and the hybrids from these crosses are evaluated to determine which have commercial potential. The hybrid progeny of the first generation is designated F1. In the development of hybrids only the F1 hybrid plants are sought. The F1 hybrid is more vigorous than its inbred parents. This hybrid vigor, or heterosis, can be manifested in many ways, including increased vegetative growth and increased yield.
  • Hybrid maize seed can be produced by a male sterility system incorporating manual detasseling. To produce hybrid seed, the male tassel is removed from the growing female inbred parent, which can be planted in various alternating row patterns with the male inbred parent. Consequently, providing that there is sufficient isolation from sources of foreign maize pollen, the ears of the female inbred will be fertilized only with pollen from the male inbred. The resulting seed is therefore hybrid (F1) and will form hybrid plants.
  • Environmental variation in plant development can result in plants tasseling after manual detasseling of the female parent is completed. Or, a detasseler might not completely remove the tassel of a female inbred plant. In any event, the result is that the female plant will successfully shed pollen and some female plants will be self-pollinated. This will result in seed of the female inbred being harvested along with the hybrid seed which is normally produced. Female inbred seed is not as productive as F1 seed. In addition, the presence of female inbred seed can represent a germplasm security risk for the company producing the hybrid.
  • Alternatively, the female inbred can be mechanically detasseled by machine. Mechanical detasseling is approximately as reliable as hand detasseling, but is faster and less costly. However, most detasseling machines produce more damage to the plants than hand detasseling. Thus, no form of detasseling is presently entirely satisfactory and a need continues to exist for alternatives which further reduce production costs and to eliminate self-pollination of the female parent in the production of hybrid seed.
  • A reliable system of genetic male sterility would provide advantages. The laborious detasseling process can be avoided in some genotypes by using cytoplasmic male-sterile (CMS) inbreds. In the absence of a fertility restorer gene, plants of a CMS inbred are male sterile as a result of factors resulting from the cytoplasmic, as opposed to the nuclear, genome. Thus, this characteristic is inherited exclusively through the female parent in maize plants, since only the female provides cytoplasm to the fertilized seed. CMS plants are fertilized with pollen from another inbred that is not male-sterile. Pollen from the second inbred may or may not contribute genes that make the hybrid plants male-fertile. Usually seed from detasseled normal maize and CMS produced seed of the same hybrid must be blended to insure that adequate pollen loads are available for fertilization when the hybrid plants are grown and to insure cytoplasmic diversity.
  • There can be other drawbacks to CMS. One is an historically observed association of a specific variant of CMS with susceptibility to certain crop diseases. This problem has discouraged widespread use of that CMS variant in producing hybrid maize and has had a negative impact on the use of CMS in maize in general.
  • One type of genetic sterility is disclosed in U.S. Pat. Nos. 4,654,465 and 4,727,219 to Brar, et al. However, this form of genetic male sterility requires maintenance of multiple mutant genes at separate locations within the genome and requires a complex marker system to track the genes and make use of the system convenient. Patterson also described a genic system of chromosomal translocations which can be effective, but which are complicated. (See, U.S. Pat. Nos. 3,861,709 and 3,710,511)
  • Many other attempts have been made to improve on these drawbacks. For example, Fabijanski, et al., developed several methods of causing male sterility in plants (see, EP 89/3010153.8 Publication Number 329,308 and PCT Application PCT/CA90/00037 published as WO 1990/08828). One method includes delivering into the plant a gene encoding a cytotoxic substance associated with a male tissue specific promoter. Another involves an antisense system in which a gene critical to fertility is identified and an antisense to the gene inserted in the plant. Mariani, et al., also shows several cytotoxic antisense systems. See EP 89/401,194. Still other systems use “repressor” genes which inhibit the expression of another gene critical to male sterility. PCT/GB90/00102, published as WO 1990/08829.
  • A still further improvement of this system is one described at U.S. Pat. No. 5,478,369 in which a method of imparting controllable male sterility is achieved by silencing a gene native to the plant that is critical for male fertility and replacing the native DNA with the gene critical to male fertility linked to an inducible promoter controlling expression of the gene. The plant is thus constitutively sterile, becoming fertile only when the promoter is induced and its attached male fertility gene is expressed.
  • In a number of circumstances, a male sterility plant trait is expressed by maintenance of a homozygous recessive condition. Difficulties arise in maintaining the homozygous condition, when a transgenic restoration gene must be used for maintenance. For example, a natural mutation in a gene critical to male sterility can impart a male sterility phenotype to plants when this mutant allele is in the homozygous state. This sterility can be restored when the non-mutant form of the gene is introduced into the plant. However, this form of restoration removes the desired homozygous recessive condition, restores full male fertility and prevents maintenance of pure male sterile maternal lines. This issue can be avoided where production of pollen containing the restoration gene is eliminated, thus providing a maintainer plant producing only pollen not containing the restoration gene and the progeny retains the homozygous condition. An example of one approach is shown in Dellaporta, et al., U.S. Pat. No. 6,743,968, in which a plant is produced having a hemizygotic construct comprising a gene that produces a product fatal to a cell, linked with a pollen-specific promoter and the restoration gene. When crossed with the homozygous recessive male sterile plant, the progeny thus retains the homozygous recessive condition.
  • As noted, an essential aspect of much of the work underway with male sterility systems is the identification of genes impacting male fertility.
  • Such a gene can be used in a variety of systems to control male fertility including those described herein. Previously, a male fertility gene has been identified in Arabidopsis thaliana and used to produce a male sterile plant. Aarts, et al., (1993) Nature, 363:715-717. U.S. Pat. No. 5,478,369 discloses therein one such gene impacting male fertility. In the present invention the inventors provide novel DNA molecules and the amino acid sequence encoded that are critical to male fertility in plants. These can be used in any of the systems where control of fertility is useful, including those described above.
  • Thus, one object of the invention is to provide a nucleic acid sequence, the expression of which is critical to male fertility in plants.
  • Another object of the invention is to provide a DNA molecule encoding an amino acid sequence, the expression of which is critical to male fertility in plants.
  • Yet another object of the invention is to provide a promoter of such nucleotide sequence and its essential sequences.
  • A further object of the invention is to provide a method of using such DNA molecules to mediate male fertility in plants.
  • Further objects of the invention will become apparent in the description and claims that follow.
    • SUMMARY OF THE INVENTION
  • This invention relates to nucleic acid sequences, and, specifically, DNA molecules and the amino acid encoded by the DNA molecules, which are critical to male fertility. A promoter of the DNA is identified, as well as its essential sequences. It also relates to use of such DNA molecules to mediate fertility in plants.
    • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a locus map of the male fertility gene Ms26.
  • FIG. 2A is a Southern blot of the ms26-m2::Mu8 family hybridized with a Mu8 probe; FIG. 2B is a Southern blot of the ms26-m2::Mu8 family hybridized with a PstI fragment isolated from the ms26 clone.
  • FIG. 3 is a Northern Blot analysis gel hybridized with a PstI fragment isolated from the Ms26 gene.
  • FIG. 4A-4D is the sequence of Ms26 (The cDNA is SEQ ID NO: 1, the protein is SEQ ID NOS: 2 and 34).
  • FIG. 5A-5C is the genomic Ms26 sequence (also referred to as SEQ ID NO: 7).
  • FIG. 6A-6D is a comparison of the genomic Ms26 sequence (Residues 1051-1450, 1501-2100 and 2201-3326 of SEQ ID NO: 7) with the cDNA of Ms26 (SEQ ID NO: 1).
  • FIG. 7A is a Northern analysis gel showing expression in various plant tissues and FIG. 7B is a gel showing expression stages of microsporogenesis.
  • FIG. 8 is the full length promoter of Ms26 (SEQ ID NO: 5)
  • FIG. 9 is a bar graph showing luciferase activity after deletions of select regions of the Ms26 promoter.
  • FIG. 10 shows essential regions of the Ms26 promoter (SEQ ID NO: 6).
  • FIG. 11 is a bar graph showing luciferase activity after substitution by restriction site linker scanning of select small (9-10 bp) regions of the Ms26 essential promoter fragment.
  • FIGS. 12A and 12B is a comparison of the nucleotide sequence (SEQ ID NO: 3) from the Ms26 orthologue from a sorghum panicle and Ms26 maize cDNA (Residues 201-750 of SEQ ID NO: 1), and the sorghum protein sequence (SEQ ID NO: 4) and Ms26 maize protein (Residues 87-244 of SEQ ID NO: 2).
  • FIG. 13 is a representation of the mapping of the male sterility gene ms26.
  • FIG. 14 shows a sequence comparison of the region of excision of the ms26-ref allele (SEQ ID NO: 8) with wild-type Ms26 (SEQ ID NO: 9).
  • FIG. 15 shows the transposon sequence within ms26-ref (SEQ ID NO: 10).
  • FIG. 16A-16B shows the entire ms26-ref sequence (SEQ ID NO: 11).
  • FIG. 17A shows a translated protein sequence alignment between regions of the CYP704B1, a P450 gene (SEQ ID NO: 12) and Ms26 (SEQ ID NO: 13); FIG. 17B shows the phylogenetic tree analysis of select P450 genes.
  • FIG. 18 demonstrates the heme binding domain frame shift, showing the translated sequence alignment of regions of the Ms26 cDNA (SEQ ID NOS: 14 and 28-29), the genomic regions of exon 5 in fertile plants (SEQ ID NOS: 15 and 30-31) and sterile plants (SEQ ID NOS: 16 and 32-33).
  • FIG. 19 shows the rice Ms26 cDNA (SEQ ID NO: 17) and protein (SEQ ID NO: 18).
  • FIG. 20 shows alignment of the Ms26 promoter of corn (Residues 650-1091 of SEQ ID NO: 5), sorghum (SEQ ID NO: 19) and rice (SEQ ID NO: 20).
  • FIG. 21 shows alignment of the maize Ms26 protein (SEQ ID NO: 21); rice Ms26 protein (SEQ ID NO: 18) and sorghum Ms26 protein (SEQ ID NO: 22) along with a consensus sequence.
  • FIG. 22 is a plasmid map of PHP 18091, containing Ms45 fertility gene with a pollen promoter, cytotoxic gene and selectable marker.
  • FIG. 23 is a plasmid map of PHP 24101, containing the Ms26 fertility gene with a pollen promoter, cytotoxic gene and selectable marker.
  • FIG. 24 shows a sequence of the Zea mays α-amylase 1 coding region (SEQ ID NOS: 26 (DNA) and 36 (protein)).
    •  DISCLOSURE OF THE INVENTION
  • All references referred to are incorporated herein by reference.
  • Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Unless mentioned otherwise, the techniques employed or contemplated therein are standard methodologies well known to one of ordinary skill in the art. The materials, methods and examples are illustrative only and not limiting.
  • Genetic male sterility results from a mutation, suppression or other impact to one of the genes critical to a specific step in microsporogenesis, the term applied to the entire process of pollen formulation. These genes can be collectively referred to as male fertility genes (or, alternatively, male sterility genes). There are many steps in the overall pathway where gene function impacts fertility. This seems aptly supported by the frequency of genetic male sterility in maize. New alleles of male sterility mutants are uncovered in materials that range from elite inbreds to unadapted populations.
  • At U.S. Pat. No. 5,478,369 there is described a method by which the Ms45 male sterility gene was tagged and cloned on maize chromosome 9. Previously, there had been described a male sterility gene on chromosome 9, ms2, which had never been cloned and sequenced. It is not allelic to the gene referred to in the '369 patent. See, Albertsen and Phillips, (1981) Canadian Journal of Genetics & Cytology 23:195-208. The only fertility gene cloned before that had been the Arabadopsis gene described at Aarts, et al., supra.
  • Examples of genes that have been discovered subsequently that are critical to male fertility are numerous and include the Arabidopsis ABORTED MICROSPORES (AMS) gene, Sorensen, et al., (2003) The Plant Journal 33(2):413-423); the Arabidopsis MS1 gene (Wilson, et al., (2001) The Plant Journal 39(2):170-181); the NEF1 gene (Ariizumi, et al., (2004) The Plant Journal 39(2):170-181); Arabidopsis AtGPAT1 gene (Zheng, et al., (2003) The Plant Cell 15:1872-1887); the Arabdiopsis dde2-2 mutation was shown to be defective in the allene oxide syntase gene (Malek, et al., (2002) Planta 216:187-192); the Arabidopsis faceless pollen-1 gene (flp1) (Ariizumi, et al., (2003) Plant Mol. Biol. 53:107-116); the Arabidopisis MALE MEIOCYTE DEATH1 gene (Yang, et al., (2003) The Plant Cell 15:1281-1295); the tapetum-specific zinc finger gene, TAZ1 (Kapoor, et al., (2002) The Plant Cell 14:2353-2367) and the TAPETUM DETERMINANT1 gene (Lan, et al., (2003) The Plant Cell 15:2792-2804).
  • The table below lists a number of known male fertility mutants or genes from Zea mays.
  • GENE NAME ALTERNATE NAME REFERENCE
    ms1 male sterile1 male sterile1, ms1 Singleton, W R and Jones, D F.
    1930. J Hered 21: 266-268
    ms10 male sterile10 male sterile10, ms10 Beadle, G W. 1932. Genetics
    17: 413-431
    ms11 male sterile11 ms11, male sterile11 Beadle, G W. 1932. Genetics
    17: 413-431
    ms12 male sterile12 ms12, male sterile12 Beadle, G W. 1932. Genetics
    17: 413-431
    ms13 male sterile13 ms*-6060, male sterile13, Beadle, G W. 1932. Genetics
    ms13 17: 413-431
    ms14 male sterile14 ms14, male sterile14 Beadle, G W. 1932. Genetics
    17: 413-431
    ms17 male sterile17 ms17, male sterile17 Emerson, R A. 1932. Science
    75: 566
    ms2 male sterile2 male sterile2, ms2 Eyster, W H. 1931. J Hered
    22: 99-102
    ms20 male sterile20 ms20, male sterile20 Eyster, W H. 1934. Genetics of
    Zea mays. Bibliographia
    Genetica 11: 187-392
    ms23 male sterile23 : ms*-6059, ms*-6031, ms*- West, D P and Albertsen, M C.
    6027, ms*-6018, ms*-6011, 1985. MNL 59: 87
    ms35, male sterile23, ms*-
    Bear7, ms23
    ms24 male sterile24 ms24, male sterile24 West, D P and Albertsen, M C.
    1985. MNL 59: 87
    ms25 male sterile25 ms*-6065, ms*-6057, ms25, Loukides, C A; Broadwater,
    male sterile25, ms*-6022 A H; Bedinger, P A. 1995. Am J
    Bot 82: 1017-1023
    ms27 male sterile27 ms27, male sterile27 Albertsen, M C. 1996. MNL
    70: 30-31
    ms28 male sterile28 ms28, male sterile28 Golubovskaya, I N. 1979. MNL
    53: 66-70
    ms29 male sterile29 male sterile29, ms*-JH84A, Trimnell, M R et al. 1998. MNL
    ms29 72: 37-38
    ms3 male sterile3 Group 3, ms3, male sterile3 Eyster, W H. 1931. J Hered
    22: 99-102
    ms30 male sterile30 ms30, msx, ms*-6028, ms*- Albertsen, M C et al. 1999.
    Li89, male sterile30, ms*-LI89 MNL 73: 48
    ms31 male sterile31 ms*-CG889D, ms31, male Trimnell, M R et al. 1998. MNL
    sterile31 72: 38
    ms32 male sterile32 male sterile32, ms32 Trimnell, M R et al. 1999. MNL
    73: 48-49
    ms33 male sterile33 : ms*-6054, ms*-6024, ms33, Patterson, E B. 1995. MNL
    ms*-GC89A, ms*-6029, male 69: 126-128
    sterile6019, Group 7, ms*-
    6038, ms*-Stan1, ms*-6041,
    ms*-6019, male sterile33
    ms34 male sterile34 Group 1, ms*-6014, ms*-6010, Patterson, E B. 1995. MNL
    male sterile34, ms34, ms*- 69: 126-128
    6013, ms*-6004, male
    sterile6004
    ms36 male sterile36 male sterile36, ms*-MS85A, Trimnell, M R et al. 1999. MNL
    ms36 73: 49-50
    ms37 male sterile 37 ms*-SB177, ms37, male sterile Trimnell, M R et al. 1999. MNL
    37 73: 48
    ms38 male sterile38 ms30, ms38, ms*-WL87A, Albertsen, M C et al. 1996.
    male sterile38 MNL 70: 30
    ms43 male sterile43 ms43, male sterile43, ms29 Golubovskaya, I N. 1979. Int
    Rev Cytol 58: 247-290
    ms45 male sterile45 Group 6, male sterile45, ms*- Albertsen, M C; Fox, T W;
    6006, ms*-6040, ms*-BS1, Trimnell, M R. 1993. Proc Annu
    ms*-BS2, ms*-BS3, ms45, Corn Sorghum Ind Res Conf
    ms45′-9301 48: 224-233
    ms48 male sterile48 male sterile48, ms*-6049, Trimnell, M et al. 2002. MNL
    ms48 76: 38
    ms5 male sterile5 : ms*-6061, ms*-6048, ms*- Beadle, G W. 1932. Genetics
    6062, male sterile5, ms5 17: 413-431
    ms50 male sterile50 ms50, male sterile50, ms*- Trimnell, M et al. 2002. MNL
    6055, ms*-6026 76: 39
    ms7 male sterile7 ms7, male sterile7 Beadle, G W. 1932. Genetics
    17: 413-431
    ms8 male sterile8 male sterile8, ms8 Beadle, G W. 1932. Genetics
    17: 413-431
    ms9 male sterile9 Group 5, male sterile9, ms9 Beadle, G W. 1932. Genetics
    17: 413-431
    ms49 male sterile49 ms*-MB92, ms49, male Trimnell, M et al. 2002. MNL
    sterile49 76: 38-39
  • Thus the invention includes using the sequences shown herein to impact male fertility in a plant, that is, to control male fertility by manipulation of the genome using the genes of the invention. By way of example, without limitation, any of the methods described infra can be used with the sequence of the invention such as introducing a mutant sequence into a plant to cause sterility, causing mutation to the native sequence, introducing an antisense of the sequence into the plant, use of hairpin formations, linking it with other sequences to control its expression or any one of a myriad of processes available to one skilled in the art to impact male fertility in a plant.
  • The Ms26 gene described herein is located on maize chromosome 1 and its dominant allele is critical to male fertility. The locus map is represented at FIG. 1. It can be used in the systems described above, and other systems impacting male fertility.
  • The maize family cosegregating for sterility was named ms*-SBMu200 and was found to have an approximately 5.5 Kb EcoRI fragment that hybridized with a Mu8 probe (FIG. 2A). A genomic clone from the family was isolated which contained a Mu8 transposon. A probe made from DNA bordering the transposon was found to hybridize to the same ˜5.5 Kb EcoRI fragment (FIG. 2B). This probe was used to isolate cDNA clones from a tassel cDNA library. The cDNA is 1906 bp, and the Mu insertion occurred in exon 1 of the gene. This probe was also used to map the mutation in an RFLP mapping population. The mutant mapped to the short arm of chromosome 1, near Ms26. Allelism crosses between ms26-ref and ms*-SBMu200 showed that these were allelic, indicating that the mutations occurred in the same gene. The ms*-SBMu200 allele was renamed ms26-m2::Mu8. Two additional alleles for the Ms26 gene were cloned, one containing a Mutator element in the second exon, named ms26-m3::Mu* and one containing an unknown transposon in the fifth exon from the ms26-ref allele. FIG. 5 (discussed further below) represents the genomic nucleotide sequence. Expression patterns, as determined by Northern analysis, show tassel specificity with peak expression at about the quartet to quartet release stages of microsporogenesis.
  • It will be evident to one skilled in the art that variations, mutations, derivations including fragments smaller than the entire sequence set forth may be used which retain the male sterility controlling properties of the gene. One of ordinary skill in the art can readily assess the variant or fragment by introduction into plants homozygous for a stable male sterile allele of Ms26, followed by observation of the plant's male tissue development.
  • The sequences of the invention may be isolated from any plant, including, but not limited to corn (Zea mays), canola (Brassica napus, Brassica rapa ssp.), alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), sunflower (Helianthus annuus), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), millet (Panicum spp.), potato (Solanum tuberosum), peanuts (Arachis hypogaea), cotton (Gossypium hirsutum), sweet potato (Ipomoea batatus), cassava (Manihot esculenta), coffee (Cofea spp.), coconut (Cocos nucifera), pineapple (Ananas comosus), citrus trees (Citrus spp.), cocoa (Theobroma cacao), tea (Camellia sinensis), banana (Musa spp.), avocado (Persea americana), fig (Ficus casica), guava (Psidium guajava), mango (Mangifera indica), olive (Olea europaea), oats (Avena sativa), barley (Hordeum vulgare), vegetables, ornamentals, and conifers. Preferably, plants include corn, soybean, sunflower, safflower, canola, wheat, barley, rye, alfalfa, rice, cotton and sorghum.
  • Sequences from other plants may be isolated according to well-known techniques based on their sequence homology to the homologous coding region of the coding sequences set forth herein. In these techniques, all or part of the known coding sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e. genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences. An extensive guide to the hybridization of nucleic acids is found in Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology—Hybridization with Nucleic Acid Probes, Part I, Chapter 2 “Overview of principles of hybridization and the strategy of nucleic acid probe assays”, Elsevier, New York (1993) and Current Protocols in Molecular Biology, Chapter 2, Ausubel, et al., Eds., Greene Publishing and Wiley-Interscience, New York (1995).
  • Thus the invention also includes those nucleotide sequences which selectively hybridize to the Ms26 nucleotide sequences under stringent conditions. In referring to a sequence that “selectively hybridizes” with Ms26, the term includes reference to hybridization, under stringent hybridization conditions, of a nucleic acid sequence to the specified nucleic acid target sequence to a detectably greater degree than its hybridization to non-target nucleic acid.
  • The terms “stringent conditions” or “stringent hybridization conditions” includes reference to conditions under which a probe will hybridize to its target sequence, to a detectably greater degree than to other sequences. Stringent conditions are target-sequence-dependent and will differ depending on the structure of the polynucleotide. By controlling the stringency of the hybridization and/or washing conditions, target sequences can be identified which are 100% complementary to a probe (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing). Generally, probes of this type are in a range of about 1000 nucleotides in length to about 250 nucleotides in length.
  • An extensive guide to the hybridization of nucleic acids is found in Tijssen, Laboratory Techniques in Biochemistry and Molecular Biology—Hybridization with Nucleic Acid Probes, Part I, Chapter 2 “Overview of principles of hybridization and the strategy of nucleic acid probe assays”, Elsevier, New York (1993); and Current Protocols in Molecular Biology, Chapter 2, Ausubel, et al., Eds., Greene Publishing and Wiley-Interscience, New York (1995). See also, Sambrook, et al., (1989) Molecular Cloning: A Laboratory Manual (2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.).
  • In general, sequences that correspond to the nucleotide sequences of the present invention and hybridize to the nucleotide sequence disclosed herein will be at least 50% homologous, 70% homologous, and even 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence. That is, the sequence similarity between probe and target may range, sharing at least about 50%, about 70% and even about 85% or more sequence similarity.
  • Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. Generally, stringent wash temperature conditions are selected to be about 5° C. to about 2° C. lower than the melting point (Tm) for the specific sequence at a defined ionic strength and pH. The melting point, or denaturation, of DNA occurs over a narrow temperature range and represents the disruption of the double helix into its complementary single strands. The process is described by the temperature of the midpoint of transition, Tm, which is also called the melting temperature. Formulas are available in the art for the determination of melting temperatures.
  • Preferred hybridization conditions for the nucleotide sequence of the invention include hybridization at 42° C. in 50% (w/v) formamide, 6×SSC, 0.5% (w/v) SDS, 100(g/ml salmon sperm DNA. Exemplary low stringency washing conditions include hybridization at 42° C. in a solution of 2×SSC, 0.5% (w/v) SDS for 30 minutes and repeating. Exemplary moderate stringency conditions include a wash in 2×SSC, 0.5% (w/v) SDS at 50° C. for 30 minutes and repeating. Exemplary high stringency conditions include a wash in 0.1×SSC, 0.1% (w/v) SDS, at 65° C. for 30 minutes to one hour and repeating. Sequences that correspond to the promoter of the present invention may be obtained using all the above conditions. For purposes of defining the invention, the high stringency conditions are used.
  • The following terms are used to describe the sequence relationships between two or more nucleic acids or polynucleotides: (a) “reference sequence”, (b) “comparison window”, (c) “sequence identity” and (d) “percentage of sequence identity.”
  • (a) As used herein, “reference sequence” is a defined sequence used as a basis for sequence comparison. A reference sequence may be a subset or the entirety of a specified sequence; for example, as a segment of a full-length cDNA or gene sequence or the complete cDNA or gene sequence.
  • (b) As used herein, “comparison window” makes reference to a contiguous and specified segment of a polynucleotide sequence, wherein the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. Generally, the comparison window is at least 20 contiguous nucleotides in length, and optionally can be 30, 40, 50 or 100 nucleotides in length or longer. Those of skill in the art understand that to avoid a high similarity to a reference sequence due to inclusion of gaps in the polynucleotide sequence a gap penalty is typically introduced and is subtracted from the number of matches.
  • Methods of aligning sequences for comparison are well-known in the art. Thus, the determination of percent sequence identity between any two sequences can be accomplished using a mathematical algorithm. Non-limiting examples of such mathematical algorithms are the algorithm of Myers and Miller, (1988) CABIOS 4:11-17; the local alignment algorithm of Smith, et al., (1981) Adv. Appl. Math. 2: 482; the global alignment algorithm of Needleman and Wunsch, (1970) J. Mol. Biol. 48: 443-453; the search-for-local-alignment-method of Pearson and Lipman, (1988) Proc. Natl. Acad. Sci. 85: 2444-2448; the algorithm of Karlin and Altschul, (1990) Proc. Natl. Acad. Sci. USA 87: 2264, modified as in Karlin and Altschul, (1993) Proc. Natl. Acad. Sci. USA 90: 5873-5877.
  • Computer implementations of these mathematical algorithms can be utilized for comparison of sequences to determine sequence identity. Such implementations include, but are not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics, Mountain View, Calif.); the ALIGN program (Version 2.0) and GAP, BESTFIT, BLAST, FASTA and TFASTA in the GCG Wisconsin Genetics Software Package, Version 10 (available from Accelrys Inc., 9685 Scranton Road, San Diego, Calif., USA). Alignments using these programs can be performed using the default parameters. The CLUSTAL program is well described by Higgins, et al., (1988) Gene 73:237-244 (1988); Higgins, et al., (1989) CABIOS 5:151-153; Corpet, et al., (1988) Nucleic Acids Res. 16:10881-90; Huang, et al., (1992) CABIOS 8:155-65 and Pearson, et al., (1994) Meth. Mol. Biol. 24:307-331. The ALIGN program is based on the algorithm of Myers and Miller, (1988) supra. A PAM120 weight residue table, a gap length penalty of 12 and a gap penalty of 4 can be used with the ALIGN program when comparing amino acid sequences. The BLAST programs of Altschul, et al., (1990) J. Mol. Biol. 215:403 are based on the algorithm of Karlin and Altschul, (1990) supra. BLAST nucleotide searches can be performed with the BLASTN program, score=100, wordlength=12, to obtain nucleotide sequences homologous to a nucleotide sequence encoding a protein of the invention. BLAST protein searches can be performed with the BLASTX program, score=50, wordlength=3, to obtain amino acid sequences homologous to a protein or polypeptide of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST (in BLAST 2.0) can be utilized as described in Altschul, et al., (1997) Nucleic Acids Res. 25:3389. Alternatively, PSI-BLAST (in BLAST 2.0) can be used to perform an iterated search that detects distant relationships between molecules. See, Altschul, et al., (1997) supra. When utilizing BLAST, Gapped BLAST, PSI-BLAST, the default parameters of the respective programs (e.g., BLASTN for nucleotide sequences, BLASTX for proteins) can be used. See http://www.ncbi.nlm.nih.gov. Alignment may also be performed manually by inspection.
  • Unless otherwise stated, sequence identity/similarity values provided herein refer to the value obtained using GAP Version 10 using the following parameters: % identity and % similarity for a nucleotide sequence using GAP Weight of 50 and Length Weight of 3 and the nwsgapdna.cmp scoring matrix; % identity and % similarity for an amino acid sequence using GAP Weight of 8 and Length Weight of 2 and the BLOSUM62 scoring matrix or any equivalent program thereof. By “equivalent program” is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by GAP Version 10.
  • GAP uses the algorithm of Needleman and Wunsch, (1970) J. Mol. Biol. 48:443-453, to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. GAP considers all possible alignments and gap positions and creates the alignment with the largest number of matched bases and the fewest gaps. It allows for the provision of a gap creation penalty and a gap extension penalty in units of matched bases. GAP must make a profit of gap creation penalty number of matches for each gap it inserts. If a gap extension penalty greater than zero is chosen, GAP must, in addition, make a profit for each gap inserted of the length of the gap times the gap extension penalty. Default gap creation penalty values and gap extension penalty values in Version 10 of the GCG Wisconsin Genetics Software Package for protein sequences are 8 and 2, respectively. For nucleotide sequences the default gap creation penalty is 50 while the default gap extension penalty is 3. The gap creation and gap extension penalties can be expressed as an integer selected from the group of integers consisting of from 0 to 200. Thus, for example, the gap creation and gap extension penalties can be 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65 or greater.
  • GAP presents one member of the family of best alignments. There may be many members of this family, but no other member has a better quality. GAP displays four figures of merit for alignments: Quality, Ratio, Identity and Similarity. The Quality is the metric maximized in order to align the sequences. Ratio is the quality divided by the number of bases in the shorter segment. Percent Identity is the percent of the symbols that actually match. Percent Similarity is the percent of the symbols that are similar. Symbols that are across from gaps are ignored. A similarity is scored when the scoring matrix value for a pair of symbols is greater than or equal to 0.50, the similarity threshold. The scoring matrix used in Version 10 of the GCG Wisconsin Genetics Software Package is BLOSUM62 (see, Henikoff and Henikoff, (1989) Proc. Natl. Acad. Sci. USA 89:10915).
  • (c) As used herein, “sequence identity” or “identity” in the context of two nucleic acid or polypeptide sequences makes reference to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window. When percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. When sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Sequences that differ by such conservative substitutions are said to have “sequence similarity” or “similarity”. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated, e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif.).
  • (d) As used herein, “percentage of sequence identity” means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison and multiplying the result by 100 to yield the percentage of sequence identity.
  • The use of the term “polynucleotide” is not intended to limit the present invention to polynucleotides comprising DNA. Those of ordinary skill in the art will recognize that polynucleotides can comprise ribonucleotides and combinations of ribonucleotides and deoxyribonucleotides. Such deoxyribonucleotides and ribonucleotides include both naturally occurring molecules and synthetic analogues. The polynucleotides of the invention also encompass all forms of sequences including, but not limited to, single-stranded forms, double-stranded forms, hairpins, stem-and-loop structures and the like.
  • Identity to the sequence of the present invention would mean a polynucleotide sequence having at least 65% sequence identity, more preferably at least 70% sequence identity, more preferably at least 75% sequence identity, more preferably at least 80% identity, more preferably at least 85% A 88%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% sequence identity.
  • Promoter regions can be readily identified by one skilled in the art. The putative start codon containing the ATG motif is identified and upstream from the start codon is the presumptive promoter. By “promoter” is intended a regulatory region of DNA usually comprising a TATA box capable of directing RNA polymerase II to initiate RNA synthesis at the appropriate transcription initiation site for a particular coding sequence. A promoter can additionally comprise other recognition sequences generally positioned upstream or 5′ to the TATA box, referred to as upstream promoter elements, which influence the transcription initiation rate. It is recognized that having identified the nucleotide sequences for the promoter region disclosed herein, it is within the state of the art to isolate and identify further regulatory elements in the region upstream of the TATA box from the particular promoter region identified herein. Thus the promoter region disclosed herein is generally further defined by comprising upstream regulatory elements such as those responsible for tissue and temporal expression of the coding sequence, enhancers and the like. In the same manner, the promoter elements which enable expression in the desired tissue such as male tissue can be identified, isolated and used with other core promoters to confirm male tissue-preferred expression. By core promoter is meant the minimal sequence required to initiate transcription, such as the sequence called the TATA box which is common to promoters in genes encoding proteins. Thus the upstream promoter of Ms26 can optionally be used in conjunction with its own or core promoters from other sources. The promoter may be native or non-native to the cell in which it is found.
  • The isolated promoter sequence of the present invention can be modified to provide for a range of expression levels of the heterologous nucleotide sequence. Less than the entire promoter region can be utilized and the ability to drive anther-preferred expression retained. However, it is recognized that expression levels of mRNA can be decreased with deletions of portions of the promoter sequence. Thus, the promoter can be modified to be a weak or strong promoter. Generally, by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By “low level” is intended levels of about 1/10,000 transcripts to about 1/100,000 transcripts to about 1/500,000 transcripts. Conversely, a strong promoter drives expression of a coding sequence at a high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1,000 transcripts. Generally, at least about 30 nucleotides of an isolated promoter sequence will be used to drive expression of a nucleotide sequence. It is recognized that to increase transcription levels, enhancers can be utilized in combination with the promoter regions of the invention. Enhancers are nucleotide sequences that act to increase the expression of a promoter region. Enhancers are known in the art and include the SV40 enhancer region, the 35S enhancer element, and the like.
  • The promoter of the present invention can be isolated from the 5′ region of its native coding region of 5′ untranslation region (5′UTR). Likewise the terminator can be isolated from the 3′ region flanking its respective stop codon. The term “isolated” refers to material such as a nucleic acid or protein which is substantially or essentially free from components which normally accompany or interact with the material as found in it naturally occurring environment or if the material is in its natural environment, the material has been altered by deliberate human intervention to a composition and/or placed at a locus in a cell other than the locus native to the material. Methods for isolation of promoter regions are well known in the art.
  • “Functional variants” of the regulatory sequences are also encompassed by the compositions of the present invention. Functional variants include, for example, the native regulatory sequences of the invention having one or more nucleotide substitutions, deletions or insertions. Functional variants of the invention may be created by site-directed mutagenesis, induced mutation or may occur as allelic variants (polymorphisms).
  • As used herein, a “functional fragment” of the regulatory sequence is a nucleotide sequence that is a regulatory sequence variant formed by one or more deletions from a larger sequence. For example, the 5′ portion of a promoter up to the TATA box near the transcription start site can be deleted without abolishing promoter activity, as described by Opsahl-Sorteberg, et al., (2004) Gene 341:49-58. Such variants should retain promoter activity, particularly the ability to drive expression in male tissues. Activity can be measured by Northern blot analysis, reporter activity measurements when using transcriptional fusions, and the like. See, for example, Sambrook, et al., (1989) Molecular Cloning: A Laboratory Manual (2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.), herein incorporated by reference.
  • Functional fragments can be obtained by use of restriction enzymes to cleave the naturally occurring regulatory element nucleotide sequences disclosed herein; by synthesizing a nucleotide sequence from the naturally occurring DNA sequence; or can be obtained through the use of PCR technology See particularly, Mullis, et al., (1987) Methods Enzymol. 155:335-350 and Erlich, ed. (1989) PCR Technology (Stockton Press, New York).
  • Sequences which hybridize to the regulatory sequences of the present invention are within the scope of the invention. Sequences that correspond to the promoter sequences of the present invention and hybridize to the promoter sequences disclosed herein will be at least 50% homologous, 70% homologous, and even 85% 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% homologous or more with the disclosed sequence.
  • Smaller fragments may yet contain the regulatory properties of the promoter so identified and deletion analysis is one method of identifying essential regions. Deletion analysis can occur from both the 5′ and 3′ ends of the regulatory region. Fragments can be obtained by site-directed mutagenesis, mutagenesis using the polymerase chain reaction and the like. (See, Directed Mutagenesis: A Practical Approach IRL Press (1991)). The 3′ deletions can delineate the essential region and identify the 3′ end so that this region may then be operably linked to a core promoter of choice. Once the essential region is identified, transcription of an exogenous gene may be controlled by the essential region plus a core promoter. By core promoter is meant the sequence called the TATA box which is common to promoters in all genes encoding proteins. Thus the upstream promoter of Ms26 can optionally be used in conjunction with its own or core promoters from other sources. The promoter may be native or non-native to the cell in which it is found.
  • The core promoter can be any one of known core promoters such as the Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), ubiquitin promoter (U.S. Pat. No. 5,510,474) the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al., “Vectors for Plant Transformation” Methods in Plant Molecular Biology and Biotechnology) et al. eds, CRC Press pp. 89-119 (1993)).
  • The regulatory region of Ms26 has been identified as including the 1005 bp region upstream of the putative TATA box. See, FIG. 8. Further, using the procedures outlined above, it has been determined that an essential region of the promoter includes the −180 bp upstream of the TATA box and specifically, the −176 to −44 region is particularly essential.
  • Promoter sequences from other plants may be isolated according to well-known techniques based on their sequence homology to the promoter sequence set forth herein. In these techniques, all or part of the known promoter sequence is used as a probe which selectively hybridizes to other sequences present in a population of cloned genomic DNA fragments (i.e., genomic libraries) from a chosen organism. Methods are readily available in the art for the hybridization of nucleic acid sequences.
  • The entire promoter sequence or portions thereof can be used as a probe capable of specifically hybridizing to corresponding promoter sequences. To achieve specific hybridization under a variety of conditions, such probes include sequences that are unique and are preferably at least about 10 nucleotides in length and most preferably at least about 20 nucleotides in length. Such probes can be used to amplify corresponding promoter sequences from a chosen organism by the well-known process of polymerase chain reaction (PCR). This technique can be used to isolate additional promoter sequences from a desired organism or as a diagnostic assay to determine the presence of the promoter sequence in an organism. Examples include hybridization screening of plated DNA libraries (either plaques or colonies; see, e.g., Innis, et al., eds., (1990) PCR Protocols, A Guide to Methods and Applications, Academic Press).
  • Further, a promoter of the present invention can be linked with nucleotide sequences other than the Ms26 gene to express other heterologous nucleotide sequences. The nucleotide sequence for the promoter of the invention, as well as fragments and variants thereof, can be provided in expression cassettes along with heterologous nucleotide sequences for expression in the plant of interest, more particularly in the male tissue of the plant. Such an expression cassette is provided with a plurality of restriction sites for insertion of the nucleotide sequence to be under the transcriptional regulation of the promoter. These expression cassettes are useful in the genetic manipulation of any plant to achieve a desired phenotypic response.
  • Examples of other nucleotide sequences which can be used as the exogenous gene of the expression vector with the Ms26 promoter, or other promoters taught herein or known to those of skill in the art or other promoters taught herein or known to those of skill in the art complementary nucleotidic units such as antisense molecules (callase antisense RNA, barnase antisense RNA and chalcone synthase antisense RNA, Ms45 antisense RNA), ribozymes and external guide sequences, an aptamer or single stranded nucleotides. The exogenous nucleotide sequence can also encode carbohydrate degrading or modifying enzymes, amylases, debranching enzymes and pectinases, such as the alpha amylase gene of FIG. 24, auxins, rol B, cytotoxins, diptheria toxin, DAM methylase, avidin or may be selected from a prokaryotic regulatory system. By way of example, Mariani, et al., (1990) Nature 347:737, have shown that expression in the tapetum of either Aspergillus oryzae RNase-T1 or an RNase of Bacillus amyloliquefaciens, designated “barnase,” induced destruction of the tapetal cells, resulting in male infertility. Quaas, et al., (1988) Eur. J. Biochem. 173:617, describe the chemical synthesis of the RNase-T1, while the nucleotide sequence of the barnase gene is disclosed in Hartley, (1988) J. Molec. Biol. 202:913. The rolB gene of Agrobacterium rhizogenes codes for an enzyme that interferes with auxin metabolism by catalyzing the release of free indoles from indoxyl-β-glucosides. Estruch, et al., (1991) EMBO J. 11:3125 and Spena, et al., (1992) Theor. Appl. Genet. 84:520, have shown that the anther-specific expression of the rolB gene in tobacco resulted in plants having shriveled anthers in which pollen production was severely decreased and the rolB gene is an example of a gene that is useful for the control of pollen production. Slightom, et al., (1985) J. Biol. Chem. 261:108, disclose the nucleotide sequence of the rolB gene. DNA molecules encoding the diphtheria toxin gene can be obtained from the American Type Culture Collection (Rockville, Md.), ATCC Number 39359 or ATCC Number 67011 and see, Fabijanski, et al., EP Application Number 90902754.2, for examples and methods of use. The DAM methylase gene is used to cause sterility in the methods discussed at U.S. Pat. No. 5,689,049 and PCT/US95/15229 Cigan and Albertsen, “Reversible Nuclear Genetic System for Male Sterility in Transgenic Plants.” Also see, discussion of use of the avidin gene to cause sterility at U.S. Pat. No. 5,962,769 “Induction of Male Sterility in Plants by Expression of High Levels of Avidin” by Albertsen, et al.
  • The invention includes vectors with the Ms26 gene. A vector is prepared comprising Ms26, a promoter that will drive expression of the gene in the plant and a terminator region. As noted, the promoter in the construct may be the native promoter or a substituted promoter which will provide expression in the plant. The promoter in the construct may be an inducible promoter, so that expression of the sense or antisense molecule in the construct can be controlled by exposure to the inducer. In this regard, any plant-compatible promoter elements can be employed in the construct, influenced by the end result desired. Those can be plant gene promoters, such as, for example, the promoter for the small subunit of ribulose-1,5-bis-phosphate carboxylase or promoters from the tumor-inducing plasmids from Agrobacterium tumefaciens, such as the nopaline synthase and octopine synthase promoters or viral promoters such as the cauliflower mosaic virus (CaMV) 19S and 35S promoters or the figwort mosaic virus 35S promoter. See, Kay, et al., (1987) Science 236:1299 and EP Application Number 0 342 926; the barley lipid transfer protein promoter, LTP2 (Kalla, et al., (1994) Plant J. 6(6):849-60); the ubiquitin promoter (see for example U.S. Pat. No. 5,510,474); the END2 promoter (Linnestad, et al., U.S. Pat. No. 6,903,205) and the polygalacturonase PG47 promoter (see, Allen and Lonsdale, (1993) Plant J. 3:261-271; WO 1994/01572; U.S. Pat. No. 5,412,085). See, International Application Number WO 1991/19806 for a review of illustrative plant promoters suitably employed in the present invention.
  • The range of available plant compatible promoters includes tissue specific and inducible promoters. An inducible regulatory element is one that is capable of directly or indirectly activating transcription of one or more DNA sequences or genes in response to an inducer. In the absence of an inducer the DNA sequences or genes will not be transcribed. Typically the protein factor that binds specifically to an inducible regulatory element to activate transcription is present in an inactive form which is then directly or indirectly converted to the active form by the inducer. The inducer can be a chemical agent such as a protein, metabolite, growth regulator, herbicide or phenolic compound or a physiological stress imposed directly by heat, cold, salt or toxic elements or indirectly through the actin of a pathogen or disease agent such as a virus. A plant cell containing an inducible regulatory element may be exposed to an inducer by externally applying the inducer to the cell or plant such as by spraying, watering, heating or similar methods.
  • Any inducible promoter can be used in the instant invention. See, Ward, et al., (1993) Plant Mol. Biol. 22:361-366. Exemplary inducible promoters include ecdysone receptor promoters, U.S. Pat. No. 6,504,082; promoters from the ACE1 system which responds to copper (Mett, et al., (1993) PNAS 90:4567-4571); In2-1 and In2-2 gene from maize which respond to benzenesulfonamide herbicide safeners (U.S. Pat. No. 5,364,780; Hershey, et al., (1991) Mol. Gen. Genetics 227:229-237 and Gatz, et al., (1994) Mol. Gen. Genetics 243:32-38); the maize GST promoter, which is activated by hydrophobic electrophilic compounds that are used as pre-emergent herbicides and the tobacco PR-1 a promoter, which is activated by salicylic acid. Other chemical-regulated promoters of interest include steroid-responsive promoters (see, for example, the glucocorticoid-inducible promoter in Schena, et al., (1991) Proc. Natl. Acad. Sci. USA 88:10421-10425 and McNellis, et al., (1998) Plant J. 14(2):247-257) and tetracycline-inducible and tetracycline-repressible promoters (see, for example, Gatz, et al., (1991) Mol. Gen. Genet. 227:229-237 and U.S. Pat. Nos. 5,814,618 and 5,789,156).
  • Tissue-preferred promoters can be utilized to target enhanced transcription and/or expression within a particular plant tissue. Promoters may express in the tissue of interest, along with expression in other plant tissue, may express strongly in the tissue of interest and to a much lesser degree than other tissue or may express highly preferably in the tissue of interest. Tissue-preferred promoters include those described in Yamamoto, et al., (1997) Plant J. 12(2):255-265; Kawamata, et al., (1997) Plant Cell Physiol. 38(7):792-803; Hansen, et al., (1997) Mol. Gen. Genet. 254(3):337-343; Russell, et al., (1997) Transgenic Res. 6(2):157-168; Rinehart, et al., (1996) Plant Physiol. 112(3):1331-1341; Van Camp, et al., (1996) Plant Physiol. 112(2):525-535; Canevascini, et al., (1996) Plant Physiol. 112(2):513-524; Yamamoto, et al., (1994) Plant Cell Physiol. 35(5):773-778; Lam, (1994) Results Probl. Cell Differ. 20:181-196; Orozco, et al., (1993) Plant Mol. Biol. 23(6):1129-1138; Matsuoka, et al., (1993) Proc Natl. Acad. Sci. USA 90(20):9586-9590 and Guevara-Garcia, et al., (1993) Plant J. 4(3):495-505. In one embodiment, the promoters are those which preferentially express to the male or female tissue of the plant. The invention does not require that any particular male tissue-preferred promoter be used in the process, and any of the many such promoters known to one skilled in the art may be employed. The native Ms26 promoter described herein is one example of a useful promoter. Another such promoter is the 5126 promoter, which preferentially directs expression of the gene to which it is linked to male tissue of the plants, as described in U.S. Pat. Nos. 5,837,851 and 5,689,051. Other examples include the Ms45 promoter described at U.S. Pat. No. 6,037,523; SF3 promoter described at U.S. Pat. No. 6,452,069; the BS92-7 promoter described at WO 02/063021; a SGB6 regulatory element described at U.S. Pat. No. 5,470,359; the TA29 promoter (Koltunow, et al., (1990) Plant Cell 2:1201-1224; Goldberg, et al., (1993) Plant Cell 5:1217-1229 and U.S. Pat. No. 6,399,856); the type 2 metallothionein-like gene promoter (Charbonnel-Campaa, et al., Gene (2000) 254:199-208) and the Brassica Bca9 promoter (Lee, et al., (2003) Plant Cell Rep. 22:268-273).
  • Male gamete preferred promoters include the PG47 promoter, supra as well as ZM13 promoter (Hamilton, et al., (1998) Plant Mol. Biol. 38:663-669); actin depolymerizing factor promoters (such as Zmabp1, Zmabp2; see, for example Lopez, et al., (1996) Proc. Natl. Acad. Sci. USA 93:7415-7420); the promoter of the maize pectin methylesterase-liked gene, ZmC5 (Wakeley, et al., (1998) Plant Mol. Biol. 37:187-192); the profiling gene promoter Zmprol (Kovar, et al., (2000) The Plant Cell 12:583-598); the sulphated pentapeptide phytosulphokine gene ZmPSK1 (Lorbiecke, et al., (2005) Journal of Experimental Botany 56(417):1805-1819); the promoter of the calmodulin binding protein Mpcbp (Reddy, et al., (2000) J. Biol. Chem. 275(45):35457-70).
  • Other components of the vector may be included, also depending upon intended use of the gene. Examples include selectable markers, targeting or regulatory sequences, stabilizing or leader sequences, introns etc. General descriptions and examples of plant expression vectors and reporter genes can be found in Gruber, et al., “Vectors for Plant Transformation” in Method in Plant Molecular Biology and Biotechnology, Glick, et al., eds; CRC Press pp. 89-119 (1993). The selection of an appropriate expression vector will depend upon the host and the method of introducing the expression vector into the host. The expression cassette will also include at the 3′ terminus of the heterologous nucleotide sequence of interest, a transcriptional and translational termination region functional in plants. The termination region can be native with the promoter nucleotide sequence of the present invention, can be native with the DNA sequence of interest, or can be derived from another source. Convenient termination regions are available from the Ti-plasmid of A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also, Guerineau, et al., (1991) Mol. Gen. Genet. 262:141-144; Proudfoot, (1991) Cell 64:671-674; Sanfacon, et al., (1991) Genes Dev. 5:141-149; Mogen, et al., (1990) Plant Cell 2:1261-1272; Munroe, et al., (1990) Gene 91:151-158; Ballas, et al., (1989) Nucleic Acids Res. 17:7891-7903; Joshi, et al., (1987) Nucleic Acid Res. 15:9627-9639.
  • The expression cassettes can additionally contain 5′ leader sequences. Such leader sequences can act to enhance translation. Translation leaders are known in the art and include by way of example, picornavirus leaders, EMCV leader (Encephalomyocarditis 5′ noncoding region), Elroy-Stein, et al., (1989) Proc. Nat. Acad. Sci. USA 86:6126-6130; potyvirus leaders, for example, TEV leader (Tobacco Etch Virus), Allison, et al.; MDMV leader (Maize Dwarf Mosaic Virus), Virology 154:9-20 (1986); human immunoglobulin heavy-chain binding protein (BiP), Macejak, et al., (1991) Nature 353:90-94; untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4), Jobling, et al., (1987) Nature 325:622-625; Tobacco mosaic virus leader (TMV), Gallie, et al., (1989) Molecular Biology of RNA, pages 237-256 and maize chlorotic mottle virus leader (MCMV) Lommel, et al., (1991) Virology 81:382-385. See also, Della-Cioppa, et al., (1987) Plant Physiology 84:965-968. The cassette can also contain sequences that enhance translation and/or mRNA stability such as introns.
  • In those instances where it is desirable to have the expressed product of the heterologous nucleotide sequence directed to a particular organelle, particularly the plastid, amyloplast or to the endoplasmic reticulum or secreted at the cell's surface or extracellularly, the expression cassette can further comprise a coding sequence for a transit peptide. Such transit peptides are well known in the art and include, but are not limited to, the transit peptide for the acyl carrier protein, the small subunit of RUBISCO, plant EPSP synthase, Zea mays Brittle-1 chloroplast transit peptide (Nelson, et al., (1998) Plant Physiol 117(4):1235-1252; Sullivan, et al., Plant Cell 3(12):1337-48; Sullivan, et al., (1995) Planta 196(3):477-84; Sullivan, et al., (1992) J. Biol. Chem. 267(26):18999-9004) and the like. One skilled in the art will readily appreciate the many options available in expressing a product to a particular organelle. For example, the barley alpha amylase sequence is often used to direct expression to the endoplasmic reticulum (Rogers, (1985) J. Biol. Chem. 260:3731-3738). Use of transit peptides is well known (e.g., see, U.S. Pat. Nos. 5,717,084; 5,728,925).
  • In preparing the expression cassette, the various DNA fragments can be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate, in the proper reading frame. Toward this end, adapters or linkers can be employed to join the DNA fragments or other manipulations can be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites or the like. For this purpose, in vitro mutagenesis, primer repair, restriction digests, annealing and resubstitutions, such as transitions and transversions, can be involved.
  • As noted herein, the present invention provides vectors capable of expressing genes of interest. In general, the vectors should be functional in plant cells. At times, it may be preferable to have vectors that are functional in E. coli (e.g., production of protein for raising antibodies, DNA sequence analysis, construction of inserts, obtaining quantities of nucleic acids). Vectors and procedures for cloning and expression in E. coli are discussed in Sambrook, et al. (supra).
  • The transformation vector comprising the promoter sequence of the present invention operably linked to a heterologous nucleotide sequence in an expression cassette, can also contain at least one additional nucleotide sequence for a gene to be cotransformed into the organism. Alternatively, the additional sequence(s) can be provided on another transformation vector.
  • Reporter genes can be included in the transformation vectors. Examples of suitable reporter genes known in the art can be found in, for example, Jefferson, et al., (1991) in Plant Molecular Biology Manual, ed. Gelvin, et al., (Kluwer Academic Publishers), pp. 1-33; DeWet, et al., (1987) Mol. Cell. Biol. 7:725-737; Goff, et al., (1990) EMBO J. 9:2517-2522; Kain, et al., (1995) BioTechniques 19:650-655 and Chiu, et al., (1996) Current Biology 6:325-330.
  • Selectable reporter genes for selection of transformed cells or tissues can be included in the transformation vectors. These can include genes that confer antibiotic resistance or resistance to herbicides. Examples of suitable selectable marker genes include, but are not limited to, genes encoding resistance to chloramphenicol, Herrera Estrella, et al., (1983) EMBO J. 2:987-992; methotrexate, Herrera Estrella, et al., (1983) Nature 303:209-213; Meijer, et al., (1991) Plant Mol. Biol. 16:807-820; hygromycin, Waldron, et al., (1985) Plant Mol. Biol. 5:103-108, Zhijian, et al., (1995) Plant Science 108:219-227; streptomycin, Jones, et al., (1987) Mol. Gen. Genet. 210:86-91; spectinomycin, Bretagne-Sagnard, et al., (1996) Transgenic Res. 5:131-137; bleomycin, Hille, et al., (1990) Plant Mol. Biol. 7:171-176; sulfonamide, Guerineau, et al., (1990) Plant Mol. Biol. 15:127-136; bromoxynil, Stalker, et al., (1988) Science 242:419-423; glyphosate, Shaw, et al., (1986) Science 233:478-481 and phosphinothricin, DeBlock, et al., (1987) EMBO J. 6:2513-2518.
  • Scorable or screenable markers may also be employed, where presence of the sequence produces a measurable product. Examples include a β-glucuronidase, or uidA gene (GUS), which encodes an enzyme for which various chromogenic substrates are known (for example, U.S. Pat. Nos. 5,268,463 and 5,599,670); chloramphenicol acetyl transferase (Jefferson, et al., The EMBO Journal 6(13):3901-3907) and alkaline phosphatase. Other screenable markers include the anthocyanin/flavonoid genes in general (see discussion at Taylor and Briggs, (1990) The Plant Cell 2:115-127) including, for example, a R-locus gene, which encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta, et al., in Chromosome Structure and Function, Kluwer Academic Publishers, Appels and Gustafson eds., pp. 263-282 (1988)); the genes which control biosynthesis of flavonoid pigments, such as the maize C1 gene (Kao, et al., (1996) Plant Cell 8:1171-1179; Scheffler, et al., (1994) Mol. Gen. Genet. 242:40-48) and maize C2 (Wienand, et al., (1986) Mol. Gen. Genet. 203:202-207); the B gene (Chandler, et al., (1989) Plant Cell 1:1175-1183), the p1 gene (Grotewold, et al., (1991) Proc. Natl. Acad. Sci. USA 88:4587-4591; Grotewold, et al., (1993) Cell 76:543-553; Sidorenko, et al., (1999) Plant Mol. Biol. 39:11-19); the bronze locus genes (Ralston, et al., (1988) Genetics 119:185-197; Nash, et al., (1990) Plant Cell 2(11):1039-1049), among others. Yet further examples of suitable markers include the cyan fluorescent protein (CYP) gene (Bolte, et al., (2004) J. Cell Science 117: 943-54 and Kato, et al., (2002) Plant Physiol 129:913-42), the yellow fluorescent protein gene (PhiYFP™ from Evrogen; see, Bolte, et al., (2004) J. Cell Science 117:943-54); a lux gene, which encodes a luciferase, the presence of which may be detected using, for example, X-ray film, scintillation counting, fluorescent spectrophotometry, low-light video cameras, photon counting cameras or multiwell luminometry (Teeri, et al., (1989) EMBO J. 8:343); a green fluorescent protein (GFP) gene (Sheen, et al., (1995) Plant J. 8(5):777-84) and DsRed2 where plant cells transformed with the marker gene are red in color, and thus visually selectable (Dietrich, et al., (2002) Biotechniques 2(2):286-293). Additional examples include a p-lactamase gene (Sutcliffe, (1978) Proc. Nat'l. Acad. Sci. U.S.A. 75:3737), which encodes an enzyme for which various chromogenic substrates are known (e.g., PADAC, a chromogenic cephalosporin); a xylE gene (Zukowsky, et al., (1983) Proc. Nat'l. Acad. Sci. U.S.A. 80:1101), which encodes a catechol dioxygenase that can convert chromogenic catechols; an α-amylase gene (Ikuta, et al., (1990) Biotech. 8:241) and a tyrosinase gene (Katz, et al., (1983) J. Gen. Microbiol. 129:2703), which encodes an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone, which in turn condenses to form the easily detectable compound melanin. Clearly, many such markers are available to one skilled in the art.
  • The method of transformation/transfection is not critical to the instant invention; various methods of transformation or transfection are currently available. As newer methods are available to transform crops or other host cells they may be directly applied. Accordingly, a wide variety of methods have been developed to insert a DNA sequence into the genome of a host cell to obtain the transcription or transcript and translation of the sequence to effect phenotypic changes in the organism. Thus, any method which provides for efficient transformation/transfection may be employed.
  • Methods for introducing expression vectors into plant tissue available to one skilled in the art are varied and will depend on the plant selected. Procedures for transforming a wide variety of plant species are well known and described throughout the literature. See, for example, Miki, et al., “Procedures for Introducing Foreign DNA into Plants” in Methods in Plant Molecular Biotechnology, supra; Klein, et al., (1992) Bio/Technology 10:268 (1992) and Weising, et al., (1988) Ann. Rev. Genet. 22:421-477. For example, the DNA construct may be introduced into the genomic DNA of the plant cell using techniques such as microprojectile-mediated delivery, Klein, et al., (1987) Nature 327:70-73; electroporation, Fromm, et al., (1985) Proc. Natl. Acad. Sci. 82:5824; polyethylene glycol (PEG) precipitation, Paszkowski, et al., (1984) EMBO J. 3:2717-2722; direct gene transfer WO 85/01856 and EP Number 0 275 069; in vitro protoplast transformation, U.S. Pat. No. 4,684,611 and microinjection of plant cell protoplasts or embryogenic callus, Crossway, (1985) Mol. Gen. Genetics 202:179-185. Co-cultivation of plant tissue with Agrobacterium tumefaciens is another option, where the DNA constructs are placed into a binary vector system. See e.g., U.S. Pat. No. 5,591,616; Ishida, et al., (1996) Nature Biotechnology 14:745-750. The virulence functions of the Agrobacterium tumefaciens host will direct the insertion of the construct into the plant cell DNA when the cell is infected by the bacteria. See, for example, Horsch, et al., (1984) Science 233:496-498 and Fraley, et al., (1983) Proc. Natl. Acad. Sci. 80:4803.
  • Standard methods for transformation of canola are described at Moloney, et al., (1989) Plant Cell Reports 8:238-242. Corn transformation is described by Fromm, et al., (1990) Bio/Technology 8:833 and Gordon-Kamm, et al., supra. Agrobacterium is primarily used in dicots, but certain monocots such as maize can be transformed by Agrobacterium. See, supra and U.S. Pat. No. 5,550,318. Rice transformation is described by Hiei, et al., (1994) The Plant Journal 6(2):271-282; Christou, et al., (1992) Trends in Biotechnology 10:239 and Lee, et al., (1991) Proc. Nat'l Acad. Sci. USA 88:6389. Wheat can be transformed by techniques similar to those used for transforming corn or rice. Sorghum transformation is described at Casas, et al., supra and sorghum by Wan, et al., (1994) Plant Physicol. 104:37. Soybean transformation is described in a number of publications, including U.S. Pat. No. 5,015,580.
  • When referring to “introduction” of the nucleotide sequence into a plant, it is meant that this can occur by direct transformation methods, such as Agrobacterium transformation of plant tissue, microprojectile bombardment, electroporation or any one of many methods known to one skilled in the art or, it can occur by crossing a plant having the heterologous nucleotide sequence with another plant so that progeny have the nucleotide sequence incorporated into their genomes. Such breeding techniques are well known to one skilled in the art.
  • The plant breeding methods used herein are well known to one skilled in the art. For a discussion of plant breeding techniques, see, Poehlman, (1987) Breeding Field Crops AVI Publication Co., Westport Conn. Many of the plants which would be most preferred in this method are bred through techniques that take advantage of the plant's method of pollination.
  • Backcrossing methods may be used to introduce a gene into the plants. This technique has been used for decades to introduce traits into a plant. An example of a description of this and other plant breeding methodologies that are well known can be found in references such as Plant Breeding Methodology, edit. Neal Jensen, John Wiley & Sons, Inc. (1988). In a typical backcross protocol, the original variety of interest (recurrent parent) is crossed to a second variety (nonrecurrent parent) that carries the single gene of interest to be transferred. The resulting progeny from this cross are then crossed again to the recurrent parent and the process is repeated until a plant is obtained wherein essentially all of the desired morphological and physiological characteristics of the recurrent parent are recovered in the converted plant, in addition to the single transferred gene from the nonrecurrent parent.
  • In certain embodiments of the invention, it is desirable to maintain the male sterile homozygous recessive condition of a male sterile plant, when using a transgenic restoration approach, while decreasing the number of plants, plantings and steps needed for maintenance plant with such traits. Homozygosity is a genetic condition existing when identical alleles reside at corresponding loci on homologous chromosomes. Heterozygosity is a genetic condition existing when different alleles reside at corresponding loci on homologous chromosomes. Hemizygosity is a genetic condition existing when there is only one copy of a gene (or set of genes) with no allelic counterpart on the sister chromosome. In an embodiment, the homozygous recessive condition results in conferring on the plant a trait of interest, which can be any trait desired and which results from the recessive genotype, such as increased drought or cold tolerance, early maturity, changed oil or protein content or any of a multitude of the many traits of interest to plant breeders. In one embodiment, the homozygous recessive condition confers male sterility upon the plant. When the sequence which is the functional complement of the homozygous condition is introduced into the plant (that is, a sequence which, when introduced into and expressed in the plant having the homozygous recessive condition, restores the wild-type condition), fertility is restored by virtue of restoration of the wild-type fertile phenotype.
  • Maintenance of the homozygous recessive condition is achieved by introducing a restoration transgene construct into a plant that is linked to a sequence which interferes with the function or formation of male gametes of the plant to create a maintainer or donor plant. The restoring transgene, upon introduction into a plant that is homozygous recessive for the genetic trait, restores the genetic function of that trait, with the plant producing only viable pollen containing a copy of the recessive allele but does not contain the restoration transgene. The transgene is kept in the hemizygous state in the maintainer plant. By transgene, it is meant any nucleic acid sequence which is introduced into the genome of a cell by genetic engineering techniques. A transgene may be a native DNA sequence, or a heterologous DNA sequence (i.e., “foreign DNA”). The term native DNA sequence refers to a nucleotide sequence which is naturally found in the cell but that may have been modified from its original form. The pollen from the maintainer can be used to fertilize plants that are homozygous for the recessive trait, and the progeny will therefore retain their homozygous recessive condition. The maintainer plant containing the restoring transgene construct is propagated by self-fertilization, with the resulting seed used to produce further plants that are homozygous recessive plants and contain the restoring transgene construct.
  • The maintainer plant serves as a pollen donor to the plant having the homozygous recessive trait. The maintainer is optimally produced from a plant having the homozygous recessive trait and which also has nucleotide sequences introduced therein which would restore the trait created by the homozygous recessive alleles. Further, the restoration sequence is linked to nucleotide sequences which interfere with the function or formation of male gametes. The gene can operate to prevent formation of male gametes or prevent function of the male gametes by any of a variety of well-know modalities and is not limited to a particular methodology. By way of example but not limitation, this can include use of genes which express a product cytotoxic to male gametes (See for example, U.S. Pat. Nos. 5,792,853; 5,689,049; PCT/EP89/00495); inhibit product formation of another gene important to male gamete function or formation (see, U.S. Pat. Nos. 5,859,341; 6,297,426); combine with another gene product to produce a substance preventing gene formation or function (see, U.S. Pat. Nos. 6,162,964; 6,013,859; 6,281,348; 6,399,856; 6,248,935; 6,750,868; 5,792,853); are antisense to or cause co-suppression of a gene critical to male gamete function or formation (see, U.S. Pat. Nos. 6,184,439; 5,728,926; 6,191,343; 5,728,558; 5,741,684); interfere with expression through use of hairpin formations (Smith, et al., (2000) Nature 407:319-320; WO 1999/53050 and WO 1998/53083) or the like. Many nucleotide sequences are known which inhibit pollen formation or function and any sequences which accomplish this function will suffice. A discussion of genes which can impact proper development or function is included at U.S. Pat. No. 6,399,856 and includes dominant negative genes such as cytotoxin genes, methylase genes and growth-inhibiting genes. Dominant negative genes include diphtheria toxin A-chain gene (Czako and An (1991) Plant Physiol. 95:687-692 and Greenfield, et al., (1983) PNAS 80:6853, Palmiter, et al., (1987) Cell 50:435); cell cycle division mutants such as CDC in maize (Colasanti, et al., (1991) PNAS 88:3377-3381); the WT gene (Farmer, et al., (1994) Hum. Mol. Genet. 3:723-728) and P68 (Chen, et al., (1991) PNAS 88:315-319).
  • Further examples of so-called “cytotoxic” genes are discussed supra and can include, but are not limited to pectate lyase gene pelE, from Erwinia chrysanthermi (Kenn, et al., (1986) J. Bacteriol 168:595); T-urf13 gene from cms-T maize mitochondrial genomes (Braun, et al., (1990) Plant Cell 2:153; Dewey, et al., (1987) PNAS 84:5374); CytA toxin gene from Bacillus thuringiensis Israeliensis that causes cell membrane disruption (McLean, et al., (1987) J. Bacteriol 169:1017, U.S. Pat. No. 4,918,006); DNAses, RNAses, (U.S. Pat. No. 5,633,441); proteases or a genes expressing anti-sense RNA. A suitable gene may also encode a protein involved in inhibiting pistil development, pollen stigma interactions, pollen tube growth or fertilization or a combination thereof. In addition genes that either interfere with the normal accumulation of starch in pollen or affect osmotic balance within pollen may also be suitable.
  • In an illustrative embodiment, the DAM-methylase gene is used, discussed supra and at U.S. Pat. Nos. 5,792,852 and 5,689,049, the expression product of which catalyzes methylation of adenine residues in the DNA of the plant. Methylated adenines will affect cell viability and will be found only in the tissues in which the DAM-methylase gene is expressed. In another embodiment, an α-amylase gene can be used with a male tissue-preferred promoter. During the initial germinating period of cereal seeds, the aleurone layer cells will synthesize α-amylase, which participates in hydrolyzing starch to form glucose and maltose, so as to provide the nutrients needed for the growth of the germ (Rogers and Milliman, (1984) J. Biol. Chem. 259(19):12234-12240; Rogers, (1985) J. Biol. Chem. 260:3731-3738). In an embodiment, the α-amylase gene used can be the Zea mays α-amylase-1 gene. Young, et al., Plant Physiol. 105(2):759-760 and GenBank Accession Numbers L25805, GI:426481). Sequences encoding α-amylase are not typically found in pollen cells and when expression is directed to male tissue, the result is a breakdown of the energy source for the pollen grains and repression of pollen development.
  • One skilled in this area readily appreciates the methods described herein are applicable to any other crops which have the potential to outcross. By way of example, but not limitation it can include maize, soybean, sorghum or any plant with the capacity to outcross.
  • Ordinarily, to produce more plants having the recessive condition, one might cross the recessive plant with another recessive plant. This may not be desirable for some recessive traits and may be impossible for recessive traits affecting reproductive development. Alternatively, one could cross the homozygous plant with a second plant having the restoration gene, but this requires further crossing to segregate away the restoring gene to once again reach the recessive phenotypic state. Instead, in one process the homozygous recessive condition can be maintained, while crossing it with the maintainer plant. This method can be used with any situation in which is it desired to continue the recessive condition. This results in a cost-effective system that is relatively easy to operate to maintain a population of homozygous recessive plants.
  • A sporophytic gene is one which operates independently of the gametes. When the homozygous recessive condition is one which produces male sterility by preventing male sporophyte development, the maintainer plant, of necessity, must contain a functional restoring transgene construct capable of complementing the mutation and rendering the homozygous recessive plant able to produce viable pollen. Linking this sporophytic restoration gene with a second functional nucleotide sequence which interferes with the function or formation of the male gametes of the plant results in a maintainer plant that produces pollen containing only the recessive allele of the sporophytic gene at the its native locus due to the action of the second nucleotide sequence in interfering with pollen formation or function. This viable pollen fraction is non-transgenic with regard to the restoring transgene construct.
  • In a still further embodiment, a marker gene, as discussed supra, may be provided in the construct with the restoring transgene. By way of example without limitation, use of a herbicide resistant marker, such as bar allows one to eliminate cells not having the restoring transgene. In yet another example, when using a scorable marker, such as a red fluorescent marker, such as DsRed2, any inadvertent transmission of the transgene can also be detected visually, and such escapes eliminated from progeny. Clearly, many other variations in the restoring construct are available to one skilled in the art.
  • In an illustrative embodiment, a method of maintaining a homozygous recessive condition of a male sterile plant at a genetic locus is provided, in which is employed a first nucleotide sequence which is a gene critical to male fertility, a second nucleotide sequence which inhibits the function or formation of viable male gametes, an optional third nucleotide sequence which is operably linked to the first sequence and preferentially expresses the sequence in male plant cells, an optional fourth nucleotide sequence operably linked to a fourth nucleotide sequence, the fourth sequence directing expression to male gametes, and an optional fifth nucleotide sequence which is a selectable or scorable marker allowing for selection of plant cells.
  • For example, it is desirable to produce male sterile female plants for use in the hybrid production process which are sterile as a result of being homozygous for a mutation in the Ms45 gene; a gene, which is critical to male fertility. Such a mutant Ms45 allele is designated as ms45 and a plant that is homozygous for ms45 (represented by the notation ms45/ms45) displays the homozygous recessive male sterility phenotype and produces no functional pollen. See, U.S. Pat. Nos. 5,478,369; 5,850,014; 6,265,640 and 5,824,524. In both the inbred and hybrid production processes, it is highly desired to maintain this homozygous recessive condition. When sequences encoding the Ms45 gene are introduced into a plant having the homozygous condition, male fertility results. By the method of the invention, a plant which is ms45/ms45 homozygous recessive may have introduced into it a functional sporophytic Ms45 gene, and thus is male fertile. This gene can be linked to a gene which operates to render pollen containing the restoring transgene construct nonfunctional or prevents its formation or which produces a lethal product in pollen, linked to the promoter directing its expression to the male gametes to produce a plant that only produced pollen containing ms45 without the restoring transgene construct.
  • An example is a construct which includes the Ms45 gene, linked with a 5126 promoter, a male tissue-preferred promoter (see, U.S. Pat. Nos. 5,750,868; 5,837,851 and 5,689,051) and further linked to the cytotoxic DAM methylase gene under control of the polygalacturonase promoter, PG47 promoter (see, U.S. Pat. Nos. 5,792,853; 5,689,049) in a hemizygotic condition. Therefore the resulting plant produces pollen, but the only viable pollen results from the alle not containing the restoring Ms45/DAM methylase construct and thus contains only the ms45 gene. It can therefore be used as a pollinator to fertilize the homozygous recessive plant (ms45/ms45) and progeny produced will continue to be male sterile as a result of maintaining homozygosity for ms45. The progeny will also not contain the introduced restoring transgene construct.
  • In yet another restoring construct example, the Ms26 gene is linked with a 5126 promoter, and further linked to the Zea mays α-amylase gene under control of the male tissue-preferred PG47 promoter. The scorable marker used in an embodiment is DS-RED EXPRESS.
  • A desirable result of the process of the invention is that the plant having the restorer nucleotide sequence may be self-fertilized, that is pollen from the plant transferred to the flower of the same plant to achieve the propagation of restorer plants. (Note that in referring to “self fertilization”, it includes the situation where the plant producing the pollen is fertilized with that same the pollen and the situation where two or more identical inbred plants are planted together and pollen from the identical inbred plant pollinate a different identical inbred plant). The pollen will not have the restoring transgene construct but it will be contained in 50% of the ovules (the female gamete). The seed resulting from the self-fertilization can be planted, and selection made for the seed having the restoring transgene construct. The selection process can occur by any one of many known processes; the most common where the restoration nucleotide sequence is linked to a marker gene. The marker can be scorable or selectable, and allows those plants produced from the seed having the restoration gene to be identified.
  • In an embodiment of the invention, it is possible to provide that the male gamete-tissue preferred promoter is inducible. Additional control is thus allowed in the process, where so desired, by providing that the plant having the restoration nucleotide sequences is constitutively male sterile. This type of male sterility is set forth the in U.S. Pat. No. 5,859,341. In order for the plant to become fertile, the inducing substance must be provided and the plant will become fertile. Again, when combined with the process of the invention as described supra, the only pollen produced will not contain the restoration nucleotide sequences.
  • Further detailed description is provided below by way of instruction and illustration and is not intended to limit the scope of the invention.
    • Example 1 Identification and Cosegregation of ms26-m2::Mu8
  • Families of plants from a Mutator (Mu) population were identified that segregated for plants that were mostly male sterile, with none or only a few extruded abnormal anthers, none of which had pollen present. Male sterility is expected to result from those instances where a Mu element has randomly integrated into a gene responsible for some step in microsporogenesis, disrupting its expression. Plants from a segregating F2 family in which the male sterile mutation was designated ms26*-SBMu200, were grown and classified for male fertility/sterility based on the above criteria. Leaf samples were taken and DNA subsequently isolated on approximately 20 plants per phenotypic classification, that is male fertility vs. male sterility.
  • Southern analysis was performed to confirm association of Mu with sterility. Southern analysis is a well known technique to those skilled in the art. This common procedure involves isolating the plant DNA, cutting with restriction endonucleases, fractioning the cut DNA by molecular weight on an agarose gel and transferring to nylon membranes to fix the separated DNA. These membranes are subsequently hybridized with a probe fragment that was radioactively labeled with P32P-dCTP, and washed in an SDS solution. Southern, (1975) J. Mol. Biol. 98:503-317. Plants from a segregating F2 ms26*-SBMu200 family were grown and classified for male fertility/sterility. Leaf samples and subsequent DNA isolation was conducted on approximately 20 plants per phenotypic classification. DNA (˜7 ug) from 5 fertile and 12 sterile plants was digested with EcoRI and electrophoresed through a 0.75% agarose gel. The digested DNA was transferred to nylon membrane via Southern transfer. The membrane was hybridized with an internal fragment from the Mu8 transposon. Autoradiography of the membrane revealed cosegregation of an approximately 5.6 Kb EcoRI fragment with the sterility phenotype as shown in FIG. 1. This EcoRI band segregated in the fertile plants suggesting a heterozygous wild type condition for the allele
    • Example 2 Library Construction, Screening, and Mapping
  • The process of genomic library screenings is commonly known among those skilled in the art and is described at Sambrook, et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor Lab Press, Plainview, N.Y. (1989). Libraries were created as follows.
  • DNA from a sterile plant was digested with EcoRI and run on a preparative gel. DNA with a molecular weight between 5.0 and 6.0 Kb was excised from the gel, electroeluted and ethanol precipitated. This DNA was ligated into the Lambda Zap vector (Stratagene™) using the manufacturer's protocol. The ligated DNA was packaged into phage particles using Gigapack Gold (Stratagene™). Approximately 500,000 PFU were plated and lifted onto nitrocellulose membranes. Membranes were hybridized with the Mu8 probe. A pure clone was obtained after 3 rounds of screening. The insert was excised from the phage as a plasmid and designated SBMu200-3.1. A PstI border fragment from this clone was isolated and used to reprobe the orginal EcoRI cosegregation blot as shown in FIG. 2B. The approximately 5.6 kb EcoRI fragment is homozygous in all the sterile plants, which confirms that the correct Mu fragment was isolated. Three of the fertile plants are heterozygous for the 5.5 kb EcoRI band and a 4.3 Kb EcoRI band. Two of the fertile plants are homozygous for the 4.3 kb EcoRI band, presumably the wild type allele.
  • The PstI probe was used to map the ms*-SBMu200 mutation in an RFLP mapping population. The mutant mapped to the short arm of chromosome 1, near the male sterile locus, Ms26 (Loukides, et al., (1995) Amer. J. Bot 82:1017-1023). To test whether ms*-SBMu200 was an allele of ms26-ref, ms*-SBMu200 and ms26-ref were crossed with each other using a known heterozygote as the pollen donor. The testcross progeny segregated male-sterile and wild-type plants in a 1:1 ratio, indicating allelism between ms*-SBMu200 and ms26-ref. The ms*-SBMu200 allele was designated ms26-m2::Mu8. The map location is shown in FIG. 13.
    • Example 3 Identification and Cloning of Additional ms26 Alleles
  • An additional Mu insertion mutations in Ms26 was identified by using a polymerase chain reaction (PCR) primer for Mu and a gene specific primer for Ms26 and screening a population of Mu F1 families. Sequence analyses of the PCR products showed that all three Mu insertions occurred in the second exon (FIG. 1). The F2 seeds from one of these families were grown and examined for male fertility/sterility. Southern blot analyses of this family confirmed the cosegregation of the Mu insertion in Ms26 with the male-sterile phenotype and the allele was designated ms26-m3::Mu.
  • The ms26 allele described in Loukides, et al., (1995) Amer. J. Bot 82:1017-1023 and designated ms26-ref was also investigated. To analyze the mutation in ms26-ref, Ms26 genomic sequences were cloned from ms26-ref sterile and fertile plants. Ms26 was cloned as a ˜4.2 kb EcoRI fragment and ms26-ref cloned as a ˜6 kb HindIII fragment and an overlapping ˜2.3 kb EcoRI fragment from the sterile plant. Sequence analysis revealed the presence of a new segment (1,430 bp) in the last exon of the ms26-ref allele shown in FIG. 1. An 8 bp host site duplication (GCCGGAGC) was found that flanks the inserted element and the element also contains a 15 bp terminal inverted repeat (TIR) (TAGGGGTGAAAACGG; SEQ ID NO: 23). The transposon sequence is shown in FIG. 15 (SEQ ID NO: 10). The ms26-ref genomic sequence in its entirety is shown in FIG. 16, SEQ ID NO: 11. A variant of the ms26-ref allele was also found. Sequence analysis of this allele, designated ms26′-0406, was found to have lost the 1430 bp segment found in the last exon of the ms26-ref allele but left an 8 bp footprint at the site of insertion. Plants homozygous for the ms26′-0406 allele were male sterile. A comparison of the excision allele, ms26′-0406 (SEQ ID NO: 8) with the region in the wild-type Ms26 gene (SEQ ID NO: 9) is shown in FIG. 14.
    • Example 4 Expression Analysis and cDNA Isolation
  • Northern analysis can be used to detect expression of genes characteristic of anther development at various states of microsporogenesis. Northern analysis is also a commonly used technique known to those skilled in the art and is similar to Southern analysis except that mRNA rather than DNA is isolated and placed on the gel. The RNA is then hybridzed with the labeled probe. Potter, et al., (1981) Proc. Nat. Acad. Sci. USA 78:6662-6666, Lechelt, et al., (1989) Mol. Gen. Genet. 219:225-234. The PstI fragment from the SBMu200-3.1 clone was used to probe a Northern blot containing kernel, immature ear, seedling and tassel RNA. A signal was seen only in tassel RNA at approximately the quartet stage of microsporogenesis, as reflected in FIG. 3. The transcript is about 2.3 kb in length. The same probe was also used to screen a cDNA library constructed from mRNA isolated from meiotic to late uninucleate staged anthers. One clone, designated Ms26-8.1, was isolated from the library.
    • Example 5 Sequence and Expression Analysis
  • The SBMu200-3.1 genomic clone and the Ms26-8.1 cDNA clone were sequenced by Loftstrand Labs Limited. Sanger, et al., (1977) Proc. Natl. Acad. Sci. USA 74:5463-5467. The sequences are set forth in FIGS. 4 and 5 and the comparison is at FIG. 6. The cDNA/genomic comparison reveals five introns are present in the genomic clone. The Mu8 insertion occurs in exon 1. Testing for codon preference and non-randomness in the third position of each codon was consistent with the major ORF in the cDNA being the likely protein-coding ORF. There is a putative Met start codon at position 1089 in the genomic clone. The cDNA homology with respect to the genomic clone begins at nucleotide 1094. Thus Ms26-8.1 does not represent a full length clone and lacks 5 bases up to the putative Met start codon. A database search revealed significant homology to P450 enzymes found in yeast, plants and mammals. P450 enzymes have been widely studied and three characteristic protein domains have been elucidated. The Ms26 protein contains several structural motifs characteristic of eukaryotic P450's, including the heme-binding domain FxxGxRxCxG (domain D; SEQ ID NO: 24), domain A A/GGXD/ETT/S (dioxygen-binding), domain B (steroid-binding) and domain C. The highly conserved heme-binding motif was found in MS26 as FQAGPRICLG (SEQ ID NO: 25), 51 amino acids away from C-terminus. The dioxygen binding domain AGRDTT (SEQ ID NO: 35) was located between amino acids 320-325. The steroid-binding domain was found as LVYLHACVTETLR (SEQ ID NO: 27), amino acids 397-409. The most significant homologous sequence detected in Genebank database is a deduced protein sequence from rice (GeneBank Accession Number 19071651). The second highest homologous sequence is a putative Arabidopsis P450 gene (CYP704B1) whose function is also unknown. FIG. 17A shows a sequence alignment between CYP704B1 (SEQ ID NO: 12) and Ms26 (SEQ ID NO: 13). Phylogenetic tree analysis of some P450 genes revealed that Ms26 is most closely related to P450s involved in fatty acid omega-hydroxylation found in Arabidopsis thaliana and Vicia sativa (FIG. 17B). The translational frame shift caused in the ms26′-0406 excision mutation is believed to destroy the activity of the heme binding domain, thus resulting in sterility. See, the comparison at FIG. 18 (Ms26 cDNA at SEQ ID NO: 14; fertile exon 5 region at SEQ ID NO: 15 and sterile exon 5 region is SEQ ID NO: 16).
  • Further expression studies were done using the Ms26 cDNA probe against a northern containing mRNA at discrete stages of microsporogenesis. FIG. 7A shows a Northern blot with RNA samples from different tissues including root (1), leaf (2), husk (3), cob (4), ear spikelet (5), silk (6), immature embryo (7) mature embryo (8) and tassel from, fertile plant (9), ms26-m2::Mu8 sterile plant (10), ms26-ref sterile plant (11) and fertile plant (12). A hybridization signal using Ms26 cDNA was detected only in tassel tissues. FIG. 7B shows a Northern blot containing mRNA at discrete stages of microsporogenesis. Hybridization signals using Ms26 cDNA were detected from meiosis II/quartet stage (4) to late-uninucleate stage (10), with the maximal signal being observed from early-uninucleate through late-uninucleate stage (10).
    • Example 6 Identification of Promoter and its Essential Regions
  • A putative TATA box can be identified by primer extension analysis as described in by Current Protocols in Molecular Biology, Ausubel, et al., eds; John Wiley and Sons, New York pp. 4.8.1-4.8.5 (1987).
  • Regulatory regions of anther genes, such as promoters, may be identified in genomic subclones using functional analysis, usually verified by the observation of reporter gene expression in anther tissue and a lower level or absence of reporter gene expression in non-anther tissue. The possibility of the regulatory regions residing “upstream” or 5′ ward of the translational start site can be tested by subcloning a DNA fragment that contains the upstream region into expression vectors for transient expression experiments. It is expected that smaller subgenomic fragments may contain the regions essential for male-tissue preferred expression. For example, the essential regions of the CaMV 19S and 35S promoters have been identified in relatively small fragments derived from larger genomic pieces as described in U.S. Pat. No. 5,352,605.
  • The selection of an appropriate expression vector with which to test for functional expression will depend upon the host and the method of introducing the expression vector into the host and such methods are well known to one skilled in the art. For eukaryotes, the regions in the vector include regions that control initiation of transcription and control processing. These regions are operably linked to a reporter gene such as UidA, encoding-glucuronidase (GUS), or luciferase. General descriptions and examples of plant expression vectors and reporter genes can be found in Gruber, et al., “Vectors for Plant Transformation” in Methods in Plant Molecular Biology and Biotechnology; Glick, et al., eds; CRC Press; pp. 89-119; (1993). GUS expression vectors and GUS gene cassettes are commercially available from Clonetech, Palo Alto, Calif., while luciferase expression vectors and luciferase gene cassettes are available from Promega Corporation, Madison, Wis. Ti plasmids and other Agrobacterium vectors are described in Ishida, et al., (1996) Nature Biotechnology 14:745-750 and in U.S. Pat. No. 5,591,616.
  • Expression vectors containing putative regulatory regions located in genomic fragments can be introduced into intact tissues such as staged anthers, embryos or into callus. Methods of DNA delivery include microprojectile bombardment, DNA injection, electroporation and Agrobacterium-mediated gene transfer (see, Gruber, et al., “Vectors for Plant Transformation,” in Methods in Plant Molecular Biology and Biotechnology, Glick, et al., eds.; CRC Press; (1993); U.S. Pat. No. 5,591,616 and Ishida, et al., (1996) Nature Biotechnology 14:745-750). General methods of culturing plant tissues are found in Gruber, et al., supra and Glick, supra.
  • For the transient assay system, staged, isolated anthers are immediately placed onto tassel culture medium (Pareddy and Petelino, (1989) Crop Sci. J.; 29:1564-1566) solidified with 0.5% Phytagel (Sigma, St. Louis) or other solidifying media. The expression vector DNA is introduced within 5 hours preferably by microprojectile-mediated delivery with 1.2 μm particles at 1000-1100 Psi. After DNA delivery, the anthers are incubated at 26° C. upon the same tassel culture medium for 17 hours and analyzed by preparing a whole tissue homogenate and assaying for GUS or for lucifierase activity (see, Gruber, et al., supra).
  • Upstream of the likely translational start codon of Ms26, 1088 bp of DNA was present in the genomic clone ms26-m2::Mu8. Translational fusions via an engineered NcoI site were generated with reporter genes encoding luciferase and β-glucuronidase to test whether this fragment of DNA had promoter activity in transient expression assays of bombarded plant tissues. Activity was demonstrated in anthers and not in coleoptiles, roots and calli, suggesting anther-preferred or anther-specific promoter activity.
  • A reasonable TATA box was observed by inspection, about 83-77 bp upstream of the translational start codon. The genomic clone ms26-m2::Mu8 thus includes about 1005 bp upstream of the possible TATA box. For typical plant genes, the start of transcription is 26-36 bp downstream of the TATA box, which would give the Ms26 mRNA a 5′-nontranslated leader of about 48-58 nt. The total ms26-m2::Mu8 subgenomic fragment of 1088 bp, including nontranslated leader, start of transcription, TATA box and sequences upstream of the TATA box, was thus shown to be sufficient for promoter activity. See FIG. 8, which is SEQ. ID NO. 5. The putative TATA box (TATATCA) is underlined. Thus, the present invention encompasses a DNA molecule having a nucleotide sequence of SEQ ID NO: 5 (or those with sequence identity) and having the function of a male tissue-preferred regulatory region.
  • Deletion analysis can occur from both the 5′ and 3′ ends of the regulatory region: fragments can be obtained by site-directed mutagenesis, mutagenesis using the polymerase chain reaction, and the like (Directed Mutagenesis: A Practical Approach; IRL Press; (1991)). The 3′ end of the male tissue-preferred regulatory region can be delineated by proximity to the putative TATA box or by 3′ deletions if necessary. The essential region may then be operably linked to a core promoter of choice. Once the essential region is identified, transcription of an exogenous gene may be controlled by the male tissue-preferred region of Ms26 plus a core promoter. The core promoter can be any one of known core promoters such as a Cauliflower Mosaic Virus 35S or 19S promoter (U.S. Pat. No. 5,352,605), Ubiquitin (U.S. Pat. No. 5,510,474), the IN2 core promoter (U.S. Pat. No. 5,364,780) or a Figwort Mosaic Virus promoter (Gruber, et al., “Vectors for Plant Transformation” in Methods in Plant Molecular Biology and Biotechnology; Glick, et al., eds.; CRC Press; pp. 89-119; (1993)). Preferably, the promoter is the core promoter of a male tissue-preferred gene or the CaMV 35S core promoter. More preferably, the promoter is a promoter of a male tissue-preferred gene and in particular, the Ms26 core promoter.
  • Further mutational analysis, for example by linker scanning, a method well known to the art, can identify small segments containing sequences required for anther-preferred expression. These mutations may introduce modifications of functionality such as in the levels of expression, in the timing of expression, or in the tissue of expression. Mutations may also be silent and have no observable effect.
  • The foregoing procedures were used to identify essential regions of the Ms26 promoter. After linking the promoter with the luciferase marker gene deletion analysis was performed on the regions of the promoter upstream of the putative TATA box, as represented in FIG. 9. The x-axis of the bar graph indicates the number of base pairs immediately upstream of the putative TATA box retained in a series of deletion derivatives starting from the 5′ end of the promoter. The y-axis shows the normalized luciferase activity as a percent of full-length promoter activity.
  • As is evident from the graph, approximately 176 bp immediately upstream of the TATA box was sufficient, when coupled to the core promoter (putative TATA box through start of transcription), plus 5′ nontranslated leader, for transient expression in anthers. By contrast, luciferase activity was minimal upon further deletion from the 5′ end to 91 bp upstream of the putative TATA box. This 176 bp upstream of the putative TATA box through the nontranslated leader can be considered a minimal promoter, which is further represented at FIG. 10. The TATA box is underlined. Deletion within the full-length promoter from −176 through −92 relative to the TATA box reduced activity to about 1% of wild type. Deletion of −39 through −8 did not greatly reduce activity. Therefore the −176 to −44 bp region contains an essential region and thus would constitute an upstream enhancer element conferring anther expression on the promoter, which we refer to as an “anther box”.
  • Linker scanning analysis was conducted across the anther box in 9-10 bp increments. The locations of the linker scanning substitutions in this region are shown in FIG. 10 and the expression levels of the mutants relative to the wild type sequence are shown in FIG. 11. The most drastic effect on transient expression in anthers was observed for mutants LS12 and LS13, in the region 52-71 bp upstream of the putative TATA box. A major effect on transient expression in anthers was also observed for mutants LS06, LS07, LS08 and LS10, within the region 82-131 bp upstream of the putative TATA box. Sequences within the anther box required for wild type levels of transient expression in anthers are thus demonstrated in the −52 to −131 region relative to the putative TATA box, particularly the −52 to −71 region. The essential regions are shown at SEQ ID NO: 6 (FIG. 10) and, as compared to the genomic sequence, SEQ ID NO: 7 (FIG. 5) are bases 1-1088; 830-962; 830-914; 917-962; 875-954; 935-954 and 875-924.
    • Example 7 Ms26 Sorghum, Rice and Maize Comparison
  • As noted above, Ms26 is a male fertility gene in maize. When it is mutated, and made homozygous recessive, male sterility will result. An orthologue of Ms26 was identified in sorghum. The sorghum orthologue of the Ms26 cDNA was isolated by using the maize Ms26 gene primers in a polymerase chain reaction with sorghum tassel cDNA as the template. The resultant cDNA fragment was sequenced by methods described supra and then compared to the Ms26 cDNA from maize. Nucleotide sequence comparisons are set forth in FIG. 12 and show 90% identity. An orthologue from rice was also identified and the predicted coding sequence (SEQ ID NO: 17) and protein (SEQ ID NO: 18) is set forth in FIG. 19. It has one intron less than the maize and sorghum Ms26, and the coding sequences are highly conserved.
  • Identification of the sorghum and rice promoters was accomplished. FIG. 20 shows an alignment of the Ms26 promoter of corn (SEQ ID NO: 5), sorghum (SEQ ID NO: 19) and rice (SEQ ID NO: 20). The last three bases of the corn promoter shown in the figure is the ATG start of translation.
  • Alignment as reflected in FIG. 21 of the maize Ms26 protein (SEQ ID NO: 2), rice Ms26 protein (SEQ ID NO: 18) and sorghum Ms26 protein (SEQ ID NO: 4) and a consensus sequence (SEQ ID NO: 21). The comparison of protein sequences shows the protein is highly conserved among the orthologues, with the rice protein sharing 92% similarity and 86% identity when compared to the maize orthologue. The predicted tissue specificity in rice and sorghum is further reflected in a comparison of the Ms26 protein in the sorghum and rice EST database derived from panicle (flower) libraries. Sorghum sequences producing significant alignments (GenBank Accession Numbers BI075441.1; BI075273.1; BI246000.1; BI246162.1; BG948686.1; BI099541.1 and BG948366.1, among others) all were sequences from immature panicle of sorghum, and sequences showing significant alignment in rice (GenBank Accession Numbers C73892.1; CR290740.1, among others) were also from rice immature panicle.
  • As is evident from the above, nucleotide sequences which map to the short arm of chromosome 1 of the Zea mays genome, at the same site as the Ms26 gene, ms26-m2::Mu8 and its alleles, are genes critical to male fertility in plants, that is, are necessary for fertility of a plant, or, when mutated from the sequence found in a fertile plant, cause sterility in the plant.
    • Example 8 Construction of a Plant Transformation Vector Comprising a Selectable Marker, a Male Fertility Gene Ms45 and a Pollen Cytotoxin Gene
  • A construct designated PHP18091, shown in FIG. 22 is made by assembling following DNA components:
    • 1. The plasmid pSB11 backbone DNA (pSB31 lacking the EcoRI fragment carrying the 35SGUS and 35SBAR genes, Ishida, et al., (1996) Nature Biotechnol. 14:745-750). This DNA backbone contains T-DNA border sequences and the replication origin from pBR322.
    • 2. The 35S:PAT gene which encodes the enzyme phosphinothricin acetyltransferase (PAT) from Streptomyces viridochomagenes (nucleotides 6-557 from accession number A02774, Strauch, et al., 1988, EP 0275957-A) under the transcriptional control of the cauliflower mosaic virus (CaMV) 35S promoter and terminator (nucleotides 6906-7439, and 7439-7632, respectively from Franck, et al., (1980) Cell 21:285-294).
    • 3. The 5126:Ms45 gene which contains the maize male fertility gene coding region (nucleotides 1392-3343, accession number AF360356, Albertsen, et al., (1993) Am. J. Bot. 80:16) under the control of the maize anther-specific promoter 5126 (nucleotides 985-1490, accession number 175204).
    • 4. The PG47:DAM gene which contains the E. coli DNA (Adenosine-N6) methyltransferase (DAM) coding region (nucleotides 195-1132, Brooks, et al., (1983) Nucleic. Acids Res 11: 837-851) driven by the maize pollen-specific promoter PG47 (nucleotides 1-2870, accession number X66692, Allen and Lonsdale, (1993) Plant J. 3:261-271). The transcription of this gene is terminated by the potato proteinase inhibitor II (PinII) terminator (nucleotides 2-310, An, et al., (1989) Plant Cell 1:115-122).
    • 5. A 3.34 kb NcoI DNA fragment containing Ms45:Ms45 was cloned upstream of the 35S:PAT gene in pUC8, creating PHP6641. A 4.7 kb HindIII/EcoRI DNA fragment containing Ms45:Ms45-35S:PAT from PHP6641 was cloned into pSB11, creating PHP10890 (Cigan, et al., (2001) Sex. Plant Reprod. 14:135-142). The native Ms45 promoter in PHP10890 was replaced by a 528 bp HindIII/NcoI fragment containing the maize 5126 promoter, creating PHP11943.
    • 6. A 2.87 kb HindIII/NcoI fragment containing PG47 promoter was ligated with a 0.8 kb NcoI/HindIII fragment containing the DAM coding region, PinII terminator and 35S enhancer which was from PHP10404 (Unger, et al., (2001) Transgenic Res. 10:409-422), creating a 3.67 kb fragment HindIII fragment containing PG47:DAM gene fusion (with the 35S enhancer). This 3.67 kbp HindIII fragment was then cloned into the HindIII site of PHP11943, creating PHP20005. The 35S enhancer in PHP20005 was removed, creating PHP18071. The PHP18071 was introduced into Agrobacterium strain LBA4404 carrying plasmid pSB1 by triparental mating (Ishida, et al., (1996) Nature Biotechnol. 14:745-750). The co-integrate of PHP18071 and pSB1 was named PHP18091.
    Example 9 Transformation of Corn with the Restoring Transgene Construct of Example 8
  • A male-sterile female which was homozygous for an ms45 mutant Ac excision allele, ms45′ 9301 (ms45) was repeatedly crossed with bulked pollen from maize Hi-type II plants (Armstrong, 1994, In: Freeling and Walbot (eds). The Maize Handbook. Springer, New York, pp 663-671) resulting in the introgression of this ms45 allele in transformation amenable maize germplasm over multiple generations. The resultant source of material for transformation consisted of embryos segregating (1:1 or 3:1) for ms45 and allowed for both transformation directly into a homozygous ms45 background and to test the genetic complementation of the ms45 mutation in T0 plants. Agrobacterum-mediated transformation was performed according to Zhao, et al., 1999, (U.S. Pat. No. 5,981,840). Genotyping and molecular analysis (integration and PTU) of transformants were done according Cigan, et al., (Sex. Plant. Reprod. (2001) 14:135-142). Transformants with single-integration and complete PTU were selected for further studies.
    • Example 10 Analysis of Maize Transformants
  • Transgenic plants (T0) from Example 9 were evaluated for the whole plant morphology and analyzed for transgene transmission through both pollen and egg cells. No morphological difference was observed between the transgenic plants and the non-transgenic control plants except for the degree of male fertility. Transformants with single-integration and intact PTU were partial male fertile while non-transgenic control plants were completely male sterile, indicating that the expression of Ms45 gene complemented the homozygous recessive ms45 male sterile phenotype. This also demonstrated that the expression of the DAM gene caused partial male sterility by eliminating the pollen grains carrying the transgenes. Without the DAM gene, Ms45 transgene can completely recover the ms45 male sterile mutation (Cigan, et al., (2001) Sex. Plant. Reprod. 14:135-142). The correct function of DAM gene was further determined by controlled pollinations between T0 transgenic plants and non-transgenic plants. Pollen grains from T0 transgenic plants were used to pollinate non-transgenic plants control plants. Immature embryos were harvested from ears of these non-transgenic plants 18 days after pollination and cultured either on MS media or MS media containing 3.0 mg/L of bialaphos (Murashige and Skoog, (1962) Physiol. Plant 15:437-439). 100% of the embryos were able to germinate on control medium while none of the embryos were able to germinate on media containing 3 mg/L of bialaphos, indicating that the restoring transgene construct was not transmitted through pollen to progeny.
  • In addition, pollen from non-transgenic plants was used to pollinate the T0 transgenic maintainer plants. Immature embryos were harvested from ears of these T0 transgenic maintainer plants 18 days after pollination and cultured as above control media or media containing 3 mg/L of bialaphos. All embryos were able to germinate on control medium while 50% of the embryos were able to germinate on the medium containing bialaphos, indicating that the restoring transgene construct was transmitted through the ovule to progeny at the expected frequency. The results of embryo rescues are summarized in Tables 1 and 2.
  • TABLE 1
    Transgene transmission through pollen
    Pollen to non-transgenic plants
    Control medium Medium + 3 mg/l bialaphos
    # # # #
    Transgenic embryo embryo embryo embryo
    plants cultured germinated % cultured germinated %
    14089263 40 40 100 60 0 0
    14089277 100 100 100 100 0 0
    14089839 40 40 100 60 0 0
  • TABLE 2
    Transgene transmission through egg cells
    Pollen from non-transgenic plants
    Medium + 3 mg/l bialaphos
    Transgenic # embryo # embryo
    plants cultured germinated %
    14089262 20 8 40
    14089277 40 22 55
    14089839 40 21 53
    • Example 11 Conversion of T0 Plants into Different Inbred Lines and Analysis of Tn Plants
  • T0 transgenic maintainer plants from Example 9 were converted into different inbred backgrounds through repeated backcross by pollination from inbred lines such as PH09B. To accomplish this, pollen produced by PH09B that is ms45 heterozygous background were used to pollinate the ears of T0 maintainer plants that were homozygous for the ms45 mutant alleles. T1 seed harvested from these T0 plants segregated for both transgenes and ms45 alleles. T1 plants that did not contain the restoring transgene construct were eliminated by herbicide selection. T1 plants containing transgenes were analyzed for ms45 background and male fertility according to Cigan, et al., (Sex. Plant. Reprod., (2001) 14:135-142). In general, T1 plants in homozygous ms45 condition that contained the restoring transgene construct showed partial male fertility like that observed for the T0 parent plants, while the T1 plants in homozygous ms45 condition but containing no transgenes were complete male sterile. This suggested that the Ms45 transgene continued to function correctly in a different genetic background. Pollen grains from T1 plants were examined for viability using microscopic and histochemical staining. Pollen grains at different developmental stages were collected and stained with fluorescein diacetate (FDA), 4′, 6-diamidino-2-phenylindole (DAPI) and ethidium bromide (EB). About 50% of the pollen grains from the transgenic T1 plants lost their viability as judged by the absence of fluorescence after staining with FDA after first pollen mitosis, while the pollen grains from non-transgenic control plants showed uniform FDA staining. This was further supported by in vitro pollen germination studies. The germination rate of the pollen grains from the transgenic T1 plants were about half of that from non-transgenic control plants. Pollen grains from transgenic T1 plant were also used to pollinate non-transgenic plants to test transgene transmission thought pollen. For instance, none of 248 embryos from a non-transgenic plant pollinated by a T1 plant (20118954) were able to germinate on the medium containing 3 mg/l bialaphos. These experiments confirmed both the correct function of the Ms45 and DAM transgenes in different genetic backgrounds. The T1 plants with desired performance were used for the next backcross iteration using pollen from the paternal inbred parent which was heterozygous for the mutant ms45 allele. This process will be repeated until sixth generation.
    • Example 12 Large Scale Transmission and Maintenance of ms45 Male Sterility Using the Construct of Example 8
  • T1 plants derived from T0 14089277 as described in Example 9 were used as males to pollinate either wild type inbred plants or ms45/ms45 male sterile inbred plants. The 10,117 T2 progeny from the wild type crosses and 6688 T2 progeny from the ms45/ms45 crosses were evaluated for transgene transmission by screening for herbicide resistance. For both types of crosses a total of 16786 T2 plants were found to be herbicide sensitive, yielding a non-transmission frequency of 99.89%. All T2 plants from the ms45/ms45 crosses that did not contain the transgene, were completely male sterile, indicating that this transgenic line can maintain ms45 sterility.
    • Example 13 Construction of a Plant Transformation Vector Comprising a Screenable Marker, a Male Fertility Gene Ms26 and a Pollen Cytotoxin Gene
  • A construct designated PHP24101, shown in FIG. 23, is made by assembling following DNA components:
    • 1. The plasmid pSB11 backbone DNA (pSB31 lacking the EcoRI fragment carrying the 35SGUS and 35SBAR genes, Ishida, et al., (1996) Nature Biotechnol. 14:745-750). This DNA backbone contains T-DNA border sequences and the replication origin from pBR322.
    • 2. The PG47PRO:ZM-AA1 gene which contains alpha-amylase 1 coding region from Zea mays as set forth in FIG. 24 (SEQ ID NO: 26). The transcription of this gene is terminated by IN2-1 terminator (U.S. Pat. No. 5,364,780).
    • 3. The Ms26 (SB200) GENOMIC gene (SEQ ID NO: 7) which contains the maize male fertility gene coding region.
    • 4. LTP2:DS-RED2 (ALT1) which contains red florescence coding region (a variant of Discosoma sp. red fluorescent protein (DsRed), from Clontech mutated to remove BstEII site, codon sequence unchanged) driven by LTP2 promoter, supra.
    • 5. A 2.143 kb EcoRV/DraI DNA fragment containing LTP2PRO:DS-RED2 (ALT1) from PHP21737 was cloned into downstream of the Ms26 GENOMIC gene in SK vector, creating SK-Ms26 GENOMIC-LTP2PRO:DS-RED2 (ALT1).
    • 6. A 2.143 kb EcoRV/DraI DNA fragment containing LTP2PRO:DS-RED2 (ALT1) from PHP21737 was cloned into downstream of the Ms45PRO:Ms45 GENOMIC gene in SK vector, creating SK-Ms45-LTP2PRO:DS-RED2 (ALT1).
    • 7. A 5.429 kb NotI fragment containing 5126PRO:Ms45 GENOMIC-UBI:MOPAT:PINII in PHP20532 was replaced by A 4.318 kb NotI fragment containing Ms45-LTP2PRO:DS-RED2 (ALT1) from SK-Ms45-LTP2PRO:DS-RED2 (ALT1), creating PHP22623.
    • 8. A 4.318 kb NotI fragment containing Ms45-LTP2PRO:DS-RED2 (ALT1) in PHP22623 was replaced by A 5.960 kb NotI DNA fragment containing Ms26 GENOMIC-LTP2PRO:DS-RED2(ALT1) from SK-Ms26 GENOMIC-LTP2PRO:DS-RED2 (ALT1), creating PHP24014. The PHP24014 was introduced into Agrobacterium strain LBA4404 carrying plasmid pSB1 by Electrophoresis. Co-integrate of PHPPHP24014 and pSB1 was named PHP24101.
    Example 14 Transformation of Corn with the Restoring Transgene Construct of Example 13
  • A male-sterile female which was homozygous for a ms26 mutant excision allele, (ms26) was repeatedly crossed with bulked pollen from maize Hi-type II plants (Armstrong, 1994, In: Freeling and Walbot, (eds). The Maize Handbook. Springer, New York, pp 663-671) resulting in the introgression of this ms26 allele in transformation amenable maize germplasm over multiple generations. The resultant source of material for transformation consisted of embryos segregating (1:1 or 3:1) for ms26 and allowed for both transformation directly into a homozygous ms26 background and to test the genetic complementation of the ms26 mutation in T0 plants. Agrobacterium-mediated transformation was performed according to Zhao, et al., 1999, (U.S. Pat. No. 5,981,840). Genotyping and molecular analysis (integration and PTU) of transformants were done according Cigan, et al., (Sex. Plant. Reprod. (2001) 1(4):135-142). Transformants with single-integration and complete PTU were selected for further studies.
    • Example 15 Analysis of Maize Transformants
  • Transgenic plants (T0) from Example 14 were evaluated for the whole plant morphology and analyzed for transgene transmission through pollen. No morphological difference was observed between the transgenic plants and the non-transgenic control plants except for the degree of male fertility. Transformants with single-integration and intact PTU were partial male fertile while non-transgenic control plants were completely male sterile, indicating that the expression of the Ms26 gene complemented the homozygous recessive ms26 male sterile phenotype. This also suggested that the pollen expression of the alpha amylase (AA) gene caused partial male sterility by disrupting the normal function of the pollen grains carrying the transgenes. Staining pollen from transformants with potassium iodide (KI), which stains starch granules, showed that approximately half of the pollen grains contained starch (black grains, non-transgenic) and the other half did not contain starch (gold grains, transgenic). The correct function of AA gene was further determined by controlled pollinations between T0 transgenic plants and non-transgenic plants. Resultant T1 kernels were evaluated for a red fluorescence phenotype. If the transgenes were transmitted through the pollen then the T1 seed would contain red fluorescent kernels due to the expression of RFP in the aleurone layer. For four independent events shown in Table 3, no RFP expression was found in the T1 seed, whereas seed from the T0 ears themselves (T1 seed) contained approximately 50% red fluorescent kernels.
  • TABLE 3
    Transgene transmission through pollen
    Pollen to non-transgenic plants
    Kernel Red Fluoresence
    Transgenic # Yellow # Red
    plants Kernels Kernels %
    42772379 338 0 100
    42772385 277 0 100
    42772400 268 0 100
    42772411 598 0 100
  • Thus it can be seen that the invention achieves at least all of its objectives.

Claims (10)

1. An isolated or recombinant polypeptide which has at least 95% identity to the full length of SEQ ID NO: 22 and impacts male fertility in a plant.
2. A plant comprising the recombinant polypeptide of claim 1, wherein said plant is male-fertile.
3. A plant comprising the recombinant polypeptide of claim 1, wherein said plant is male-sterile.
4. The plant of claim 2, wherein said plant is sorghum, maize, or rice.
5. The plant of claim 3, wherein said plant is sorghum, maize, or rice.
6. An isolated or recombinant polynucleotide which encodes a polypeptide of claim 1.
7. An expression cassette comprising a regulatory sequence operably linked to the polynucleotide of claim 6.
8. The expression cassette of claim 7, wherein said regulatory sequence comprises SEQ ID NO: 19.
9. An isolated or recombinant polynucleotide which has at least 95% identity to the full length of SEQ ID NO: 19 and is capable of driving male-tissue-preferred expression of an operably-linked polynucleotide.
10. A functional fragment of the polynucleotide of claim 9, said functional fragment being capable of driving male-tissue-preferred expression of an operably-linked polynucleotide.
US13/470,618 2000-09-26 2012-05-14 Nucleotide sequences mediating male fertility and method of using same Abandoned US20120227136A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/470,618 US20120227136A1 (en) 2000-09-26 2012-05-14 Nucleotide sequences mediating male fertility and method of using same
US14/136,988 US20140123338A1 (en) 2000-09-26 2013-12-20 Nucleotide sequences mediating male fertility and method of using same

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US67015300A 2000-09-26 2000-09-26
US10/412,000 US7151205B2 (en) 2000-09-26 2003-04-11 Plant male tissue-preferred promotor, regulatory regions and methods of use in mediating plant male fertility
US11/166,609 US7517975B2 (en) 2000-09-26 2005-06-24 Nucleotide sequences mediating male fertility and method of using same
US11/471,202 US7612251B2 (en) 2000-09-26 2006-06-20 Nucleotide sequences mediating male fertility and method of using same
US12/400,578 US7875764B2 (en) 2000-09-26 2009-03-09 Nucleotide sequences mediating male fertility and method of using same
US12/966,606 US8013218B2 (en) 2000-09-26 2010-12-13 Nucleotide sequences mediating plant male fertility and method of using same
US13/189,631 US8178750B2 (en) 2000-09-26 2011-07-25 Nucleotide sequences mediating male fertility and method of using same
US13/470,618 US20120227136A1 (en) 2000-09-26 2012-05-14 Nucleotide sequences mediating male fertility and method of using same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/189,631 Continuation US8178750B2 (en) 2000-09-26 2011-07-25 Nucleotide sequences mediating male fertility and method of using same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/136,988 Continuation US20140123338A1 (en) 2000-09-26 2013-12-20 Nucleotide sequences mediating male fertility and method of using same

Publications (1)

Publication Number Publication Date
US20120227136A1 true US20120227136A1 (en) 2012-09-06

Family

ID=46324700

Family Applications (16)

Application Number Title Priority Date Filing Date
US11/471,202 Expired - Fee Related US7612251B2 (en) 2000-09-26 2006-06-20 Nucleotide sequences mediating male fertility and method of using same
US12/400,578 Expired - Fee Related US7875764B2 (en) 2000-09-26 2009-03-09 Nucleotide sequences mediating male fertility and method of using same
US12/564,675 Expired - Fee Related US7759544B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/564,684 Expired - Fee Related US7863500B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/564,665 Expired - Fee Related US7759543B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,191 Expired - Fee Related US7888550B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/785,722 Expired - Fee Related US7893317B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/785,917 Expired - Fee Related US7893318B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,253 Expired - Fee Related US7893319B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,556 Expired - Fee Related US7888551B2 (en) 2000-09-26 2010-05-25 Nucleotide sequences mediating plant male fertility and method of using same
US12/966,637 Expired - Fee Related US8614367B2 (en) 2000-09-26 2010-12-13 Nucleotide sequences mediating plant male fertility and method of using same
US12/966,606 Expired - Fee Related US8013218B2 (en) 2000-09-26 2010-12-13 Nucleotide sequences mediating plant male fertility and method of using same
US13/189,631 Expired - Fee Related US8178750B2 (en) 2000-09-26 2011-07-25 Nucleotide sequences mediating male fertility and method of using same
US13/470,618 Abandoned US20120227136A1 (en) 2000-09-26 2012-05-14 Nucleotide sequences mediating male fertility and method of using same
US14/108,553 Abandoned US20140215652A1 (en) 2000-09-26 2013-12-17 Nucleotide sequences mediating male fertility and method of using same
US14/136,988 Abandoned US20140123338A1 (en) 2000-09-26 2013-12-20 Nucleotide sequences mediating male fertility and method of using same

Family Applications Before (13)

Application Number Title Priority Date Filing Date
US11/471,202 Expired - Fee Related US7612251B2 (en) 2000-09-26 2006-06-20 Nucleotide sequences mediating male fertility and method of using same
US12/400,578 Expired - Fee Related US7875764B2 (en) 2000-09-26 2009-03-09 Nucleotide sequences mediating male fertility and method of using same
US12/564,675 Expired - Fee Related US7759544B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/564,684 Expired - Fee Related US7863500B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/564,665 Expired - Fee Related US7759543B2 (en) 2000-09-26 2009-09-22 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,191 Expired - Fee Related US7888550B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/785,722 Expired - Fee Related US7893317B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/785,917 Expired - Fee Related US7893318B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,253 Expired - Fee Related US7893319B2 (en) 2000-09-26 2010-05-24 Nucleotide sequences mediating plant male fertility and method of using same
US12/786,556 Expired - Fee Related US7888551B2 (en) 2000-09-26 2010-05-25 Nucleotide sequences mediating plant male fertility and method of using same
US12/966,637 Expired - Fee Related US8614367B2 (en) 2000-09-26 2010-12-13 Nucleotide sequences mediating plant male fertility and method of using same
US12/966,606 Expired - Fee Related US8013218B2 (en) 2000-09-26 2010-12-13 Nucleotide sequences mediating plant male fertility and method of using same
US13/189,631 Expired - Fee Related US8178750B2 (en) 2000-09-26 2011-07-25 Nucleotide sequences mediating male fertility and method of using same

Family Applications After (2)

Application Number Title Priority Date Filing Date
US14/108,553 Abandoned US20140215652A1 (en) 2000-09-26 2013-12-17 Nucleotide sequences mediating male fertility and method of using same
US14/136,988 Abandoned US20140123338A1 (en) 2000-09-26 2013-12-20 Nucleotide sequences mediating male fertility and method of using same

Country Status (1)

Country Link
US (16) US7612251B2 (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517975B2 (en) * 2000-09-26 2009-04-14 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
US7612251B2 (en) * 2000-09-26 2009-11-03 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
EP1320618B1 (en) * 2000-09-26 2012-03-07 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
CN104313049A (en) * 2003-12-16 2015-01-28 先锋高级育种国际公司 Dominant gene suppression transgenes and methods of using same
US20080244765A1 (en) * 2004-12-16 2008-10-02 Pioneer Hi-Bred International, Inc. Methods and compositions for pollination disruption
US7915478B2 (en) * 2007-08-03 2011-03-29 Pioneer Hi-Bred International, Inc. Msca1 nucleotide sequences impacting plant male fertility and method of using same
US7910802B2 (en) * 2007-08-03 2011-03-22 Pioneer Hi-Bred International, Inc. MSCA1 nucleotide sequences impacting plant male fertility and method of using same
US7919676B2 (en) * 2007-08-03 2011-04-05 Pioneer Hi-Bred International, Inc. Msca1 nucleotide sequences impacting plant male fertility and method of using same
AR074135A1 (en) 2008-02-14 2010-12-29 Pioneer Hi Bred Int SPT EVENT FLANKING GENOMIC DNA AND METHODS TO IDENTIFY THE EVENT OF SEED PRODUCTION TECHNOLOGY (SPT)
EP2257076B1 (en) * 2009-05-28 2015-02-25 Advanced Digital Broadcast S.A. Video data signal, system and method for controlling shutter glasses
US8993844B1 (en) 2010-05-27 2015-03-31 University Of Wyoming Production of spider silk protein in corn
US10117411B2 (en) 2010-10-06 2018-11-06 Dow Agrosciences Llc Maize cytoplasmic male sterility (CMS) C-type restorer RF4 gene, molecular markers and their use
EA201391373A1 (en) 2011-03-23 2014-07-30 Пайонир Хай-Бред Интернэшнл, Инк. METHODS OF OBTAINING A COMPLEX LOCUS OF TRANSGENIC SIGNS
CA2844470A1 (en) 2011-06-21 2013-05-10 Pioneer Hi-Bred International, Inc. Methods and compositions for producing male sterile plants
MX2014011043A (en) 2012-03-13 2015-06-02 Pioneer Hi Bred Int Genetic reduction of male fertility in plants.
WO2013138354A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
WO2013138309A1 (en) 2012-03-13 2013-09-19 Pioneer Hi-Bred International, Inc. Genetic reduction of male fertility in plants
CN104703998B (en) 2012-03-13 2020-08-21 先锋国际良种公司 Genetic reduction of male fertility in plants
CN113416738A (en) 2012-09-06 2021-09-21 先锋国际良种公司 Compositions and methods comprising male fertility sequences
WO2014063442A1 (en) 2012-10-23 2014-05-01 中国农业大学 Method for propagating sterile male plant line
US9803214B2 (en) 2013-03-12 2017-10-31 Pioneer Hi-Bred International, Inc. Breeding pair of wheat plants comprising an MS45 promoter inverted repeat that confers male sterility and a construct that restores fertility
MX2016002306A (en) 2013-08-22 2016-07-08 Du Pont A soybean u6 polymerase iii promoter and methods of use.
WO2015070113A1 (en) * 2013-11-09 2015-05-14 Mice With Horns, Llc Materials and methods for making a recessive gene dominant
US20150157111A1 (en) * 2013-12-05 2015-06-11 Aisha Smith-Thompson Make-up apparatus
CN103667278B (en) * 2013-12-31 2015-10-28 北京大北农科技集团股份有限公司 The nucleotide sequence of mediating plant male fertility and use its method
UY35927A (en) 2013-12-31 2015-07-31 Dow Agrosciences Llc ? GENE RESTORATOR RF3 TYPE S OF MALE CYLOPLASM MATIC STERILITY (CMS), MOLECULAR MARKERS AND ITS USES ?.
AU2015288157A1 (en) 2014-07-11 2017-01-19 E. I. Du Pont De Nemours And Company Compositions and methods for producing plants resistant to glyphosate herbicide
MX2017002930A (en) 2014-09-12 2017-06-06 Du Pont Generation of site-specific-integration sites for complex trait loci in corn and soybean, and methods of use.
CA2962419A1 (en) 2014-09-26 2016-03-31 Pioneer Hi-Bred International, Inc. Wheat ms1 polynucleotides, polypeptides, and methods of use
WO2016100309A1 (en) * 2014-12-16 2016-06-23 Pioneer Hi-Bred International, Inc. Restoration of male fertility in wheat
AU2016223151A1 (en) 2015-02-25 2017-08-03 Pioneer Hi-Bred International, Inc. Composition and methods for regulated expression of a guide RNA/Cas endonuclease complex
BR112017017260A2 (en) 2015-03-27 2018-04-17 Du Pont dna constructs, vector, cell, plants, seed, rna expression method, and target site modification method
DE102015004187A1 (en) 2015-04-02 2016-10-06 Kws Saat Se Male sterile plant of the genus Triticum
MX2017014561A (en) 2015-05-15 2018-03-02 Pioneer Hi Bred Int Guide rna/cas endonuclease systems.
WO2017019998A1 (en) * 2015-07-30 2017-02-02 Uwm Research Foundation, Inc. Methods for creating both male and female sterile plants and restoration of fertility
AU2016341041A1 (en) 2015-10-20 2018-03-15 Pioneer Hi-Bred International, Inc. Methods and compositions for marker-free genome modification
WO2017079026A1 (en) 2015-11-06 2017-05-11 E. I. Du Pont De Nemours And Company Generation of complex trait loci in soybean and methods of use
WO2017155714A1 (en) 2016-03-11 2017-09-14 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
DE102016106656A1 (en) 2016-04-12 2017-10-12 Kws Saat Se Nuclear encoded male sterility by mutation in cytochrome P450 oxidase
DE102016015741A1 (en) 2016-04-12 2017-11-30 Kws Saat Se Nuclear encoded male sterility by mutation in cytochrome P450 oxidase
CA3022854A1 (en) 2016-06-14 2017-12-21 Pioneer Hi-Bred International, Inc. Use of cpf1 endonuclease for plant genome modifications
CA3018430A1 (en) 2016-06-20 2017-12-28 Pioneer Hi-Bred International, Inc. Novel cas systems and methods of use
US20200407737A1 (en) 2017-05-03 2020-12-31 KWS SAAT SE & Co. KGaA Use of crispr-cas endonucleases for plant genome engineering
AU2018325363A1 (en) 2017-08-29 2020-04-09 Global Crop Innovations Pty. Ltd. Improved BLue Aleurone and other segregation systems
US10489613B2 (en) 2017-11-15 2019-11-26 Dell Products L.P. System and method of controlling light emissions of displays
US20210105962A1 (en) * 2018-02-22 2021-04-15 Elsoms Developments Ltd Methods and compositions relating to maintainer lines
WO2019165168A1 (en) 2018-02-23 2019-08-29 Pioneer Hi-Bred International, Inc. Novel cas9 orthologs
US10684507B2 (en) 2018-03-19 2020-06-16 Dell Products L.P. System and method of controlling light emissions of displays
US10833692B1 (en) 2018-04-17 2020-11-10 Ali Tasdighi Far Small low glitch current mode analog to digital converters for artificial intelligence
US10862495B1 (en) 2018-04-17 2020-12-08 Ali Tasdighi Far Glitch free current mode analog to digital converters for artificial intelligence
US10581448B1 (en) 2018-05-28 2020-03-03 Ali Tasdighi Far Thermometer current mode analog to digital converter
US10797718B1 (en) 2018-04-17 2020-10-06 Ali Tasdighi Far Tiny low power current mode analog to digital converters for artificial intelligence
CN109161551B (en) * 2018-09-27 2022-07-26 西南大学 Cabbage BoMS1 gene and application thereof in creating sterile materials
CN109566396A (en) * 2018-11-06 2019-04-05 浙江大学 A kind of plant hybridization system and application
CN113166744A (en) 2018-12-14 2021-07-23 先锋国际良种公司 Novel CRISPR-CAS system for genome editing
CN110714022B (en) * 2019-11-25 2023-01-24 中国农业大学 A gene STK1 for pollen competitiveness; 2 and application thereof in improving efficiency of propagating plant nuclear male sterile line
CN111575284A (en) * 2020-05-07 2020-08-25 海南波莲水稻基因科技有限公司 Vector containing oryza sativa promoter and capable of restoring male fertility of rice OsCYP704B2 mutant and application
CN112021176A (en) * 2020-08-06 2020-12-04 西南大学 Breeding method of cabbage type yellow seed rape glyphosate-resistant recessive nuclear sterility temporary maintainer line
CN113088524B (en) * 2021-04-09 2023-03-24 武汉市农业科学院 Separation clone and application of male nuclear sterility gene Brams of pakchoi

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040172684A1 (en) * 2000-05-08 2004-09-02 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4037523A (en) * 1974-11-29 1977-07-26 Karl Eickmann Application of an entering or deep-diving piston shoe with a central radial support member and means for securing the same in fluid handling radial piston devices
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
DK198089D0 (en) * 1989-04-24 1989-04-24 Danske Spritfabrikker DNA MATERIALS AND USE THEREOF
US5689041A (en) 1989-08-10 1997-11-18 Plant Gentic Systems N.V. Plants modified with barstar for fertility restoration
US5432068A (en) 1990-06-12 1995-07-11 Pioneer Hi-Bred International, Inc. Control of male fertility using externally inducible promoter sequences
US5478369A (en) 1990-06-12 1995-12-26 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
GB9015671D0 (en) 1990-07-17 1990-09-05 Pacific Seeds Pty Limited Production of hybrid cereal crops
US5409832A (en) 1990-08-29 1995-04-25 Stratecon Diagnostics International Membrane holder for use in an assay device
US5750867A (en) 1992-06-12 1998-05-12 Plant Genetic Systems, N.V. Maintenance of male-sterile plants
DE69333880T2 (en) 1992-06-12 2006-06-22 Bayer Bioscience N.V. CONSERVATION OF MALE STERILE PLANTS
US5409823A (en) * 1992-09-24 1995-04-25 Ciba-Geigy Corporation Methods for the production of hybrid seed
US6288302B1 (en) 1992-11-04 2001-09-11 National Science Council Of R.O.C. Application of α-amylase gene promoter and signal sequence in the production of recombinant proteins in transgenic plants and transgenic plant seeds
US5470359A (en) 1994-04-21 1995-11-28 Pioneer Hi-Bred Internation, Inc. Regulatory element conferring tapetum specificity
US5837850A (en) 1994-04-21 1998-11-17 Pioneer Hi-Bred International, Inc. Regulatory element conferring tapetum specificity
JPH10504706A (en) 1994-06-06 1998-05-12 プラント・ジェネティック・システムズ・エヌ・ブイ Use of anthocyanin genes for maintenance of male sterile plants
ATE296886T1 (en) 1994-10-28 2005-06-15 Pioneer Hi Bred Int NUCLEOTIDE SEQUENCES PROVIDING MALE FERTILITY AND METHODS FOR USE THEREOF
US5763243A (en) 1994-12-08 1998-06-09 Pioneer Hi-Bred International, Inc. Reversible nuclear genetic system for male sterility in transgenic plants
US5750868A (en) 1994-12-08 1998-05-12 Pioneer Hi-Bred International, Inc. Reversible nuclear genetic system for male sterility in transgenic plants
US6008437A (en) 1995-06-06 1999-12-28 Plant Genetic Systems Use of anthocyanin genes to maintain male sterile plants
KR20000016379A (en) * 1997-04-07 2000-03-25 롤페스 요하네스 게라투스 알베르투스 Bridge driving amplifier and electric communication apparatus
GB9710475D0 (en) 1997-05-21 1997-07-16 Zeneca Ltd Gene silencing
AU744121B2 (en) * 1997-05-30 2002-02-14 Mcgill University Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production
US6037523A (en) 1997-06-23 2000-03-14 Pioneer Hi-Bred International Male tissue-preferred regulatory region and method of using same
US6632980B1 (en) 1997-10-24 2003-10-14 E. I. Du Pont De Nemours And Company Binary viral expression system in plants
PL342856A1 (en) 1998-02-17 2001-07-16 Univ Jefferson Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes
US20030237110A9 (en) * 1998-05-12 2003-12-25 Incyte Pharmaceuticals, Inc. Polynucleotides and polypeptides derived from corn seedling
US20090093620A1 (en) * 2000-09-05 2009-04-09 David Kovalic Annotated Plant Genes
US7868149B2 (en) * 1999-07-20 2011-01-11 Monsanto Technology Llc Plant genome sequence and uses thereof
US20080114160A1 (en) * 2000-10-31 2008-05-15 Andrey Boukharov Plant Genome Sequence and Uses Thereof
US7365185B2 (en) * 2000-07-19 2008-04-29 Monsanto Technology Llc Genomic plant sequences and uses thereof
IL131095A0 (en) 1999-07-25 2001-01-28 Israel State A method for obtaining 100% male sterile plants to serve as the female parent in hybrid seeds production
GB9925459D0 (en) 1999-10-27 1999-12-29 Plant Bioscience Ltd Gene silencing
US6743968B2 (en) 2000-02-28 2004-06-01 Yale University Methods and compositions to reduce or eliminate transmission of a transgene
CZ9936U1 (en) 2000-03-13 2000-04-26 Josef Vavra Floating rescue apparatus
US20110131679A2 (en) * 2000-04-19 2011-06-02 Thomas La Rosa Rice Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US20070016976A1 (en) * 2000-06-23 2007-01-18 Fumiaki Katagiri Plant genes involved in defense against pathogens
US20070067865A1 (en) * 2000-09-05 2007-03-22 Kovalic David K Annotated plant genes
EP1320618B1 (en) 2000-09-26 2012-03-07 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
US7612251B2 (en) 2000-09-26 2009-11-03 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
US7517975B2 (en) 2000-09-26 2009-04-14 Pioneer Hi-Bred International, Inc. Nucleotide sequences mediating male fertility and method of using same
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AU2002248325A1 (en) 2001-01-04 2002-07-16 Fleit, Lois Method to maintain a genic male-sterile female parental lines for the production of hybrid wheat
WO2003000898A1 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Plant genes involved in defense against pathogens
WO2003000905A2 (en) 2001-06-22 2003-01-03 Syngenta Participations Ag Identification and characterization of plant genes
EP1404814B1 (en) * 2001-07-12 2013-06-19 McGill University Nuclear fertility restorer genes and methods of use in plants
ATE488585T1 (en) 2001-08-27 2010-12-15 Syngenta Participations Ag SELF-PROCESSING PLANTS AND PLANT PARTS
US20040016025A1 (en) * 2001-09-26 2004-01-22 Paul Budworth Rice promoters for regulation of plant expression
AU2002364613A1 (en) 2001-12-31 2003-07-24 Yeda Research And Development Co., Ltd A method to maintain a genic male-sterile female parental line of wheat through selfing of the maintainer line
FR2836782B1 (en) 2002-03-08 2004-06-04 Biogemma Fr NOVEL PROCESS FOR PRODUCING HYBRID CORN SEEDS
JP2005185101A (en) * 2002-05-30 2005-07-14 National Institute Of Agrobiological Sciences VEGETABLE FULL-LENGTH cDNA AND UTILIZATION THEREOF
US20060107345A1 (en) * 2003-09-30 2006-05-18 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060150283A1 (en) * 2004-02-13 2006-07-06 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060048240A1 (en) * 2004-04-01 2006-03-02 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
CN104313049A (en) 2003-12-16 2015-01-28 先锋高级育种国际公司 Dominant gene suppression transgenes and methods of using same
JP2007527726A (en) 2004-03-08 2007-10-04 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト Self-processing plants and plant parts
US20060141495A1 (en) * 2004-09-01 2006-06-29 Kunsheng Wu Polymorphic markers and methods of genotyping corn
US7750207B2 (en) * 2004-09-01 2010-07-06 Monsanto Technology Llc Zea mays ribulose bisphosphate carboxylase activase promoter
US20080244765A1 (en) * 2004-12-16 2008-10-02 Pioneer Hi-Bred International, Inc. Methods and compositions for pollination disruption
ATE548811T1 (en) 2008-06-30 2012-03-15 Alcatel Lucent METHOD FOR ALLOCATING PRECODING VECTORS IN A MOBILE CELLULAR NETWORK

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040172684A1 (en) * 2000-05-08 2004-09-02 Kovalic David K. Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Kovalic et al. Accession No AFR23978 (SEQ ID NO:13826 of US 2004/0172684 filed January 2004) *
Wu et al. SEQ ID NO: 5942 of US 7,750,207 effectively filed September 2004 *

Also Published As

Publication number Publication date
US20090183284A1 (en) 2009-07-16
US7893319B2 (en) 2011-02-22
US7875764B2 (en) 2011-01-25
US7888550B2 (en) 2011-02-15
US20100313292A1 (en) 2010-12-09
US20100313293A1 (en) 2010-12-09
US7863500B2 (en) 2011-01-04
US20100017906A1 (en) 2010-01-21
US20140123338A1 (en) 2014-05-01
US20100017905A1 (en) 2010-01-21
US8013218B2 (en) 2011-09-06
US20110173725A1 (en) 2011-07-14
US7893318B2 (en) 2011-02-22
US7759543B2 (en) 2010-07-20
US7893317B2 (en) 2011-02-22
US20060288440A1 (en) 2006-12-21
US20120005792A1 (en) 2012-01-05
US20100017907A1 (en) 2010-01-21
US7759544B2 (en) 2010-07-20
US20110107460A1 (en) 2011-05-05
US8178750B2 (en) 2012-05-15
US20100287655A1 (en) 2010-11-11
US8614367B2 (en) 2013-12-24
US20140215652A1 (en) 2014-07-31
US20100287656A1 (en) 2010-11-11
US20100313294A1 (en) 2010-12-09
US7888551B2 (en) 2011-02-15
US7612251B2 (en) 2009-11-03

Similar Documents

Publication Publication Date Title
US8178750B2 (en) Nucleotide sequences mediating male fertility and method of using same
CA2755369C (en) Nucleotide sequences mediating plant male fertility and method of using same
US8293970B2 (en) MSCA1 nucleotide sequences impacting plant male fertility and method of using same
US9803215B2 (en) MSCA1 nucleotide sequences impacting plant male fertility and method of using same
US8648228B2 (en) MSCA1 nucleotide sequences impacting plant male fertility and method of using same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION